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Abstract	  
 
Equilibrative nucleoside transporter 1 (ENT1) transfers adenosine across plasma membranes. Mice 
lacking ENT1 (ENT1-/-) develop pathological calcification of spinal tissues resembling diffuse 
idiopathic skeletal hyperostosis (DISH) in humans. Our goal was to investigate the mechanism 
underlying ectopic mineralization in ENT1-/- mice. We detected aberrant alkaline phosphatase (ALP, 
promoter of mineralization) activity in the annulus fibrosus (AF) of ENT1-/- mice. In vitro, AF cells 
from ENT1-/- mice exhibited greater ALP activity than cells from wild-type (WT) mice. Inhibition of 
ENT1 in the presence of extracellular adenosine modeled in WT cells the phenotype of ENT1-/- cells. 
We also characterized differences in the AF cell phenotype between WT and ENT1-/- mice using 
transcriptome analysis, revealing the association between activation of cell cycle and B cells with the 
induction of mineralization. In summary, both cell-autonomous and systemic mechanisms contribute 
to ectopic mineralization in ENT1-/- mice, possibly through alterations in ALP distribution and 
activity.   
 
 
 
 
 
 
 
 
 
 
Keywords: Adenosine, alkaline phosphatase, equilibrative nucleoside transporters, intervertebral 
discs, ectopic mineralization 
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INTRODUCTION
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1.1 Nucleobases, nucleosides and nucleotides 
Nucleobases, also known as nitrogenous bases, are the building blocks of DNA, 
RNA, nucleosides and nucleotides. Nucleobases are nitrogen-containing heterocyclic 
compounds that are categorized as either purines (containing two carbon-nitrogen rings) or 
pyrimidines (containing one carbon-nitrogen ring) (1). The primary nucleobases are adenine, 
guanine, cytosine, thymine (DNA only) and uracil (RNA only); where the purine bases are 
adenine and guanine and the pyrimidine bases are cytosine, thymine and uracil.   
Nucleosides (adenosine, guanosine, cytidine, thymidine, and uridine) are purine or 
pyrimidine nucleobases attached to a ribose or 2-deoxyribose pentose sugar (2).  Nucleosides 
are the monomers of nucleic acids (3) and can be phosphorylated by specific kinases to 
become nucleotides (2). Nucleotides, especially adenosine triphosphate (ATP), play central 
roles in energy metabolism, acting as stores of free energy within the cell through high-
energy phosphate bonds (4). Nucleosides and nucleotides are important biological molecules 
essential to numerous processes involved in cell survival (5). Additionally, nucleosides and 
nucleotides can be thought of as more than just an intracellular “high energy” source (e.g. 
nucleoside triphosphate), but also as signaling molecules (2, 5) and intracellular messengers 
(6). 
 
1.2 Nucleoside Transporters 
 Nucleosides are relatively hydrophilic molecules and depend on specific trans-
membrane proteins to shuttle them across the plasma membrane (7). The presence or absence 
of specific transporters has a significant impact on the pharmacokinetics and biological 
activity of nucleosides and nucleobases (8). Two families of solute carrier (SLC) membrane 
transporters are responsible for the transmembrane flux of nucleosides – the sodium-
dependent concentrative nucleoside transporters (CNTs, SLC28A) and the sodium-
independent equilibrative nucleoside transporters (ENTs, SLC29A) (Fig. 1.1). In 
concentrative transport, nucleoside flux is coupled to sodium ions, whereas in equilibrative 
transport, nucleoside flux is dependent on the nucleoside concentration gradient (7). 
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Figure 1.1. Schematic representation of the nucleoside transporter systems including the 
concentrative nucleoside transporters (CNT) and equilibrative nucleoside transporters (ENT). 
CNTs are Na+-dependent symporters that transport nucleosides, such as adenosine (Ado), 
against their concentration gradient. ENTs are Na+-independent, facilitative diffusion 
transporters, which transport nucleosides down their concentration gradient. ENT1 and ENT2 
are distinguished by their sensitivity to inhibition by nitrobenzylthioinosine (NBMPR). 
ENT1 is sensitive to inhibition to NBMPR. In contrast, ENT2 is insensitive to inhibition by 
NBMPR. 
4	  
	  
1.2.1 Concentrative Nucleoside Transport (SLC28A) 
 The concentrative nucleoside transporters (SLC28A family) consist of three sodium-
dependent transporters: CNT1, CNT2 and CNT3 (encoded by the SLC28A1, SLC28A2 and 
SLC28A3 genes, respectively). These proteins transport purines and pyrimidines across the 
plasma membrane against the concentration gradient established by nucleosides. 
 The CNTs are functionally similar; however, they differ based on their substrate 
specificities. CNT1 transports predominantly pyrimidine nucleosides and adenosine (9). 
CNT1 is expressed primarily by epithelial tissues (small intestine, liver and kidney) (10-12), 
localized within cells to the apical membrane to work in concert with ENTs, which are 
primarily localized to the basolateral membrane of these tissues. (13). CNT2 transports 
predominantly purine nucleosides and uridine and is widely expressed in many tissues, 
including the kidney, liver, heart, brain, placenta, pancreas, skeletal muscle, colon, rectum, 
duodenum, jejunum, and ileum in humans (9).CNT3 is broadly selective and transports both 
purine and pyrimidine nucleosides (9, 14). CNT3 is expressed by cells in the pancreas, 
trachea, liver, intestine, lung and bone marrow (14). CNTs are thought to play a critical role 
in salvage pathways of nucleosides and are important in maintaining nucleoside homeostasis 
(9). 
 
1.2.2 Equilibrative Nucleoside Transporters (SLC29A) 
 The SLC29A family consists of four equilibrative nucleoside transporters (ENT1-4) 
which function by sodium-independent facilitated diffusion to transport nucleosides bi-
directionally across the plasma membranes with the concentration gradient (15). All four 
ENTs have the ability to transport adenosine; however, they differ in their abilities to 
transport other nucleosides and nucleobases (15). The predicted topology consistent among 
the ENTs consists of 11 trans-membrane spanning domains with an intracellular N- and an 
extracellular C-terminus (16) (Fig. 1.2).  Within the SLC29A family, ENT1 and ENT2 are 
the most studied and have been characterized on the basis of their sensitivity to the 
pharmacological compound nitrobenylmercaptopurine riboside (NBMPR) as either es (e, 
equilibrative; s, sensitive to inhibition by NBMPR; ENT1) or ei (e, equlibrative; i, insensitive 
to inhibition by NBMPR; ENT2) (7). 
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Figure 1.2. Topographical model of the ENT1 protein structure. (With permission from 
Baldwin et al., 2004, Appendix B) Predicted membrane-spanning helices are numbered. 
Coloured boxes indicate regions implicated in the recognition of the ENT1 inhibitor, 
nitrobenzylthioinosine (NBMPR). 
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1.2.2.1 ENT1 (SLC29A1) 
 Mouse ENT1 (mENT1, encoded by the SLC29A1 gene) is a 460-residue glycoprotein 
that shows 79% identity to the 456-residue human protein (hENT1) (7, 17). ENT1is 
classified as es, almost ubiquitously expressed in human and rodent tissues with transcripts 
detected in the heart, brain, spleen, lung, liver, skeletal muscle, kidney, testis and 
intervertebral disc (17-19). Interestingly, our lab has shown that ENT1 is the primary 
nucleoside transporter in the fibrocartilagenous annulus fibrosus of the intervertebral disc 
(IVD) (20). ENT1 transports purines and pyrimidines with Km values ranging from 40 µM 
(adenosine) to 580 µM (cytidine) (21). ENT1 transport can be inhibited by NBMPR (Ki ~ 5 
nM) (22). 
1.2.2.2 ENT2 (SLC29A2) 
 Mouse ENT2 (mENT2) is a 456-residue protein that shows 88% identity to the 456-
residue human ENT2 (hENT2) (18, 22, 23). Similar to ENT1, ENT2 is expressed almost 
ubiquitously; however, previous studies show that expression of ENT2 is at very low levels 
in cartilaginous tissues such as the knee and IVD (20). ENT2 can transport a broad range of 
purine and pyrimidine nucleosides; however, ENT2 has a lower affinity than ENT1 to 
transport these nucleosides except for inosine (18, 21). ENT2 differs from ENT1 by being 
insensitive to inhibition by NBMPR (23). 
1.2.2.3 ENT3 and ENT4 
 ENT3 and ENT4 are members of the SLC29 family that are the least characterized. 
Mouse ENT3 (mENT3) is a 475-residue protein that shows 74% sequence identity to the 
human homologue (hENT3) (24). The ENT3 transcript and protein is abundant in many 
human and rodent tissues, but is highly expressed in placental tissues (15). Similar to ENT2, 
ENT3 is insensitive to inhibition by NBMPR and is thought to function with lower affinity 
for the nucleosides compared to ENT2 (15). ENT3 has broad selectivity for nucleosides and 
nucleobases, but unlike ENT2, it does not transport hypoxanthine (15, 25). Studies have 
shown that ENT3 activity is pH-dependent (optimal at pH 5.5), which reflects the location of 
the transporter in acidic, intracellular compartments, such as lysosomes (25). Finally, human 
ENT4 (hENT4) is a 530-residue protein that shows 86% sequence identity to the mouse 
homologue (mENT4) (26). Interestingly, ENT4 differs from ENT1 in that it demonstrates 
pH-dependent adenosine transport, which is optimal in both human and mouse at acidic pH 
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(5.5). Unlike the other SLC29 family members, ENT4-mediated nucleoside transport is 
adenosine selective (26).  
 
1.3 Adenosine 
 The purine nucleoside adenosine is one of the most important biological molecules. 
In addition to the well-established role as a component for adenosine triphosphate (ATP), 
extracellular adenosine has been shown to participate in the regulation of a number of 
physiological systems including the central nervous system (e.g. anxiety, ethanol 
consumption, and sleep regulation), cardiovascular system, renal system, pulmonary system 
and immune system (27-33). There has been increasing interest in the role of purinergic 
signaling in the regulation of numerous biological processes, including the effect of 
adenosine metabolism and signaling on musculoskeletal homeostasis (34-36). Alterations in 
purine metabolism have been linked to a number of musculoskeletal pathologies associated 
with either insufficient or ectopic mineralization (see below, Section 1.6) (35, 37-41).  
 
1.3.1 Adenosine bioactivity 
Extracellular adenosine acts as a ligand and can activate the P1 purinergic G protein 
coupled receptors – A1, A2A, A2B, and A3 – to increase or decrease the production of 
intracellular cyclic adenosine monophosphate (cAMP) by adenylyl cyclase (42, 43).  
Although these receptors share the same ligand (adenosine), the effects of specific receptor 
activation differ in their ligand affinity and downstream signaling mechanism (43, 44). The 
A1 and A3 receptors signal through an inhibitory G protein (Gi), resulting in decreased 
intracellular cAMP levels. In contrast, A2A and A2B receptors are coupled to a stimulatory G 
protein (Gs), resulting in increased intracellular cAMP (42, 43). Although adenosine receptor 
signaling is classically thought to occur through the inhibition or stimulation of adenylyl 
cyclase, it is apparent that other pathways, such as phospholipase C (PLC), calcium (Ca2+), 
and mitogen-activated protein kinases (MAPKs) are also interconnected with these adenosine 
receptors (45). In addition to inhibiting cAMP production, A1 and A3 receptor activation 
increases the activity of PLC via Gβγ subunits (45). Furthermore, all four subtypes of 
adenosine receptors have the ability to couple to MAPKs, which could give it a role in cell 
proliferation, differentiation and survival (45, 46). 
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1.4 Connective tissue 
 Connective tissues are a diverse group of tissues that differ based on both 
composition and function. The primary function of connective tissues is to support, anchor or 
connect various tissues. All connective tissues are composed of extracellular matrix, ground 
substance, and cells, which differ in a tissue-specific manner (47). Depending on the 
structural requirements, the portions of these three components vary in a tissue-specific 
manner, based on the physiological function of the connective tissue. The extracellular 
matrix (ECM) is generally composed of various types of fibrous components (collagenous, 
elastic and reticular). The ground substance is made up of glycoaminoglycans (GAGs), 
proteoglycans (PGs) and glycoproteins, to maintain tissue hydration. Finally, the cells of 
connective tissues can either be resident (fibroblasts) or motile (mast cells, macrophages, 
lymphocytes). Specific examples of connective tissues relevant to the current study include 
cartilage, bone, ligaments and intervertebral disc (47). 
 
1.4.1 Cartilage 
 One type of connective tissue is cartilage, which is physically characterized by its 
tissue rigidity and resistance to compression. One of the defining traits of cartilage is that it is 
avascular; chondrocytes are the primary cell type. There are various forms of cartilage 
including hyaline, elastic, and fibrocartilage – each having their own properties (47). More 
than 95% of the cartilage volume consists of ECM, which is the structure that gives this 
tissue its physical properties (48). Despite the low fraction of chondrocytes in the cartilage, 
these cells are responsible for production of the matrix that provides mechanical stability to 
the tissue (47). 
1.4.1.1 Hyaline cartilage, elastic cartilage and fibrocartilage 
 Hyaline cartilage, also known as articular cartilage, is formed by chondrocytes 
embedded in an ECM composed predominantly of type II collagen fibers and glycoproteins, 
like proteoglycans with GAG side chains, that imbibe water enabling the tissue to withstand 
compressive forces (49). It is found on the articular surfaces of synovial joints, the costal 
cartilages of the rib cage, the nasal cavity and the trachea. In early development, hyaline 
cartilage forms the template for the skeleton as precursors for bones that develop by 
endochondral ossification (47, 50-52). 
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 Elastic cartilage is found principally in the external ear, larynx and epiglottis. Elastic 
cartilage is similar in composition to hyaline cartilage in terms of collagen and aggrecan 
content; however, it contains a high content of elastin, which provides the mechanical 
properties enabling the tissue to resist deformation (e.g. stretch and recoil) (47) (53).  
 Fibrocartilage is a specialized tissue that serves the distinct mechanical function of 
providing resistance to compressive, shearing and tensile forces. Fibrocartilage is located 
primarily in transition zones where it serves to anchor tissues with distinct mechanical 
properties together (54).  For example, fibrocartilage forms the menisci of the knee joint and 
the annulus fibrosus of the IVDs and can be found on the ends of tendons and ligaments, 
where they insert into muscle or bone (55-57). To resist complex mechanical loads, 
fibrocartilage is composed of type I collagen lamellae separated by a proteoglycan-rich ECM 
similar to that of hyaline cartilage. Fibrocartilage has dense collagen bundles with cartilage-
like cells occupying lacunae that are arranged in rows between the parallel bundles of 
collagen (47). In many cases, fibrocartilage is a predominantly avascular tissue.  
 
1.4.2 Bone 
 Bone comprises the largest portion of the body’s connective tissue. Unlike most 
connective tissue, bone matrix is mineralized calcium phosphate in the form of 
hydroxyapatite crystals (58). Bone consists of three cell types: 1) the bone-forming 
osteoblasts, which when surrounded by bone matrix become 2) osteocytes, and 3) the bone-
resorbing osteoclasts (58). Bone serves as a physiological storage site for phosphate and 
calcium, important in homeostatic regulation of blood calcium levels. In addition to the 
hydroxyapatite mineral, bone matrix consists of type 1 collagen and glycoproteins that serve 
as the sites of assembly for the mineralized matrix (58). 
1.4.2.1 Role of adenosine in regulation of bone 
Bone development is a dynamic process and requires both osteoblasts and osteoclasts 
to work in concert to actively maintain tissue homeostasis (59, 60). Activation of P1 
receptors, through adenosine signaling effects on osteoclasts and osteoblasts, has previously 
been shown to influence bone homeostasis (35, 61-64). Briefly, long bones from the A1 
receptor knockout mouse showed increased bone mineral density and volume at 6 months of 
age, with no accompanying changes in osteoblast number (62). Similarly, studies showed 
that A1 receptor antagonists inhibited osteoclast formation, leading to the hypothesis that A1 
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receptors are necessary for osteoclast differentiation (62, 63). It has also been reported that 
the A2a receptor plays an important role in osteoclastogenesis. In contrast to the A1 receptors, 
activation of A2a receptors appears to inhibit osteoclast formation (65) and regulates the 
proliferation and differentiation of mouse bone-marrow derived mesenchymal stem cells 
(MSC) (64). Interestingly, of all the adenosine receptors, A2B appear to have the largest 
impact on osteoblast differentiation by regulating the expression of Runx2 and Osterix, 
transcription factors required for MSC to osteoblast differentiation (66, 67). Currently, there 
is little information on the role of A3 receptors in bone homeostasis; however, there is 
evidence for its importance in treating musculoskeletal diseases such as arthritis (34, 68).  In 
rodent models of rheumatoid arthritis, the specific activation of A3 receptor showed 
protective outcomes against the diseases by reducing pannus, fibrosus formation, cartilage, 
and bone destruction (68, 69).  
 
1.4.3 Connective tissues of the axial skeleton 
 The vertebral column is the main structural element of the spine and is composed of 
the vertebrae and the intervertebral discs (IVDs) (Fig. 1.3). The function of the vertebral 
column is to provide rigidity to the axial skeleton while permitting for limited rotation and 
bending. The vertebral bodies are the osseous elements, which provide the rigidity to the 
spine. The IVDs serve to anchor adjacent vertebral bodies along the spinal column. IVDs are 
essential for stabilization of the spine and load bearing during axial compression. 
Surrounding the vertebral column are supporting ligaments, which provide passive stability 
(70). In mice, the vertebral column is divided into five distinct regions: cervical (7 vertebrae), 
thoracic (13 vertebrae), lumbar (6 vertebrae), sacral (4 fused vertebrae), and caudal (24-28 
vertebrae) from anterior to posterior (70). 
1.4.3.1 Paraspinal ligaments 
 Ligaments are a type of dense connective tissue composed of collagenous fibers. The 
two main types of spinal ligaments are the anterior longitudinal ligament (ALL) and the 
poster longitudinal ligament (PLL) (71). The ALL is a broad fibrous band on the anterior 
aspect of the vertebral column, whereas the PLL is a narrower and weaker band on the 
posterior aspect of the vertebral body (71). Both the ALL and PLL are well innervated and 
merge with the annulus fibrosus at each IVD (71, 72). 
11	  
	  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3. Schematic representation of the vertebral column and associated paraspinal 
ligaments. Schematic shows the orientation of paraspinal ligaments that provide structural 
strength, flexibility and stability to the vertebral column. Paraspinal ligaments include the 
anterior longitudinal ligament, posterior longitudinal ligament, ligamentum flavum, 
intertransverse ligament, supraspinous ligament, interspinous ligament, and the facet 
capsulary ligament (Reproduced from Eidelson, 2002). 
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1.4.3.2 Intervertebral discs 
 The IVDs are specialized fibrocartilagenous structures responsible for absorbing 
compressive, tensile and torsional strain on the axial skeleton (73, 74). The IVDs are 
composed of three distinct tissues: 1) the nucleus pulposus (NP); 2) the annulus fibrosus 
(AF); and 3) superior and inferior cartilage endplates (CEP) (70) (Fig. 1.4).  
 The NP is a highly hydrated gelatinous tissue in the center of the IVD, which serves 
to absorb compressive loading on the axial skeleton (49, 75). The NP is derived from the 
early embryonic notochord (75) and is composed of the proteoglycans, type II collagen and 
elastin fibers (49, 76). The major proteoglycan of the IVD is aggrecan, which contains 
approximately 100 chondroitin sulfate-glycosaminoglycans (CS-GAGs) chains. Each of 
these chains contains one sulfonic and one carboxylic group, resulting in the GAG holding a 
negative charge in physiological conditions (77). Through these negative charges, the NP has 
the ability to create the osmotic environment responsible for the tissues ability to resist 
compressive loads and to maintain height and turgor (49, 76, 77). 
 The AF is a fibrocartilage structure composed predominantly of type I collagen fibers 
organized in concentric lamellae (78). The AF encapsulates the NP and serves to resist 
tensile and torsional strains (74, 79). The AF consists of two distinct regions: the inner 
annulus fibrosus (IAF) and outer annulus fibrosus (OAF). The cells of the OAF have been 
described as more fibroblast-like, where the OAF is comprised of type I collagen.  The 
ligament-like structure of the OAF serves to anchor the IVD to the adjacent vertebral bodies 
(70, 80). In contrast, cells of the IAF display a chondrocyte-like appearance, located within 
lacunae surrounded by a PG-rich ECM (80). The IAF is rich in type I and II collagen and 
serves as a transition zone between the NP and AF (81). 
 The CEP exists above and below the IVD between adjacent vertebrae. The CEP 
consists of a thin layer of hyaline cartilage (70). The CEP is rich in type II collagen and 
proteoglycans and is a gateway for nutrients and waste products to exchange between the 
IVD and underlying bone. (82). The IVD receives nutrients via diffusion from blood vessels 
in the vertebral body to the AF and NP (83).  
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Figure 1.4. Schematic representation of an intervertebral disc (IVD). The IVD consists of 
three distinct tissues: 1) the gelatinous nucleus pulposus (centre), 2) the surrounding 
fibrocartilagenous annulus fibrosus, and 3) the cartilage endplates that connect the disc both 
superiorly and inferiorly to the vertebral bodies (Modified from Neumann, 2010). 
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1.5 Extracellular matrix calcification 
 Mineralization is a tightly controlled process; in physiological conditions it is 
restricted to the bone, teeth and growth plate cartilage (37). For mineralization to occur, there 
must be extracellular matrix molecules (e.g. type 1 collagen), an abundance of calcium and 
inorganic phosphate (Pi) as substrates for mineralization, and low levels of inhibitors of 
extracellular mineralization.  
 
1.5.1 Physiological matrix mineralization 
 Two fundamental models have been proposed to explain the regulation of matrix 
mineralization: the cell-mediated model and the extracellular matrix-mediated model (84). In 
the cell-mediated model, it is proposed that osteoblasts secrete matrix vesicles (MVs), which 
act as primary sites of mineral deposition (84, 85). MVs contain enzymes, such as alkaline 
phosphatase (ALP), that enable the local accumulation of calcium and Pi to allow for 
crystallization of calcium phosphate (84). Additionally, the matrix vesicles contain 
hydroxyapatite, which acts as a site of nucleation enabling rapid growth and accumulation of 
calcium phosphate crystals (84-86). It is proposed that once the crystals reach a certain size 
within MVs, they rupture and act as sites of nucleation for rapid growth of mineral (86, 87). 
In the extracellular matrix-mediated model, mineralization occurs in the absence of cell-
generated matrix vesicles (88). Proponents of this model suggest that once there is Ca2+ and 
Pi, mineralization is an inherent property of the extracellular matrix and initiates in the space 
between collagen fibrils. These spaces between collagen fibrils are proposed to act as sites of 
nucleation for mineral deposition to accumulate (88). 
 
1.5.2 Proteins involved in matrix mineralization 
The mineralization inhibitors matrix gla protein (MGP), ectonucleotide 
pyrophosphatase (ENPP1), osteopontin (SPP1) and the progressive ankylosis protein (ANK) 
interfere with mineral deposition (41, 89-92) (Fig 1.5). Briefly, MGP affects mineralization 
by binding to bone morphogenetic proteins (BMPs, growth factors that promote 
mineralization) and inhibiting their function (89). ENPP1 and ANK are both transmembrane 
proteins, which function to increase extracellular pyrophosphate (PPi), an inhibitor of 
mineralization. PPi is a potent mineral-binding, small molecule that prevents the nucleation 
and growth of calcium phosphate crystals (93). ENPP1 is an ecto-enzyme responsible for the 
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hydrolysis of ATP to adenosine monophosphate (AMP) and PPi, whereas ANK is a putative 
PPi efflux transporter (41, 92).   
Equally important to the regulation of mineralization are proteins such as bone 
sialoprotein (BSP) and alkaline phosphatase (ALP), which serve to promote matrix 
mineralization (38, 94-96). BSP is a matrix protein that is highly expressed and largely 
restricted to cells directly involved in the formation of mineralized tissues (97). In vitro 
studies have demonstrated that BSP serves as a potent nucleator of hydroxyapatite formation 
and is thought to promote mineralization during de novo bone synthesis (96, 98, 99). ALP is 
a metalloenzyme tethered to the cell-surface of the plasma membrane through a phosphatidyl 
inositol-glycophospholipid (GPI) anchor (100). ALP increases the extracellular concentration 
of Pi through hydrolysis of the mineralization inhibitor PPi (38, 94). Several studies have 
established that ALP is critical for mineralization. Loss-of-function mutations in humans or 
loss of alkaline phosphatase in a knockout mouse model result in reduced bone 
mineralization, characteristic of hypophosphatasia (38, 94, 95).  
 
1.5.3 Effects of adenosine on alkaline phosphatase activity and tissue mineralization 
 Previous studies have elucidated the mechanisms by which ALP expression and 
activity is regulated and established the critical role of BMP and WNT signaling in these 
processes (101-103). BMP and canonical WNT signaling are interconnected since BMP-2 
increases the expression of β-catenin, a downstream effector of WNT signaling. Furthermore, 
WNT signaling, through β-catenin, can induce the expression and activity of ALP in MSC 
(103). In addition to these mechanisms, adenosine signaling has been investigated for its 
ability to regulate the differentiation of cells to osteogenic lineages and its direct influence on 
ALP activity (35, 36, 67, 104). Interestingly, adenosine-mediated A1 stimulation can enhance 
the osteogenic differentiation of human dental pulp-derived mesenchymal stem cells (105).  
These studies established that ALP activity was increased following adenosine-mediated A1 
stimulation (101). Similarly, other groups have shown that the stimulation of the A2A and A2B 
receptors by adenosine analogues results in an increase in ALP activity and promotes 
osteogenic differentiation of mesenchymal stem cells (66, 105, 106). These studies 
demonstrate the potential of purinergic signaling in the regulation of bone homeostasis and 
establish the relationship between adenosine receptor stimulation and the regulation of 
alkaline phosphatase activity in vitro. 
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Figure 1.5. Schematic representation of pathways influencing biomineralization. Adenosine 
can regulate cell behaviour through cell surface receptors. Adenosine is primarily 
metabolised or converted by adenosine kinase (ADK) or adenosine deaminase (ADA). ADK 
is the enzyme that catalyzes the transfer of a phosphate from ATP to adenosine to form 
AMP. Ecto-5’-nucleotidase (Nt5e) generates adenosine from the breakdown of AMP. 
Conversely, ADA metabolizes adenosine to inosine. ATP is released into the extracellular 
fluid and is subsequently metabolized by cell-surface enzymes. Ectonucleotide 
pyrophosphatase/phosphodiesterase 1 (ENPP1) metabolizes ATP into AMP and inorganic 
pyrophosphate (PPi), an inhibitor of mineralization. Extracellular PPi is also regulated by the 
progressive ankylosis protein (ANK), a transporter that mediates the efflux of PPi. PPi is 
metabolized by another cell surface enzyme, alkaline phosphatase (ALP), which produces 
inorganic phosphate (Pi), a substrate required for mineralization. The presence of Pi and 
Calcium (Ca2+) promotes crystallization to form of calcium phosphate mineral. Additionally, 
biomineralization is also regulated by the mineralization inhibitors matrix Gla protein (MGP) 
and osteopontin (SPP1). 
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1.6 Disorders of ectopic tissue mineralization 
 As previously described (see Section 1.4), physiological tissue mineralization is 
regulated by an intricate balance between the expression of promoters and inhibitors of 
mineralization. When the balance between these factors is disrupted, pathologic 
mineralization results in both animal models and humans (37). Many pathologic conditions 
of ectopic mineralization occur when there is an imbalance in promoters and inhibitors of 
mineralization or an imbalance in the ratio of PPi/Pi (41, 107). Interestingly, the induction of 
pathologic mineralization is also associated with alterations in the expression and/or activity 
of nucleoside transporters. Recent reports described that in human populations, a mutation in 
the splice site (c.589+1G>C) in SLC29A1 resulted in non-functional ENT1, which was 
associated with ectopic mineral formation around the joints of the hand, hips and lumbar 
IVDs (108). Similarly, our group previously reported that mice lacking ENT1 demonstrate 
progressive ectopic mineralization of spinal tissues (described in detail below, Section 1.7) 
(19). 
 
1.6.1 Vascular calcification  
 One example of ectopic mineralization is the progressive accumulation of calcium 
deposits in arteries, known as vascular calcification (109). Vascular calcification was 
originally thought to be a passive process; however, it has been established that vascular 
calcification is tightly regulated by the activity of inhibitors and promoters of mineralization 
(109, 110). For example, mice deficient in the expression of either matrix gla protein or 
osteopontin (inhibitors of mineralization) demonstrate spontaneous vascular calcification (41, 
111).  
 
1.6.2 Ossification of the posterior longitudinal ligament (OPLL) 
 Ossification of the posterior longitudinal ligament (OPLL) is a disorder characterized 
by abnormal calcification of the posterior longitudinal ligament (112). OPLL is prevalent in 
the Japanese population and is associated with many diseases, including diffuse idiopathic 
skeletal hyperostosis (DISH), ankylosing spondylitis, and other spondyloarthropathies (113). 
OPLL is commonly detected in the cervical region of the spine; however, its pathogenesis is 
poorly understood (113). Several studies have reported genetic associations with OPLL, 
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including mutations in collagen 11A2 (COL11A2)(114), collagen 6A1 (Col6A1) (112) and 
nucleotide pyrophosphatases (115). 
 
1.6.3 Diffuse idiopathic skeletal hyperostosis (DISH) 
 Diffuse idiopathic skeletal hyperostosis (DISH, previously known as Forestier’s 
disease (116)) is a common progressive disorder  characterized by spinal stiffness, back pain 
and, in severe cases, dysphagia (117-120). DISH involves the pathologic calcification of the 
anterolateral spinal ligaments, at ligamentous attachments known as entheses, and 
periarticular soft tissues (116, 118, 120). Affecting approximately 10% of the general 
population, the Arthritis Society lists DISH as the second most common form of arthritis after 
osteoarthritis. This disease progresses with age, affecting approximately 38% of men and 
12% of women over the age of 80 (121). The etiology of DISH is poorly understood, likely 
since in early stages this disease is largely asymptomatic (122). Currently, the diagnosis of 
DISH is based on specific radiographic criteria: 1) flowing calcifications along the 
anterolateral aspect of at least four contiguous vertebral bodies; 2) preservation of disc height 
in the involved vertebral segments without degenerative disc disease; and 3) absence of bone 
ankylosis of facet joints and absence of sacroiliac erosions or intra-articular osseous fusion 
(116).  
 To date there are no genetic defects associated with DISH; however, a correlation has 
been reported between a patient population with a single nucleotide polymorphism in the 
COL6A1 gene and the presentation of DISH (112). Although there is no definitive 
mechanism associated with the induction or progression of DISH, studies have begun to 
establish an association between the clinical presentation of DISH and alterations in 
endogenous inhibitors of mineralization such as dickkopf-1 (DKK1) and matrix gla protein 
(MGP). These studies showed that serum DKK1 levels were decreased in patients with 
DISH, where lower levels of DKK1 were associated with increased severity of DISH. (123). 
In contrast, a study showed increased serum concentrations of MGP in DISH patients (124).  
 
1.7 ENT1-/- mouse model 
The ENT1-/- mouse was originally developed by Dr. Doo-Sup Choi at the Mayo 
Clinic College of Medicine by deleting exon coding regions 2-4, eliminating 425 of the 1,380 
base pairs in the protein-coding region and producing a non-functional truncated protein (28). 
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These mice were originally used to study the role of adenosine transport in regulating ethanol 
consumption (28). In these studies, ENT1-/- mice were found to consume higher amounts of 
ethanol and this effect was mediated by a reduction in A1 receptor stimulation (28). 
Subsequent studies showed that ENT1-/- mice demonstrate reduced anxiety (29) and also 
some interesting skeletal phenotypes, such as ectopic mineralization and reduced bone 
mineral density, as the mice age (19, 125). 
Our lab previously characterized the skeletal phenotype of ENT1-/- mice and reported 
a striking resemblance to the clinical presentation of DISH. ENT1-/- mice demonstrated 
ectopic mineral formation in the paraspinal ligaments and rib enthuses as early as 2 months 
of age. Mineralization of spinal tissues progressed with age, localizing to the AF of the IVD 
at 6 months of age. At 12 months of age, ENT1-/- mice displayed signs of spine stiffness, hind 
limb dysfunction and paralysis. Histological examination revealed irregular accumulations of 
eosinophillic material affecting fibrocartilagenous structures of the spine (19). Serum 
analysis of ENT1-/- mice revealed elevated adenosine and inorganic pyrophosphate, 
indicating a potential role for adenosine-mediated signaling and the disruption of 
pyrophosphate homeostasis in the induction of ectopic mineralization (19). Interestingly, 
more recent studies by Hinton et al., reported that ENT1-/- mice showed reduced bone mineral 
density in the vertebrae of the thoracic and lumbar spine compared to wild-type controls 
(125). These studies reveal the importance of ENT1 in skeletal pathologies associated with 
ectopic mineralization; however, the mechanism linking loss of ENT1 function with the 
induction of tissue mineralization is not understood.  
 
1.8 Rationale, Objectives and Hypothesis 
Recent studies by our group reported a novel mouse model of DISH (19). Mice 
lacking the expression of equilibrative nucleoside transporter 1 demonstrate progressive 
ectopic mineralization of fibrocartilagenous tissues of the spine, including the annulus 
fibrosus of the intervertebral disc (IVD), resembling the clinical presentation of DISH (19). 
Our group also established that ENT1 is the primary nucleoside transporter in annulus 
fibrosus cells of the IVD (20). Together, with elevated plasma adenosine observed in ENT1-/- 
mice (19), these findings suggest both cell-autonomous and systemic mechanisms contribute 
to the ectopic mineralization observed in ENT1-/- mice. 
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1.8.1 Hypothesis 
Ectopic mineralization of spinal tissues in ENT1-/- mice is caused by altered levels of 
adenosine and can be modeled in vitro following exposure of intervertebral disc cells to 
elevated extracellular adenosine. 
 
1.8.2 Specific Objectives 
Objective 1: To investigate the role of adenosine signaling and alkaline phosphatase activity 
in ectopic calcification of the IVD. 
Objective 2: To examine alterations in the annulus fibrosus cell phenotype between ENT1-/- 
and WT mice using global transcriptome analysis. 
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CHAPTER 2 
 
Role of Alkaline Phosphatase in the ectopic mineralization 
of spinal tissues induced by loss of ENT1  
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2.1 Introduction 
Diffuse idiopathic skeletal hyperostosis (DISH) is a non-inflammatory 
spondyloarthropathy that involves ectopic calcification of soft tissues along the vertebrae of 
the spine (1-3). Often asymptomatic in the early stages of disease, DISH leads to spinal 
stiffness, susceptibility to spinal fractures and, in severe cases, dysphagia (4-7). DISH is 
diagnosed based on specific radiographic criteria: i) flowing calcifications along the 
anterolateral aspect of at least four contiguous vertebral bodies; ii) preservation of disc height 
in the involved vertebral segments without signs of degenerative disc disease; and iii) 
absence of bone ankylosis of facet joints, sacroiliac erosions or intra-articular osseous fusion 
(8). The Arthritis Society lists DISH as the second most common form of arthritis after 
osteoarthritis. DISH affects approximately 10% of the general population, and is more 
prevalent in men (22%) than in women (4.8%) (9). This disease progresses with age, 
affecting approximately 38% of men and 12% of women over the age of 80 (9). The etiology 
of DISH is a poorly understood; however, numerous studies have associated obesity, 
hypertension, diabetes mellitus and dyslipidemia with DISH (10-12).  
Recent studies by our group reported a novel mouse model of DISH (13). Mice 
lacking expression of equilibrative nucleoside transporter 1 (ENT1, also known as solute 
carrier family 29 member 1, encoded by the Slc29a1 locus) were found to demonstrate 
progressive ectopic mineralization of spinal tissues (13), resembling the clinical presentation 
of DISH in humans. ENT1, one of the four members of the SLC29 family, is a bi-directional 
transporter responsible for the facilitated diffusion of hydrophilic nucleosides, such as 
adenosine, across the plasma membrane (14, 15). ENT1-/- mice exhibit ectopic mineral 
formation in the paraspinal ligaments and rib entheses, as early as 2 months of age, with 
mineralized lesions present within the annulus fibrosus (AF) of the intervertebral disc (IVD) 
by 6 months of age. By 12 months of age, mineralization in ENT1-/- mice progressed to 
involve >60% of the appendicular spine leading to spine stiffness, hind limb dysfunction and 
paralysis. Histological examination revealed irregular accumulations of eosinophilic material 
within fibrocartilaginous structures, including the paraspinal ligaments and entheses, the AF 
of IVDs and the sternocostal articulations (13).  
Subsequent studies from our group (16) demonstrated that IVD tissues of ENT1-/- 
mice exhibit deregulation of the pathways that regulate biomineralization. At the level of 
gene expression, IVD tissues from ENT1-/- mice showed less expression of the mineralization 
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inhibitors matrix Gla protein (Mgp), ectonucleotide pyrophosphatase/phosphodiesterase 1 
(Enpp1) and osteopontin (Spp1) than IVD tissues from wild-type (WT) mice (16). On the 
other hand, expression of tissue non-specific alkaline phosphatase (Alpl), which promotes 
mineral formation (17, 18), was also suppressed in IVD tissues from ENT1-/- compared to 
WT mice. Alkaline phosphatase (ALP) is responsible for metabolism of the mineralization 
inhibitor inorganic pyrophosphate (PPi) into inorganic phosphate (Pi), thus supplying a 
source of phosphate for mineral formation (19-21). Interestingly, our previous 
characterization of the ENT1-/- mouse also showed significant increase in plasma PPi 
compared to WT controls, suggesting a potential deregulation of pyrophosphate metabolism.  
Consistent with the loss of ENT1, plasma levels of adenosine were greater in ENT1-/- 
mice than in WT mice (13). Thus, it is possible that the aberrant mineralization observed in 
ENT1-/- mice may also be associated with altered adenosine signaling. The role of adenosine 
in the induction of mineralization in bone has been well characterized (22); however, the 
effect of adenosine signaling in fibrocartilaginous tissues of the spine remains unexplored. 
Previous studies have demonstrated that adenosine signaling through its receptors induces 
expression of ALP and regulates processes involved in osteoblast differentiation and tissue 
mineralization (23). Moreover, stimulation of the A1 adenosine receptor promotes 
differentiation of human dental-pulp mesenchymal stem cells to an osteogenic lineage, and 
increases ALP activity (24). Similarly, other groups have shown that specific activation of 
the A2A and A2B adenosine receptors promotes the differentiation of mesenchymal stem cells 
to osteoblasts, and increases ALP activity in vitro (24-26). 
Our recent studies demonstrated that ENT1 is the primary nucleoside transporter in 
AF cells of the IVD (16); however, the mechanism linking loss of ENT1 function to the 
induction of ectopic mineralization remains unknown. To better understand mechanisms that 
induce ectopic mineralization in ENT1-/- mice, we investigated the role of adenosine. In this 
paper, we report that AF cells from ENT1-/- mice show increased ALP activity compared to 
WT, both in vivo and in vitro. Using an in vitro micromass culture system, we also 
demonstrate that pharmacological inhibition of ENT1 in the presence of elevated 
extracellular adenosine increased ALP activity in WT AF cells, recapitulating in part the 
phenotype observed in ENT1-/- cells. Moreover, we show that, in culture, AF cells lacking 
ENT1 have greater intracellular adenosine levels compared to WT cells. Thus, our results 
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suggest that cell-autonomous mechanisms contribute to the formation of ectopic mineral in 
the AF of ENT1-/- mice, possibly through alterations in the distribution and activity of ALP.   
 
2.2 Methods 
2.2.1 Animals 
ENT1-/- mice generated by deletion of exons 2-4 of the gene encoding ENT1 were 
generously provided by Dr. Doo-Sup Choi (Mayo Clinic College of Medicine, Rochester, 
MN, USA) (27). ENT1-/- mice were backcrossed with C57BL/6 mice and the colony was 
maintained by breeding heterozygote mice (ENT1+/-) to obtain wild-type (ENT1+/+) and 
knock-out (ENT1-/-) littermate mice. Genotyping was performed, as previously described 
(13). Mice were housed in standard cages and maintained on a 12 h light/dark cycle, with 
rodent chow and water available ad libitum. Male and female mice were sacrificed at 2 or 6 
months of age and spinal tissues were used for histological analysis or IVD cell isolation. All 
aspects of this study were conducted in accordance with the policies and guidelines of the 
Canadian Council on Animal Care and were approved by the Animal Use Subcommittee of 
the University of Western Ontario (protocol 2009-050). 
 
2.2.2 Detection of ALP activity in situ 
Intact cervical IVDs were isolated from 6-month-old WT and ENT1-/- mice, inclusive 
of nucleus pulposus (NP), annulus fibrosus (AF), and cartilage endplates (CEP). ALP activity 
was assessed using azo dye histochemical staining (Sigma), as previously reported (28). 
Briefly, the samples were fixed overnight in 10% formalin. Tissues were rinsed three times 
with phosphate-buffered saline (PBS) and incubated in 30% sucrose (in PBS) overnight. 
IVDs tissues were rapidly frozen in OCT (Tissue-Tek, Netherlands) and stored at -80°C. 
Eight to ten µm-thick serial sections were cut using a Leica CM 1900 UV Routine Diagnostic 
cryostat in the coronal plane, mounted on glass slides and air-dried. Sections were incubated 
in 200 µL azo dye solution (3 mg naphthol AS-MX phosphate, dissolved in 20 µL dimethyl 
sulfoxide and 10 mg of Fast Blue BB salt, and brought to a final volume of 10 mL with 0.2 
M Tris buffer, pH 9.2) for 10 min at room temperature. The stain was aspirated and slides 
were washed with distilled H2O. Slides were air-dried and mounted with aqueous mounting 
medium (Dako, Carpinteria, CA) and imaged using a Leica DM1000 microscope coupled to 
a Leica DFC295 camera.  
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2.2.3 Cell isolation and culture  
IVDs from the cervical, thoracic, lumbar and caudal regions were microdissected and 
pooled from wild-type and ENT1-/- mice at 2 months of age. The nucleus pulposus was 
removed from isolated IVDs and the AF tissue was retained. AF tissue was then minced and 
cells were isolated by enzymatic digestion in 0.2% type-2 collagenase (Worthington 
Biochemical Corp., Lakewood, NJ) for 45 min at 37°C, triturating the minced tissue after 20 
min to mechanically dissociate cells. The cell suspension was filtered through a 100 µm 
sterile mesh and seeded at 8 x 105 cells/cm2 in DMEM-F12, 10% FBS, 1% 
penicillin/streptomycin. After 6-7 days AF cells were trypsinized and plated in either 
monolayer or micromass cultures (passage 1). Monolayer cultures were plated at 5 x 104 
cells/cm2 and medium was changed every other day. For micromass cultures, 5 x 104 cells 
were plated in an initial volume of 150 µL in the center of each well in a 12-well dish. 24 
hours after plating, the volume was increased to 1 mL. The cells grew in DMEM-F12, 10% 
FBS, 1% penicillin/streptomycin for 4 days to establish a high-density culture. To promote 
matrix synthesis and permit mineralization, micromass culture medium was supplemented 
with 50 µg/mL ascorbic acid and 2 mM β-glycerophosphate after the initial 4 days in culture. 
Cultures were maintained up to 3 weeks with medium replaced daily. 
 
2.2.4 Tissue isolation, RNA extraction and real-time PCR 
Intact IVDs were microdissected from the cervical, thoracic, lumbar and caudal 
regions from 2-month-old wild-type and ENT1-/- mice and placed in 1 mL of TRIzol reagent 
(Invitrogen, Life Technologies). Tissues were homogenized using a Polytron® benchtop 
homogenizer and stored at -80°C. AF cell cultures were harvested in 0.5 mL of TRIzol 
reagent (Invitrogen). RNA was extracted according to the manufacturer’s protocol and 
quantified using NanoDrop 2000 spectrophotometer (Thermo Scientific, Pittsburg, PA, 
USA). cDNA synthesis was performed using the iScript cDNA synthesis kit (Bio-Rad, 
Philadelphia, PA) from 500 ng RNA/sample. Gene expression was determined by real-time 
PCR using the Bio-Rad CFX384 system. PCR reactions were run using 310 nM forward and 
reverse primers (sequences provided in Table 2.1) with SsoFast™ EvaGreen® Supermix 
(Bio-Rad). The PCR program consisted of the following: initial 3 min at 95ºC for denaturing; 
95ºC for 10 s denaturing; 30 s annealing/elongation, for a total of 40 cycles. For all genes 
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assessed, transcript levels were determined relative to a six-point calibration curve made 
from pooled cDNA generated from wild-type murine heart, brain, kidney, muscle, IVD, and 
calvarial RNA.  
 
2.2.5 Detection of ALP activity in vitro 
AF cell micromass cultures were fixed with 4% formalin overnight at 4ºC. ALP 
activity was detected cytochemically, as previously described (29) following incubation with 
0.25 mM naphthol AS-MX phosphate and 1.25 mM Fast Red B salt (Sigma-Aldrich, St. 
Louis, MO) in 0.1 M Tris-HCL, pH 8, for 1 h in the dark. To detect mineral deposition, the 
same cultures were stained with 2.5% wt/vol silver nitrate solution (Electron Microscopy 
Sciences, Hatfield, PA) (von Kossa staining) for 1 h with exposure to light. Images of 
micromass cultures were captured using a SMZ1500 Nikon microscope attached to a charge-
coupled device camera (CoolSNAP; Roper Scientific). ALP-positive areas were quantified 
from 5 fields of view per well; n = 4 cell preparations / genotype. The size of the acquisition 
field and color balance were standardized and 2D images were analyzed using Image Master 
software (Photon Technology International, London, ON, Canada). 
 
2.2.6 Measurement of intracellular adenosine 
Confluent monolayer cultures of AF cells (passage 1; 4 days in culture) were scraped 
in 1 mL ice-cold PBS containing 13C5-adenosine (5 µM) as an internal standard,                   
5-iodotubercidin (10 µM) to inhibit adenosine kinase, and erythro-9-(2-hydroxy-3-nonyl) 
adenine hydrochloride (EHNA, 100 µM) to inhibit adenosine deaminase.  The cell lysate was 
sonicated for 10 min and sedimented for 5 min at 14,000 rpm. Adenosine was extracted from 
cell lysates using solid phase extraction as described previously (30). Briefly, Strata-X 
Polymeric Reverse Phase SPE cartridges (C18, 33 µm, Phenomenex, Torrance, CA) were 
conditioned according to manufacturer’s guidelines. Cell lysate   (500 µL) was added to SPE 
cartridges along with 500 µL of 13C5-adenosine (5 µM) in PBS for use as an internal 
standard. SPE cartridges were washed with 1 mL water and analytes were eluted into a clean 
glass tube with 1 mL methanol containing 0.1% trifluoroacetic acid. The eluent was dried, 
reconstituted in mobile phase and injected onto a Waters Cortecs UPLC C18+ column (1.6 
µm, 50 x 2.1 mm) maintained at 40°C in a Waters Acquity I-Class UPLCTM (Waters,  
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Table 2.1: Real-time PCR Primer Sequences 
Gene 
Name 
Primer Sequence (5’ to 3’) Annealing/ Elongation 
temperature (°C) 
Alpl Fwd – CCAACTCTTTTGTGCCAGAGAA  
 Rev – GGCTACATTGGTGTTGAGCTTTT 
60 
 
Ank Fwd – CCCTGATAGCCTACAGTGACTTAGG  
 Rev – GAAGGCAGCGAGATACAGGAA 
60 
Cd24 Fwd – ACCCACGCAGATTTACTGCAA 
  Rev – CCCCTCTGGTGGTAGCGTTA 
60 
Ck19 Fwd – GTTCAGTACGCATTGGGTCAG 
 Rev – GAGGAACGAGGTCACGAAGC 
60 
Col1a1 Fwd – CTGGCGGTTCAGGTCCAAT 
 Rev – TCCAGGCAATCCAGGAGC 
60 
Col2a1 Fwd – GCACATCTGGTTTGGAGAGACC 
Rev – TAGCGGTGTTGGGAGCCA 
60 
Col10a1 Fwd – GGGACCCCAAGGACCTAAAG  
 Rev – GCCCAACTAGACCTATCTCACCT 
60 
Enpp1 Fwd – CAAAACCCACAATGACTGTTGC  
 Rev – CTGGACACTCCGGGGTATCG 
56 
Gdf10 Fwd – GAAGTACAACCGAAGAGGTGC  
 Rev – AGGCTTTTGGTCGATCATTTCC 
60 
Ibsp Fwd – ACGGCGATAGTTCCGAAGAG  
 Rev – CTAGCTGTTACACCCGAGAGT 
60 
Mgp Fwd – GGCAACCCTGTGCTACGAAT  
 Rev – CCTGGACTCTCTTTTGGGCTTTA 
56 
Prg4 Fwd - GGGTGGAAAATACTTCCCGTC 
 Rev – CAGGACAGCACTCCATGTAGT 
60 
Spp1 Fwd - AAGCAAGAAACTCTTCCAAGCAA  
 Rev – GTGAGATTCGTCAGATTCATCCG 
56 
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Milford, MA). Mobile phase flow rate was set to 0.7 mL/min and consisted of water (A) and 
acetonitrile (B) containing 0.1% formic acid.  The ultra-performance liquid chromatography 
(UPLC) conditions were as follows: 0-0.5 min, 0%B; 0.5-2.0 min, 0-5%B; 2.0-3.0 min, 
80%B; 3.0-4.0 min, 0%B. Tandem mass spectrometry was performed using a Waters XevoTM  
G2S-QTofMS (Waters, Milford, MA). Analytes were measured in positive electrospray 
mode with capillary voltage and cone voltage set at 2 kV and 40 V, respectively. The source 
temperature was 150°C.  The desolvation gas flow was set to 1200 L/h at 600°C and the cone 
gas flow was 50 L/h. The data was acquired in centroid mode using the lockspray to ensure 
mass accuracy. Leucine-enkephalin (500 ng/mL) was used as the lockmass set at a flow rate 
of 10 µL/min, measured every 10 s and averaged over 3 scans. Adenosine and 13C5-adenosine 
ions were measured at 268.1046 m/z and 273.1214 m/z, respectively, using QuanLynx within 
the Waters MassLynx v4.1 software. 
 
2.2.7 Measurement of intracellular cAMP 
AF cells (passage 1) were plated in monolayer at 6.8 x 104 cells/cm2 in DMEM-F12, 
10% FBS, 1% penicillin/streptomycin. Following 2 days in culture, cells were serum-starved 
for 24 h. The cells were then incubated with 3-isobutyl-1-methylxanthine (IBMX, 0.5 mM) 
in DMEM-F12 for 20 min, followed by treatment in the presence or absence of forskolin (10 
µM) in DMEM-F12 containing IBMX for 10 min. Intracellular cAMP was then determined 
using the cAMP-Screen® System (Applied Biosystems), according to the manufacturer’s 
protocol. The plate was read on a luminometer (LMAX II microplate reader, Molecular 
Devices) at 470 nm. cAMP levels were interpolated from a 6 point standard curve (n ≥ 3 cell 
preparations  of each genotype).  
 
2.2.8 Statistical analyses 
Data are presented as means ± SEM or as medians and ranges. Differences between 
two groups were assessed using t tests. Differences among three or more groups were 
evaluated by two-way analysis of variance followed by a Bonferroni multiple comparisons 
test. For variables with non-normal distribution, comparisons were performed using a 
nonparametric Mann–Whitney U test. Differences were accepted as statistically significant at 
p <0.05. All n values represent the number of mice of each genotype used in each group. For 
histological studies, at least two sections were examined of each tissue from each mouse. 
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2.3 Results 
2.3.1 Aberrant expression of alkaline phosphatase activity in vivo 
Given the role of alkaline phosphatase as a regulator of mineralization, we examined 
whether its activity was altered in IVD tissues from ENT1-/- mice. Cervical IVDs and 
adjacent vertebral bone were isolated from 2- and 6-month-old WT and ENT1-/- mice and 
histological sections were stained for alkaline phosphatase activity. As previously reported in 
bovine IVDs (28), alkaline phosphatase activity was detected at the annulus fibrosus–
vertebral bone (AF-VB) interface in both WT and ENT1-/- mice (Fig. 2.1A arrows). 
Interestingly, we also detected aberrant alkaline phosphatase activity in cells of the inner AF 
(Fig. 2.1A, arrowhead). Histological sections were scored for the presence or absence of 
alkaline phosphatase activity in specific IVD regions from 2-month-old (Fig. 2.1B) or 6-
month-old (Fig. 2.1C) mice. No significant differences were detected in the prevalence of 
alkaline phosphatase activity in tissues isolated from 2-month-old mice. Similarly, in 6-
month-old mice, no significant differences were detected in the prevalence of alkaline 
phosphatase activity at the AF-VB interface between WT and ENT1-/- IVDs. However, 
alkaline phosphatase activity was detected to a greater extent in the inner AF in ENT1-/- mice 
compared to WT in cervical IVDs.    
 
2.3.2 Characterization of primary cultures of annulus fibrosus cells  
To further investigate the mechanisms involved in ectopic mineralization of 
fibrocartilaginous tissues in ENT1-/- mice, we developed a cell culture model to study AF 
cells. AF cell cultures demonstrated a typical spindle-like morphology, and the absence of 
large vacuolated cells indicative of notochord-derived nucleus pulposus (NP) cells (Fig. 2.2A 
& B). No overt morphological differences were observed between WT and ENT1-/- cells. To 
characterize the phenotype and ensure that cells maintained an AF-like phenotype in vitro, 
we quantified the expression of IVD-associated extracellular matrix genes (Col1a1, Col2a1 
and Col10a1), AF markers (Gdf10 and Prg4), and nucleus pulposus markers (Cd24 and 
Ck19) (Fig. 2.2C-E). When compared to intact IVDs, AF cell cultures showed no significant 
difference in the expression of Col1a1, Col2a1, Gdf10, Prg4 or Col10a1; however, AF cell 
cultures showed expression of the NP markers Ck19 and significantly lower expression of 
Cd24 compared to intact IVDs. Of note, no significant differences were observed in the 
expression of IVD-associated genes between WT and ENT1-/- mice, either in AF cell cultures  
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Figure 2.1 Localization of alkaline phosphatase activity in intervertebral disc tissues in situ. 
Cervical IVDs (with adjacent vertebral bone) were isolated by microdissection from 2- and 
6-month-old WT and ENT1-/- mice and coronal sections were stained for alkaline 
phosphatase activity. (A) Representative histological images from 6-month-old WT and 
ENT1-/- mice are shown. Alkaline phosphatase-positive cells (stained blue) were observed at 
the annulus fibrosus – vertebral body interface in both WT and ENT1-/- mice (AF-VB, 
arrows). Aberrant alkaline phosphatase activity was also detected in the inner annulus 
fibrosus (arrow head) in ENT1-/- mice. Images were evaluated by three blinded observers for 
the presence or absence of alkaline phosphatase activity in IVD cells from 2-month-old (B 
n=11 WT and 15 ENT1-/- IVDs) or 6-month-old (C, n=11 WT and 8 ENT1-/- IVDs) mice. The 
proportion of discs exhibiting alkaline phosphatase activity at the AF-VB interface or inner 
AF was expressed as a percentage of discs evaluated from 6 mice of each genotype. A 
significantly greater proportion of discs from 6-month-old ENT1-/- than from WT mice 
exhibited alkaline phosphatase in the inner AF (p<0.05, assessed by Chi-squared test). 
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Figure 2.2 Characterization of primary AF cell cultures established from WT and ENT1-/- 
mice. (A) Representative phase contrast images of WT and ENT1-/- AF cells (passage 1). (B) 
AF cells were stained for F-actin (green) using Alexa fluor 488 phalloidin and for nuclei 
using Hoechst (blue). AF cell cultures isolated from 2-month-old WT and ENT1-/- mice 
demonstrated similar morphologies. The phenotype of WT (black bars) and ENT1-/- (white 
bars) AF cells was characterized by quantifying the expression of (C) IVD-associated 
extracellular matrix genes (Col1a1, Col2a1 and Col10a1), (D) AF markers (Gdf10 and 
Prg4), and (E) the nucleus pulposus markers (Cd24 and Ck19). Gene expression in AF cell 
cultures (n=5) was compared to that of intact IVDs (n=3). Bars labeled by different letters are 
significant (p<0.05, using one-way ANOVA followed by a Bonferroni multiple comparisons 
test).  
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or intact IVDs. These data suggest that primary cells maintain an AF-like phenotype in 
culture and therefore represent a suitable model for our subsequent studies.  
 
2.3.3 Greater alkaline phosphatase activity in ENT1-/- than in WT AF cultures 
To assess whether the aberrant ALP activity observed in vivo (Fig. 2.1) was 
maintained in vitro, AF cell micromass cultures were established from 2-month-old WT and 
ENT1-/- mice and cultured in the presence of ascorbic acid (to permit matrix synthesis) and   
β-glycerophosphate (to permit mineralization). AF cells derived from ENT1-/- mice showed a 
significantly greater ALP activity after 1 week (2.6-fold increase over WT) and 3 weeks in 
culture (7-fold increase over WT) (Fig. 2.3).  
To gain further insight into the differences between WT and ENT1-/- cells, we 
investigated the expression of genes associated with biomineralization in micromass cultures 
(Fig. 2.4). No significant differences were detected in the expression of Alpl (Fig. 2.4A) or 
Ibsp (Fig. 2.4B) between WT and ENT1-/- AF cultures, genes associated with the promotion 
of mineralization. Similarly, no significant differences were detected in the expression of 
Enpp1 (Fig. 2.4C), Spp1 (Fig. 2.4D) or Ank (Fig. 2.4E), genes associated with inhibition of 
mineralization. Although there was no significant difference in expression of Mgp in WT and 
ENT1-/- cultures, there was increased expression of Mgp over time (Fig. 2.4F). 
 
2.3.4 High extracellular adenosine and pharmacological inhibition of ENT1 increase 
alkaline phosphatase activity in WT AF cell cultures 
Using the in vitro micromass model, we next investigated the role of elevated 
extracellular adenosine as a potential stimulus for mineralization in AF cells, since our 
previous studies demonstrated greater levels of adenosine in the plasma of ENT1-/- mice 
compared to WT (13). To model the pathological changes observed in ENT1-/- mice, we 
supplemented micromass cultures of AF cells with exogenous adenosine (6 µM, plasma 
concentration detected in ENT1-/- mice) and/or nitrobenzylthioinosine (NBMPR 50 nM, a 
selective pharmacological inhibitor of ENT1), and quantified ALP activity following 3 weeks 
in culture (Fig. 2.5). Micromass cultures of ENT1-/- AF cells showed no changes in ALP 
activity in the presence of adenosine or NBMPR when compared to vehicle control. 
Similarly, the addition of adenosine or NBMPR alone did not alter ALP activity in 
micromass cultures of WT AF cells. Interestingly, there was a modest but significant  
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Figure 2.3 Alkaline phosphatase activity in WT and ENT1-/- AF micromass cultures. Cells 
were isolated from 2-month-old mice and cultured in high density micromass cultures in the 
presence of ascorbic acid (50 µg/mL) and β-glycerophosphate (2 mM) to permit synthesis 
and mineralization of extracellular matrix. Representative images of cells fixed and stained 
for alkaline phosphatase activity (red, arrows) and mineral (black, arrow head) after 1 or 3 
weeks in culture. Alkaline phosphatase-positive area was quantified using 2D image analysis 
and expressed as a percentage of the total area. Data are presented as means ± SEM (n = 4 
independent cell preparations from one mouse of each genotype, each with triplicate wells, 
quantified using 5 fields of view per well). *indicates (p<0.05), assessed using Student’s t-
test. 
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Figure 2.4 Expression of biomineralization genes over time in AF cell micromass cultures. 
Micromass cultures of AF cells isolated from 2-month-old WT (black bars) and ENT1-/- 
(white bars) mice were cultured for 0, 1, 2 or 3 weeks in the presence of ascorbic acid (50 
µg/mL) and β-glycerophosphate (2 mM) to permit matrix synthesis and mineralization. Week 
0 represents cells after 4 days of culture in micromass (time required to establish high density 
cultures), prior to the addition of ascorbic acid and β-glycerophosphate. RNA was isolated 
for real-time RT-PCR analysis to assess the expression of genes associated with 
mineralization (Alpl, Ibsp, Enpp1, Spp1, Ank and Mgp). Transcript levels were determined 
using a 6 point calibration curve. Data are means ± SEM, n = 4 independent experiments. 
*indicates significant difference (p < 0.05) and assessed using two-way ANOVA.  
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Figure 2.5 WT AF cells maintained in NBMPR and high extracellular adenosine show 
increased alkaline phosphatase activity. AF cells were isolated from 2-month-old WT (black 
bars) and ENT1-/- (white bars) mice and maintained in micromass cultures in the presence of 
ascorbic acid (50 µg/ml) and β-glycerophosphate (2 mM). Culture media was supplemented 
daily with adenosine (6 µM), the pharmacological inhibitor of ENT1, NBMPR (50 nM) or 
vehicle control (0.1% DMSO) for 3 weeks. ALP activity was quantified using 2D image 
analysis. Data are presented as relative fold change in ALP activity from either WT or  
ENT1-/- vehicle control (Dashed line), and are means ± SEM, n ≥ 4 independent experiments. 
*indicates significant difference (p<0.05) compared to vehicle control. 
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increase, in ALP activity in WT micromass cultures in the presence of both exogenous 
adenosine and NBMPR.  
Gene expression analysis was also conducted on parallel samples of WT and ENT1-/- 
micromass cultures supplemented with adenosine and/or NBMPR for 3 weeks (Fig. 2.6).  
When compared to vehicle control, there was no significant change in the expression of 
genes associated with either the promotion of mineralization (Alp, Ibsp) or the inhibition of 
mineralization (Enpp1, Spp1, Ank, Mgp).  
Extracellular adenosine acts through four G protein-coupled receptors to regulate 
intracellular cAMP levels (22). Since loss of ENT1 might disrupt endogenous adenosine 
levels in AF cell cultures, we measured basal cAMP levels in AF cell cultures derived from 
2-month-old WT and ENT1-/- mice. Basal levels did not differ significantly in WT and  
ENT1-/- cell cultures (Fig. 2.7). As expected, the positive control forskolin (a 
pharmacological activator of adenylyl cyclase) increased intracellular cAMP levels. Again, 
there was no significant difference between WT and ENT1-/- cells in levels of forskolin-
stimulated cAMP.   
 
2.3.5 Intracellular adenosine levels are greater in ENT1-/- than in WT AF cell cultures  
Given that ENT1 is the primary adenosine transporter in AF cells (16) and ENT1-/- 
mice show increased circulating adenosine levels in vivo (13), we examined if adenosine 
levels differed in WT and ENT1-/- AF cells in vitro. In vitro studies were performed in 
adenosine-free culture medium. Intracellular adenosine was quantified in cultures of AF cells 
isolated from WT and ENT1-/- mice at 2 months of age using mass spectrometry (Fig. 2.8). 
AF cells from ENT1-/- mice demonstrated significantly greater levels of intracellular 
adenosine than AF cells from WT mice.  
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Figure 2.6 Expression of biomineralization genes in AF cell micromass cultures is not 
altered by exposure to NBMPR and/or adenosine. Micromass cultures of AF cells isolated 
from 2-month-old WT (black bars) and ENT1-/- (white bars) mice were cultured for 3 weeks 
in the presence of ascorbic acid (50 µg/ml) and β-glycerophosphate (2 mM). Culture medium 
was supplemented daily with NBMPR (50 nM) and/or adenosine (6 µM) or vehicle control 
(0.1% DMSO). RNA was isolated for real-time RT-PCR analysis to assess the expression of 
genes associated with mineralization (Alp, Ibsp, Enpp1, Spp1, Ank and Mgp). Transcript 
levels were determined using a 6 point calibration curve. Data are means ± SEM, n = 4 
independent experiments, expressed as fold change from vehicle control set to 1 (dashed 
line).  
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Figure 2.7 Basal and forskolin-stimulated intracellular cAMP levels are similar in AF cell 
cultures from WT and ENT1-/- mice. AF cell monolayer cultures isolated from 2-month-old 
WT (black bars) and ENT1-/- (white bars) mice were incubated with IBMX (0.5 mM) for 10 
minutes, to prevent the breakdown of cAMP, followed by a 10 minute exposure to vehicle or 
forskolin (10 µM), an adenylyl cyclase activator. Data are presented as means ± SEM, n ≥ 3 
independent cell preparations. * indicates p<0.05, assessed using a two-way ANOVA. 
  
 
48	  
	  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.8 AF cells from ENT1-/- mice demonstrate greater levels of intracellular adenosine. 
Intracellular adenosine was quantified in monolayer cultures of AF cells isolated from WT 
and ENT1-/- mice at 2 months of age. Cell lysates were isolated in the presence of                  
13C5- adenosine (5 µM) as an internal standard, 5-iodotubercidin (10 µM) to inhibit 
adenosine kinase, and EHNA (100 µM) to inhibit adenosine deaminase. Adenosine was 
purified using solid-phase extraction and measured in the cell lysates against a five-point 
standard curve generated using purified adenosine (Sigma) using a quadrupole and 
orthogonal acceleration time-of-flight tandem mass spectrometer. Adenosine concentrations 
are presented normalized to total cellular protein (µg). Data are presented as means ± SEM 
(WT n = 6, ENT1-/- n = 7 independent cell preparations). * indicates p<0.05, assessed using 
Student’s t-test. 
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2.4 Discussion 
The mechanisms that induce the formation of ectopic mineral in disorders of aberrant 
mineralization, such as DISH, are poorly understood. Using the ENT1-/- mouse model, the 
present study shows aberrant or greater activity of alkaline phosphatase, an enzyme whose 
expression is a good predictor of biomineralization (18), in tissues and cells derived from 
ENT1-/- mice. The importance of ALP in biomineralization is exemplified by studies of Alpl-/- 
mice and the clinical presentation of ALP disruption in humans. In both cases, loss of 
functional ALP results in hypophosphatasia, characterized by skeletal hypomineralization 
(17, 19, 31). The amorphous acellular mineral within the AF of the ENT1-/- mice (13) may be 
related to the aberrant ALP activity that we observed in the IVDs of ENT1-/- mice.   
 To evaluate the mechanisms responsible for the ectopic mineralization in 
fibrocartilaginous tissues, we developed and characterized an in vitro model of AF cell 
micromass cultures. We show that cultures derived from WT and ENT1-/- mouse AF tissue 
had comparable levels of gene expression of IVD-associated extracellular matrix genes 
(Col1a1, Col2a1 and Col10a1), the AF markers (Gdf10 and Prg4) and low expression of the 
nucleus pulposus markers CK19 and Cd24 compared to intact IVDs. These findings suggest 
that our protocols favor the isolation and maintenance of AF cells rather than NP cells. 
Consistent with the changes that we detected in vivo, ALP activity was increased in ENT1-/- 
AF micromass cultures compared to WT.  Interestingly, increased ALP activity in ENT1-/- 
AF cells was not associated with increased Alpl gene expression. Therefore, we propose that 
the aberrant ALP activity observed in ENT1-/- AF micromass cultures is not controlled at the 
transcriptional level and that other factors are responsible for this phenomenon (e.g. 
translational control, post-translational modifications, allosteric regulation, etc.).   
 To discern the mechanism involved with aberrant ALP activity in ENT1-/- micromass 
AF cultures, we attempted to model the phenotype by altering the culture conditions. 
Interestingly, pharmacological inhibition of ENT1 activity in the presence of exogenous 
adenosine induced a modest, but significant increase in ALP activity in WT micromass AF 
cultures. In contrast, ALP activity was not altered in micromass cultures of ENT1-/- AF cells 
following exposure to the inhibitor of ENT1 or exogenous adenosine. This observation helps 
to rule out the possibility that NBMPR was acting through a nonspecific effect to induce 
ALP activity in WT cells.  
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 Although the addition of exogenous adenosine and NBMPR augmented ALP activity, 
the WT micromass cultures did not completely recapitulate the levels of ALP activity 
observed in ENT1-/- cells. These experiments show that ALP activity is regulated in part by 
extracellular adenosine and ENT1 transport activity; however, other mechanisms are likely 
involved. There are several possibilities. First, we do not know the levels of extracellular 
adenosine in the IVDs of ENT1-/- or WT mice. As well, the partial induction of ALP activity 
in WT cells may relate to cell autonomous traits. Tissues derived from ENT1-/- mice have 
been exposed to a different microenvironment as a result of the germline constitutive loss of 
ENT1 function, whereas ENT1 function was only inhibited in WT cells in vitro for a short 
period of time (3 weeks of culture). As a result, we investigated the mRNA expression of 
genes associated with biomineralization, which we previously reported were altered in IVD 
tissues from ENT1-/- mice at 6 months of age (16). We assessed the transcript levels of 
promoters of mineralization (Alpl and Ibsp)(18, 32) and inhibitors of mineralization (Enpp1, 
Spp1, Ank and Mgp) (33-36); however, we did not detect any differences in WT or ENT1-/- 
micromass AF cultures after treatments with adenosine and NBMPR. Differences in the time 
course of gene expression may reflect the onset of lesions, which are not evident in the 
ENT1-/- IVDs at 2 months, but present at 6 months.  Therefore, changes in expression 
observed at 6 months (16) may reflect responses to the presence of ectopic mineral in these 
tissues, which have not developed at 2 months. Taken together, our findings suggest that 
deletion of ENT1-/- gives rise to both cell autonomous and nonautonomous changes in the AF 
in vivo.   
 A number of studies have established that purine signaling regulates 
biomineralization through the stimulation of adenosine receptors (22, 24, 25). Previous 
characterization of ENT1-/- mice demonstrated elevated plasma adenosine, which may result 
in altered adenosine signaling in the affected tissues. However, we did not detect any 
difference in basal or forskolin-stimulated cAMP levels in WT and ENT1-/- AF cells. These 
observations help rule out the possibility that differences in AF cell behavior in vitro are 
controlled by endogenous extracellular adenosine signaling through its cell surface receptors.  
On the other hand, we observed accumulation of intracellular adenosine in ENT1-/- 
AF cell cultures compared to WT cells. This observation is consistent with the culture 
conditions, which utilized adenosine-free medium. Thus, the concentration gradient of 
adenosine was from intracellular to extracellular (and therefore net equilibrative transport of 
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adenosine would be outward). In the absence of ENT1, less efflux of adenosine would be 
expected, resulting in greater intracellular levels in the knockout. Elevated intracellular 
adenosine may have a number of outcomes, such as increased adenosine metabolism (to 
inosine or adenosine monophosphate, AMP), which could lead to enhanced ALP activity and 
in turn result in ectopic calcification. In addition, adenosine deaminase deficient mice have 
elevated intracellular adenosine and leading to pathologies such as lung fibrosis (37). 
Findings from the current study suggest that adenosine levels may have an integral role in the 
induction of pathologic mineralization in fibrocartilaginous tissues.  
 In summary, the characterization of ALP activity in vivo and in vitro provides 
valuable insight into potential mechanisms underlying ectopic mineralization in ENT1-/- 
mice. Findings from the ENT1-/- mouse model may be directly relevant to understanding the 
etiology of DISH. In this regard, a recent study reported an association between humans with 
a null mutation for ENT1 and ectopic mineralization in multiple joints, resembling DISH 
(38). Additional preclinical and clinical studies will contribute to better understanding of 
adenosine metabolism and signaling in the IVD, and guide future investigation of 
mechanisms responsible for ectopic mineralization in diseases such as DISH.  
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Chapter 3 
Global Transcriptome Analysis of the Annulus Fibrosus 
(AF) from ENT1-/- Mice Reveals Putative Changes 
Associated With Ectopic Mineralization 
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3.1 Introduction 
 Physiological connective tissue mineralization is a tightly regulated process 
controlled by protein effectors that either promote mineralization (e.g. alkaline phosphatase, 
ALP) or inhibit mineralization (e.g. matrix gla protein, MGP; osteopontin, SPP1; and the 
progressive ankylosis protein, ANK) (1-5). Pathologic conditions typically arise when there 
is disruption in the balanced expression of proteins regulating mineralization. Abnormal 
calcification of the extracellular matrix in soft connective tissues contributes to the pathology 
of many disease processes, such as chronic kidney disease, vascular calcification, and 
skeletal disorders (6-9). For example, Mgp-/- mice demonstrate aberrant calcification of the 
growth plate and die within two months as a result of arterial calcification (10). Similarly, 
Enpp1-/- mice demonstrate ectopic mineralization in the intervertebral disc, peripheral joint 
and articular cartilage (11). Disorders of ectopic mineralization that primarily affect 
paraspinal ligaments, including ossification of the posterior longitudinal ligament (OPLL) 
and diffuse idiopathic skeletal hyperostosis (DISH) are common disorders of the elderly 
where the etiology remains unknown (8, 12-14).  
 Although often misdiagnosed, DISH and OPLL are non-inflammatory 
spondyloarthropathies distinct from degenerative disc disease, osteoarthritis and ankylosing 
spondylitis (15). DISH involves calcification of fibrocartilagenous tissues along the spine, 
including the spinal ligaments, entheses, and intervertebral discs (IVDs) (16-18). DISH can 
also be associated with aberrant mineralization of extra-axial locations including sites of 
ligament and tendon attachment to bone. Often asymptomatic in its early stages, DISH 
manifests as back pain, spinal stiffness, and susceptibility to fractures; in severe cases it can 
lead to compression of the spinal cord or dysphagia (17, 19, 20). OPLL is common in the 
Japanese population. In advanced cases, OPLL is associated with head and neck pain and 
stiffness, parasthesias, motor disturbances and cervical myelopathy (21). Segregation studies 
indicate autosomal inheritance in OPLL; potential susceptibility genes include collagen 11A2 
(COL11A2), collagen 6A1 (COL6A1) and ectonucleotide pyrophosphatase/ 
phosphodiesterase 1 (ENPP1) (22). Importantly, few familial cases of DISH have been 
reported, and the pathogenic mechanisms regulating the initiation and progression of DISH 
remain unknown. 
 Although the etiology is unknown, correlative studies have associated DISH with 
metabolic disorders including obesity, diabetes mellitus, hyperinsulinemia, and elevated 
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growth hormone levels (17, 23, 24). In a subset of DISH patients of Asian descent, a single 
nucleotide polymorphism in COL6A1 may confer a genetic susceptibility to DISH (25). In a 
separate patient population, deregulation of WNT signaling via reduced circulating levels of 
the WNT inhibitor, dickkopf -1 (DKK1) was associated with the onset of DISH (26). 
Furthermore, recent studies reported the association between patients with a null mutation in 
ENT1 and the presentation of ectopic mineral formation in multiple joints including spinal 
mineralization resembling DISH (27).  
 Our group recently characterized a novel mouse model of DISH in mice lacking 
expression of the equilibrative nucleoside transporter 1 (ENT1-/-). At 2 months of age ENT1-/- 
exhibit ectopic mineral formation in the paraspinal ligaments and enthuses, which progresses 
with time to also involve the annulus fibrosus (AF) of the intervertebral disc (IVD) in mice at 
6 months of age (28). Subsequent studies from our group showed a deregulation of 
biomineralization pathways in IVD tissues from ENT1-/-mice, including reduced expression 
of the mineralization inhibitors Enpp1, Mgp, Spp1 and abnormal ALP activity ((29) and 
Chapter 2). Further studies investigating the ENT1-/- mouse revealed additional skeletal 
phenotypes, showing reduced bone density of the lower thoracic and lumbar regions of the 
spine (30). 
 Since diseases of ectopic mineralization such as DISH are largely asymptomatic in 
their early stages, and surgical treatment for patients to resect mineralized material is only 
carried out in extreme cases, our understanding of the cellular mechanisms associated with 
disease initiation and progression, as well as access to human patient samples are limited. 
These limitations underscore the value of animal models to characterize the pathogenesis and 
etiology of DISH. The current study conducted global gene expression analysis to compare 
the transcriptional signature of IVD tissues from wild-type (WT) and ENT1-/- mice, 
previously characterized sites of ectopic mineralization. Our global transcriptome analysis 
was designed to examine differences in gene expression in wild-type and ENT1-/- mice prior 
to the radiographic detection of ectopic mineralization (IVD tissues from mice at 2 months of 
age) and tissues affected by ectopic mineralization (IVD tissues from mice at 6 months of 
age) (28). The analysis of changes in gene expression based on both age and genotype 
identified a common signature of cellular processes involved in cell proliferation, B cell 
signaling and mineralization-associated genes altered in ENT1-/- IVD tissues, providing 
further insight into potential mediators of disease progression. 
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3.2 Methods 
3.2.1 Mice 
ENT1-/- mice were previously generated by deletion of exons 2-4 of the gene encoding 
ENT1 (Dr. Doo-Sup Choi, Mayo Clinic College of Medicine, Rochester, MN, USA) (31). 
ENT1-/- mice were backcrossed with C57BL/6 mice and the colony was maintained by 
breeding heterozygote mice (ENT1+/-) to obtain wild-type (ENT1+/+) and knock-out (ENT1-/-) 
littermate mice. Genotyping was performed, as previously described (28). Mice were housed 
in standard cages and maintained on a 12 h light/dark cycle, with rodent chow and water 
available ad libitum. Male mice were sacrificed at 2 or 6 months of age for tissue isolation. 
All aspects of this study were conducted in accordance with the policies and guidelines set 
forth by the Canadian Council on Animal Care and were approved by the Animal Use 
Subcommittee of the University of Western Ontario (protocol 2009-050). 
 
3.2.2 RNA isolation and purification 
 IVDs were microdissected from the thoracic spine of 2- or 6-month-old wild-type and 
ENT1-/- mice. Intact IVDs were lacerated on the anterior side in phosphate buffered saline 
(PBS) to remove the gelatinous nucleus pulposus, isolating the AF tissue. Following 
microdissection, AF tissues were placed in RNAlater (Life technologies) and stored at -80˚C. 
Samples were subsequently thawed and centrifuged for 2 min at 2, 500 rpm, RNAlater was 
aspirated and tissues were incubated in 1 mL of PureZOL®  (Bio-Rad Laboratories). Tissues 
were homogenized using Polytron® benchtop homogenizer and RNA was extracted using the 
Aurum Total RNA Fatty and Fibrous Kit (Bio-Rad Laboratories), according to the 
manufacturer’s protocol. RNA was quantified using a Nanodrop 2000 spectrophotometer 
(Thermo Scientific) and sample quality was verified using a 2100 Bioanalyzer (Agilent 
Technologies). RNA samples with RNA integrity number (RIN) values greater than 7 were 
used for subsequent microarray analysis. 
 
3.2.3 Microarray analysis 
 Microarray analysis was performed on AF tissues from 2- and 6-month-old wild-type 
and ENT1-/- mice (n=2 of each age genotype). Analysis was completed at the London 
Regional Genomics Centre (Robarts Research Institute, London, ON). Briefly, single 
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stranded complementary DNA (sscDNA) was prepared from 200 ng of total RNA using the 
Ambion WT Expression Kit for Affymetrix GeneChip Whole Transcript WT Expression 
Arrays. Total RNA was first converted to cDNA, followed by in vitro transcription to make 
cRNA. 5.5 µg of sscDNA was synthesized, end labeled and hybridized for 16 hr at 45°C, to 
Mouse Gene 2.0 ST arrays. All liquid steps were performed using the GeneChip Fluidics 
Station 450 and scanned with GeneChip Scanner 3000 7G (Affymetrix). Probe level data 
from CEL data was analyzed and summarized in Partek Genomics Suite v6.6 (Partek). Partek 
was used to determine gene level, ANOVA p-values and fold changes. Genes demonstrating 
at least 2.0 fold change with a p<0.05 were considered significant and used for downstream 
analysis.  
 
3.2.4 Pathway analysis 
 Probes demonstrating a significant change between groups (2 month ENT1-/- vs 2 
month WT; 6 month ENT1-/- vs 6 month WT; 6 month ENT1-/- vs 2 month ENT1-/-) were used 
for functional categorization and pathway analysis. Database categories were generated based 
on the Mus musculus annotations for Gene Ontology (GO) analysis (geneontology.org) and 
KEGG pathway analysis (genome.jp/kegg/). Partek was used to cluster samples using 
principal component analysis (PCA) and Ingenuity Pathway Analysis (IPA) (ingenuity.com) 
was used to generate canonical pathways based on significantly changed probes. GO, KEGG 
and IPA canonical pathway analysis were performed using a Fisher’s exact test and the data 
is presented as enrichment scores. 
 
3.2.5 Fluorescence activated cell sorting (FACS) 
B and T cell frequencies were assessed in the spleens of 6-month-old WT and ENT1-/- 
by FACS (n=2 mice / genotype). The percentage of B cells (B220+, CD3-), T cells (B220-, 
CD3+) and myeloid cells (B220-, CD11b+) were quantifying by FACS using a LSRII system 
(BD Biosciences), and data analysis was performed using FlowJo software (TreeStar Inc., 
Ashland, OR). Antibodies and reagents purchased from eBioscience (San Diego, CA), BD 
Bioscience (Franklin Lakes, NJ), or BioLegend included brilliant violet 421 conjugated anti-
CD45R/B220 (Ra3-6B2), allophycocyanin (APC)-conjugated CD3 (YG 780/60), PE-
conjugated CD11b (YG 582/15). Cells were blocked with purified anti-CD16/CD32 (Mouse 
BD Fc BlockTM). Cells are washed with FACS buffer (5% FBS, 25mM EDTA, in PBS) 3x 
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after ACK lysis, then resuspended in 100 uL of FACS buffer along with the antibody 
(dilutions of 1:100) for 20 min on ice in the dark, or in the fridge. After staining, cells are 
washed again 3x with FACS buffer. 
 
3.2.6 Immunohistochemistry and histology 
Thoracic intervertebral discs (IVDs) were isolated from 6-month-old WT and ENT1-/- 
mice and prepared as previously described (32). Briefly, IVDs were fixed overnight at 4°C in 
Periodate-Lysine-Paraformaldehyde (PLP) and passed through sucrose gradients (10%, 20% 
and 30% sucrose in PBS) to protect from freezing artifacts. Intact IVDs were frozen in OCT 
compound (TissueTek), sectioned using a Cryostat (Leica CM 3050S), and serial transverse 
sections (8 µm) were stored at -80°C. Slides were blocked for 20 minutes at room 
temperature in PBS containing 1% Bovine Serum Albumin, 0.1% Tween-20 and 10% rat 
serum before proceeding with immunofluorescent staining for B (B220+) and T (CD3+) cells. 
Antibodies were diluted 1:200 for optimal staining at room temperature for 1hr. Sections 
were mounted with ProLong Gold Antifade Reagent (Invitrogen) and stored at -20°C. 
Tissues were imaged using a DM5500B fluorescence microscope (Leica Microsystems).  
Serial sections were stained with haematoxylin and eosin (H&E) and images were acquired 
using a Leica DM1000 microscope. Antibodies and reagents purchased from BD Bioscience 
(Franklin Lakes, NJ), or BioLegend included Alexa Fluor 647 anti-CD45R/B220 (Ra3-6B2) 
and FITC anti-CD3ε (145-2C11). 
 
3.3 Results 
3.3.1 Global transcriptome analysis 
 To investigate age- and genotype-related changes associated with ectopic 
mineralization in ENT1-/- mice (28), we performed microarray analysis of annulus fibrosus 
(AF) tissues from thoracic IVDs of four groups: 2-month old WT mice, 6-month old WT 
mice, 2-month-old ENT1-/- mice, and from 6-month-old ENT1-/- mice. Using the total gene 
expression signature, we first assessed the degree of similarity between samples using 
principal component analysis (Fig. 3.1). As expected, samples within the same group 
(genotype and age) were the most closely related. Interestingly, the gene expression 
signatures of AF tissues isolated from 2- and 6- month-old WT mice and 2-month-old    
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Figure 3.1 Two-dimensional (2D) principal component analysis (PCA) comparing total gene 
expression between WT and ENT1-/- AF tissues. Global transcriptome analysis of AF tissues 
isolated from 2 (spheres)- and 6 (diamonds) -month-old WT (blue) and ENT1-/- (red) mice 
were used to construct a similarity matrix for PCA. Similarity between samples is denoted by 
proximity in 2D space, where samples that are closer are similar in a large number of 
variables (n=2 each group). 
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ENT1-/- mice grouped closer together (absence of ectopic mineralization), than that of AF 
tissue isolated from 6-month-old ENT1-/- mice (presence of ectopic mineralization).  
 
3.3.2 Gene expression profiles during progressive AF mineralization in ENT1-/- mice 
 To decipher in detail changes in gene expression associated with age, loss of ENT1 
function and AF mineralization, we identified genes significantly altered in AF tissues using 
four distinct comparisons (Fig. 3.2): i) 6 month WT vs. 2 month WT; ii) 2 month ENT1-/- vs. 
2 month WT; iii) 6 month ENT1-/- vs. 6 month WT; and iv) 6 month ENT1-/- vs. 2 month 
ENT1-/-. Interestingly, in all comparisons the majority of changes detected involved the 
upregulation of gene expression (>77% based on threshold of >2 fold change) (Fig. 3.2A). 
Based on our analysis, the profile of age-dependent AF gene expression demonstrated the 
least amount of change (total of 53 probes altered). Conversely, the largest degree of change 
in the profile of gene expression was detected when comparing AF tissues isolated from WT 
and ENT1-/- mice at 6 months of age (total of 1596 probes altered). Notably, 241 probes were 
altered in ENT1-/- AF cells at 2 months of age compared to WT (prior to the onset of ectopic 
mineralization) while 1596 probes were altered in ENT1-/- AF cells at 6 months of age 
compared to WT (in the presence of ectopic mineralization).    
 Venn diagrams were generated to identify common gene expression signatures (Fig. 
3.2B). This analysis identified 22 probes altered in ENT1-/- AF cells at 2 months of age 
compared to WT, but not altered in ENT1-/- AF cells at 6 months of age (Appendix A: Table 
3.1); 219 probes were altered in ENT1-/- AF cells at both 2 and 6 months of age compared to 
each respective WT (Appendix A: Table 3.2); and 1386 probes were altered in ENT1-/- AF 
cells at 6 months of age compared to WT, but not altered in ENT1-/- AF cells at 2 months of 
age (Appendix A: Table 3.3). These specific gene expression signatures may contain 
intriguing candidates for genes associated with the initiation, progression and tissue response 
to mineralization, respectively. 
 
3.3.3 Bioinformatic analysis of biological pathways affected in ENT1-/- mice 
 To provide insight into the biological pathways associated with ectopic mineralization 
in ENT1-/- mice, the AF gene expression profiles were assessed using bioinformatic pathway 
analysis. We first conducted KEGG pathway analysis (Fig. 3.3), and focused on the 5 most 
enriched pathways altered between WT and ENT1-/- tissues at 6 months of age: cell cycle, B  
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Figure 3.2 Summary of the number of probes significantly altered betweenWT and ENT1-/- 
annulus fibrosus (AF) tissues from 2- and 6-month-old mice. A) Table showing total number 
of up- and down- regulated probes in each group wise comparison. B) Venn diagram of 
overlapping up-regulated probes (left) and down-regulated probes (right) between three 
comparisons: 1) 2 month ENT1-/- vs 2 month WT tissues (blue), 2) 6 month ENT1-/- vs 6 
month WT tissues (green), and 3) 6 month ENT1-/- vs 2 month ENT1-/- tissues (red). The 
threshold for significance was set at >2-fold change, p<0.05. 
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Figure 3.3. KEGG pathway analysis demonstrating the five most enriched pathways in 
ENT1-/- vs WT AF tissues. Enrichment scores corresponding to cell cycle, B cell receptor 
signaling pathway, osteoclast differentiation, hematopoietic lineage, and DNA replication for 
A) 2 month ENT1-/- compared to 2 month WT, B) 6 month ENT1-/- compared to 6 month WT, 
and C) 6 month ENT1-/- compared to 2 month ENT1-/- AF tissues. The length of each column 
represents the enrichment score for each pathway. 
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cell receptor signaling pathway, osteoclast differentiation, hematopoietic lineage, and DNA 
replication (Fig. 3.3). Interestingly, these KEGG pathways showed significant enrichment in 
each group wise comparison (2 month ENT1-/- vs. 2 month WT, Fig. 3.3A; 6 month ENT1-/- 
vs. 6 month WT, Fig. 3.3B; and 6 month ENT1-/- vs. 2 month ENT1-/-, Fig. 3.3C). Of these 
pathways, cell cycle showed the highest enrichment score in each comparison. Furthermore, 
the enrichment scores for each of these pathways increased between ENT1-/- AF tissues at 2 
and 6 months of age (compared to their age matched WT), corresponding to the formation of 
ectopic AF mineralization.  
 Interestingly, GO analysis of biological pathways revealed terms similar to those 
identified by KEGG analysis. Focusing again on the 5 most enriched pathways altered 
between WT and ENT1-/- tissues at 6 months of age, this analysis identified biological 
processes associated with the immune system and cell cycle. Again, these pathways showed 
significant enrichment in each group wise comparison (2 month ENT1-/- vs. 2 month WT, 
Fig. 3.4A; 6 month ENT1-/- vs. 6 month WT, Fig. 3.4B; and 6 month ENT1-/- vs. 2 month 
ENT1-/-, Fig. 3.4C). The enrichment scores for each of these pathways also increased 
between ENT1-/- AF tissues at 2 and 6 months of age (compared to their age-matched WT), 
corresponding to the formation of ectopic AF mineralization 
To complement this analysis, we also conducted Ingenuity Pathway Analysis (IPA), a 
predictive bioinformatic tool developed for functional pathway analysis, causal network 
analysis and gene regulatory analysis. The summaries of the top 10 predicted canonical 
pathways for each group wise comparison are presented in Figure 3.5. Compared to WT, 
IPA analysis predicted the activation of pathways including leukocyte extravasation signaling 
and chemokine signaling and the inhibition of cell cycle checkpoint regulation and ATM 
signaling in ENT1-/- tissues at 2 months of age (Fig. 3.5A). Interestingly, in ENT1-/- tissues at 
6 months of age, our analysis identified an increased number of pathways associated with 
changes in leukocyte signaling and cell cycle regulation (Fig. 3.5B). Similar pathways were 
predicted as activated or inhibited in ENT1-/- tissues between 2 and 6 months of age (Fig. 
3.5C). 
 
3.3.4 Assessment of B cell immune response 
 Bioinformatic analysis of microarray data consistently identified deregulated 
pathways in ENT1-/- AF tissues associated with immune system response, specifically  
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Figure 3.4. Gene ontology (GO) analysis identified the five most enriched biological 
pathways in ENT1-/- vs WT AF tissues. Enrichment scores corresponding to the immune 
system process, cell cycle, cell cycle process, regulation of immune system process, and 
response to stress GO pathways for A) 2 month ENT1-/- compared to 2 month WT, B) 6 
month ENT1-/- compared to 6 month WT, and C) 6 month ENT1-/- compared to 2 month 
ENT1-/- AF tissues. The length of each column represents the enrichment score for each 
pathway. 
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Figure 3.5. Ingenuity Pathway Analysis (IPA) identified the top ten canonical pathways 
predicted as altered in ENT1-/- vs WT AF tissues. Significant pathways for A) 2 month  
ENT1-/- compared to 2 month WT, B) 6 month ENT1-/- compared to 6 month WT, and C) 6 
month ENT1-/- compared to 2 month ENT1-/- AF tissues are shown. The length of each 
column represents the level of significance for each pathway established by a Fisher’s exact 
test, p<0.05. Predictive outcomes were assigned to each category based on observed 2-fold 
changes in microarray probes as either pathway activation (orange) or inhibition (blue). 
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increased expression of genes in B cell-associated pathways. Therefore, we first investigated 
whether systemic changes in B cell frequency were detectable in the ENT1-/- mouse model 
(Fig. 3.6). We quantified the expression of cell-type specific markers by flow cytometry to 
compare the frequency of B and T cells (Fig. 3.6A) and myeloid cells (Fig. 3.6C) in the 
spleens of WT and ENT1-/- mice at 6 months of age. This quantitative analysis showed no 
differences in either the frequency or absolute number of B and T cells in 6-month-old  
ENT1-/- mice compared to WT littermate controls. 
 We therefore sought to examine if changes in B cell number or tissue-specific 
localization could be detected within the IVD tissues of ENT1-/- mice. Immunohistochemical 
analysis showed no B cell localization within IVD tissues of WT mice, not surprising given 
the avascular nature of the IVD. Interestingly, preliminary analysis identified B220-positive 
B cells within the AF of ENT1-/- mice observed (Fig. 3.7A,B). Interestingly, histological 
evaluation IVD morphology in serial sections using H&E associated the area containing 
putative B cells in ENT1-/- mice with structural disorganization of the AF we previously 
characterized as associated with the early stages of ectopic mineral formation (Fig. 3.7C). 
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Figure 3.6. Characterization of B and T cell frequency in WT and ENT1-/- mice. A) 
Frequencies of B220-CD3+ (T cells) and B220+CD3- (B cells) cells were analyzed in spleens 
of 6-month-old WT and ENT1-/- mice by FACS. B) The frequency and absolute number of 
B220-CD3+ and B220+CD3- cells. (C) Frequencies of B220-CD11b+ (myeloid) cells were 
analyzed from spleens of WT and ENT1-/- mice. No significant differences in B cell, T cell or 
myeloid cell frequencies were detected between WT and ENT1-/- mice, suggesting no 
systemic alterations in immune cell levels (n=2 mice of each genotype). 
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Figure 3.7. Immunohistochemical examination of B cell localization within IVDs 
from 6-month-old WT and ENT1-/- mice. A) Representative images demonstrate the 
immunolocalization of B220+ B cells (white, red arrow) and dapi in blue (nuclei). B) A 
magnified view of the area in the square shows B cell localization (white, red arrow) in WT 
and ENT1-/- mice. C) Representative images of IVDs from WT and ENT1-/- mice demonstrate 
histological appearance when stained for haematoxylin and eosin (H&E). Samples were 
sectioned in the transverse plane with representative of 2 animals of each genotype. Scale 
bars represent 100 µm. 
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3.4 Discussion 
 Despite a systemic loss of ENT1 function, our previous studies have demonstrated 
that the phenotype of ectopic mineralization in ENT1-/- mice is limited to fibrocartilagenous 
paraspinal tissues and sternocostal articulations (28). Importantly, the mechanism(s) causing 
ectopic mineralization are not understood with only a few candidate pathways having been 
investigated in IVD tissues of ENT1-/- mice ((29) and Chapter 2). In the current study, we 
employed transcriptional profiling paired with bioinformatics analysis to determine changes 
in the global AF transcriptional profile, both preceding and associated with mineralization of 
the AF in ENT1-/- mice.  
Previous studies by our group suggest that decreased gene expression of regulatory 
proteins that normally prevent soft tissue mineralization (Mgp, Enpp1, Ank, Spp1) may 
contribute to ectopic calcification of spinal tissues in ENT1-/- mice (29). In the current 
microarray analysis, although the observed changes did not meet the parameters set by this 
study for significance (>2 fold change), we did observe decreases in the expression of Mgp 
(1.4 fold change), Ank (1.6 fold change), and Enpp1 (1.8 fold change) in AF tissues from 6-
month-old ENT1-/- mice compared to WT littermate controls. 
Through the comparisons designed in this study we are able to assess changes prior to 
the onset of mineralization (2 month ENT1-/- vs. 2 month WT), along with gene expression 
changes associated with mineralization (6 month ENT1-/- vs. 6 month WT and 6 month  
ENT1-/- vs. 2 month ENT1-/-).  From these comparisons we are able to obtain potential 
candidate genes responsible for the onset of mineralization. For example, dickopf 1 (Dkk1) 
was found to be significantly downregulated in ENT1-/- vs. WT AF tissues from 2-month-old 
mice, however it was unchanged in 6-month-old mice. Dkk1 is a known inhibitor of the 
canonical WNT signaling cascade (33). Interestingly, in a subset of patients, decreased serum 
DKK1 was associated with the onset of DISH (26). Conversely, pannexin 3 (Panx3) was 
found to be downregulated in ENT1-/- vs. WT AF tissues from 6-month-old mice, but not in 
2-month-old mice. This is interesting since studies have shown that Panx3 regulates 
intracellular ATP/cAMP levels, and also promotes chondrocyte differentiation (34).  
   When our data was assessed using IPA, KEGG and GO bioinformatic tools, a 
common signature of pathways related to cell cycle and B cell associated markers were 
identified as enriched in ENT1-/- samples compared to WT at both 2 and 6 months of age. 
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After assessing genes with the largest associated fold change (Appendix A, Table 3.3), 
many upregulated genes were identified as part of the common enriched B cell and cell cycle 
pathways. Consistent with the loss of ENT1, plasma adenosine was reported to be 
approximately three times higher in ENT1-/- mice compared to WT (28). Similarly, in 
Chapter 2 we show elevated intracellular adenosine in AF cells derived from 2-month-old 
ENT1-/- mice compared to WT. In previous studies, the addition of extracellular adenosine 
resulted in increased proliferation of endothelial cells, osteoblast-like cells, mouse 
fibroblasts, and rat arterial smooth muscle cells (35-37), suggesting that alterations in 
adenosine may be associated with altered cell cycle regulation in AF cells of ENT1-/- mice. 
Subsequent studies have shown that adenosine receptor activation results in increased cell 
proliferation through mitogen-activated protein kinase (MAPK) signaling (38). Interestingly, 
while our previous characterization of changes in the AF of ENT1-/- mice in situ did not 
assess cell proliferation, preliminary (unpublished) work from our group show that AF cells 
isolated from ENT1-/- mice exhibit increased cell proliferation in vitro compared to WT AF 
cells.  
 During the initial histological characterization of ectopic mineralization in 
fibrocartilagenous tissues of the ENT1-/- mice, we reported the absence of a local 
inflammatory response at the site of mineral formation. Interestingly, the transcriptome 
analysis conducted in the current study identified multiple pathways associated with B cells 
as upregulated in ENT1-/- AF tissues. While no differences in B cell, T cell or myeloid cell 
frequencies were detected systemically in 6-month-old ENT1-/- mice, preliminary data 
suggest B cell infiltration to areas of pathological change in the AF of 6-month-old ENT1-/- 
mice. It is well established that B cell infiltration is associated with the local expression of 
chemoattractants, such as CXCL12 and CXCR4. Interestingly, microarray analysis showed 
that both Cxcl12 and Cxcr4 were significantly upregulated in ENT-/- AF tissues compared to 
WT at 6 months of age. Recent studies have established a role for immune cells during the 
bone healing; specifically both B and T cells were shown to make direct cell-cell contact 
with both osteoclasts (cells that resorb bone) and osteoblast (cells that build bone) (39). This 
study showed that during bone regeneration, B cells outnumbered T cells and downregulated 
osteoclast activity, suggesting that B cells play an important role during fracture healing (39, 
40). The association between B cell infiltration and the induction of ectopic mineralization in 
ENT1-/- mice warrants further investigation. 
73	  
	  
 The current study reports global transcriptome changes associated with pathological 
mineralization of AF tissues using the ENT1-/- mouse model. The identification of novel 
molecular pathways associated with the induction of paraspinal mineralization may provide 
new insight into the mechanisms controlling the initiation or progression of human diseases 
such as DISH and OPLL. These analyses will provide avenues and potential targets for future 
studies aimed at elucidating the mechanism causing ectopic mineralization in ENT1-/- mice as 
a model of DISH. 
74	  
	  
3.5 References 
1. Kim HJ, Minashima T, McCarthy EF, Winkles JA, & Kirsch T (2010) Progressive 
ankylosis protein (ANK) in osteoblasts and osteoclasts controls bone formation and 
bone remodeling. J Bone Miner Res 25(8):1771-1783. 
2. Orimo H & Shimada T (2008) The role of tissue-nonspecific alkaline phosphatase in 
the phosphate-induced activation of alkaline phosphatase and mineralization in SaOS-
2 human osteoblast-like cells. Mol Cell Biochem 315(1-2):51-60. 
3. Golub EE, Harrison G, Taylor AG, Camper S, & Shapiro IM (1992) The role of 
alkaline phosphatase in cartilage mineralization. Bone Miner 17(2):273-278. 
4. El-Maadawy S, Kaartinen MT, Schinke T, Murshed M, Karsenty G, & McKee MD 
(2003) Cartilage formation and calcification in arteries of mice lacking matrix Gla 
protein. Connect Tissue Res 44 Suppl 1:272-278. 
5. Yuan Q, Jiang Y, Zhao X, Sato T, Densmore M, Schuler C, Erben RG, McKee MD, 
& Lanske B (2014) Increased osteopontin contributes to inhibition of bone 
mineralization in FGF23-deficient mice. J Bone Miner Res 29(3):693-704. 
6. Sardiwal S, Magnusson P, Goldsmith DJ, & Lamb EJ (2013) Bone alkaline 
phosphatase in CKD-mineral bone disorder. Am J Kidney Dis 62(4):810-822. 
7. Demer LL & Tintut Y (2008) Vascular calcification: pathobiology of a multifaceted 
disease. Circulation 117(22):2938-2948. 
8. Kagotani R, Yoshida M, Muraki S, Oka H, Hashizume H, Yamada H, Enyo Y, 
Nagata K, Ishimoto Y, Teraguchi M, Tanaka S, Nakamura K, Kawaguchi H, Akune 
T, & Yoshimura N (2015) Prevalence of diffuse idiopathic skeletal hyperostosis 
(DISH) of the whole spine and its association with lumbar spondylosis and knee 
osteoarthritis: the ROAD study. J Bone Miner Metab 33(2):221-229. 
9. Resnick D, Shaul SR, & Robins JM (1975) Diffuse idiopathic skeletal hyperostosis 
(DISH): Forestier's disease with extraspinal manifestations. Radiology 115(3):513-
524. 
10. Luo G, Ducy P, McKee MD, Pinero GJ, Loyer E, Behringer RR, & Karsenty G 
(1997) Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA 
protein. Nature 386(6620):78-81. 
11. Harmey D, Hessle L, Narisawa S, Johnson KA, Terkeltaub R, & Millan JL (2004) 
Concerted regulation of inorganic pyrophosphate and osteopontin by akp2, enpp1, 
and ank: an integrated model of the pathogenesis of mineralization disorders. Am J 
Pathol 164(4):1199-1209. 
12. Kornak U (2011) Animal models with pathological mineralization phenotypes. Joint 
Bone Spine 78(6):561-567. 
13. Johnson RC, Leopold JA, & Loscalzo J (2006) Vascular calcification: pathobiological 
mechanisms and clinical implications. Circ Res 99(10):1044-1059. 
14. Orimo H (2010) The mechanism of mineralization and the role of alkaline 
phosphatase in health and disease. J Nippon Med Sch 77(1):4-12. 
15. Olivieri I, D'Angelo S, Palazzi C, Padula A, Mader R, & Khan MA (2009) Diffuse 
idiopathic skeletal hyperostosis: differentiation from ankylosing spondylitis. Curr 
Rheumatol Rep 11(5):321-328. 
16. Belanger TA & Rowe DE (2001) Diffuse idiopathic skeletal hyperostosis: 
musculoskeletal manifestations. J Am Acad Orthop Surg 9(4):258-267. 
17. Mader R, Verlaan JJ, & Buskila D (2013) Diffuse idiopathic skeletal hyperostosis: 
clinical features and pathogenic mechanisms. Nat Rev Rheumatol 9(12):741-750. 
75	  
	  
18. Mader R (2008) Diffuse idiopathic skeletal hyperostosis: time for a change. J 
Rheumatol 35(3):377-379. 
19. Krishnarasa B, Vivekanandarajah A, Ripoll L, Chang E, & Wetz R (2011) Diffuse 
Idiopathic Skeletal Hyperostosis (DISH)-A Rare Etiology of Dysphagia. Clin Med 
Insights Arthritis Musculoskelet Disord 4:71-75. 
20. Zhang C, Ruan D, He Q, Wen T, & Yang P (2014) Progressive dysphagia and neck 
pain due to diffuse idiopathic skeletal hyperostosis of the cervical spine: a case report 
and literature review. Clin Interv Aging 9:553-557. 
21. Resnick D, Guerra J, Jr., Robinson CA, & Vint VC (1978) Association of diffuse 
idiopathic skeletal hyperostosis (DISH) and calcification and ossification of the 
posterior longitudinal ligament. AJR Am J Roentgenol 131(6):1049-1053. 
22. Armas JB, Couto AR, & Bettencourt BF (2009) Spondyloarthritis, diffuse idiopathic 
skeletal hyperostosis (DISH) and chondrocalcinosis. Adv Exp Med Biol 649:37-56. 
23. Kiss C, Szilagyi M, Paksy A, & Poor G (2002) Risk factors for diffuse idiopathic 
skeletal hyperostosis: a case-control study. Rheumatology (Oxford) 41(1):27-30. 
24. Mader R & Lavi I (2009) Diabetes mellitus and hypertension as risk factors for early 
diffuse idiopathic skeletal hyperostosis (DISH). Osteoarthritis Cartilage 17(6):825-
828. 
25. Tsukahara S, Miyazawa N, Akagawa H, Forejtova S, Pavelka K, Tanaka T, Toh S, 
Tajima A, Akiyama I, & Inoue I (2005) COL6A1, the candidate gene for ossification 
of the posterior longitudinal ligament, is associated with diffuse idiopathic skeletal 
hyperostosis in Japanese. Spine (Phila Pa 1976) 30(20):2321-2324. 
26. Senolt L, Hulejova H, Krystufkova O, Forejtova S, Andres Cerezo L, Gatterova J, 
Pavelka K, & Vencovsky J (2012) Low circulating Dickkopf-1 and its link with 
severity of spinal involvement in diffuse idiopathic skeletal hyperostosis. Ann Rheum 
Dis 71(1):71-74. 
27. Daniels G, Ballif BA, Helias V, Saison C, Grimsley S, Mannessier L, Hustinx H, Lee 
E, Cartron JP, Peyrard T, & Arnaud L (2015) Lack of the nucleoside transporter 
ENT1 results in the Augustine-null blood type and ectopic mineralization. Blood. 
28. Warraich S, Bone DB, Quinonez D, Ii H, Choi DS, Holdsworth DW, Drangova M, 
Dixon SJ, Seguin CA, & Hammond JR (2013) Loss of equilibrative nucleoside 
transporter 1 in mice leads to progressive ectopic mineralization of spinal tissues 
resembling diffuse idiopathic skeletal hyperostosis in humans. J Bone Miner Res 
28(5):1135-1149. 
29. Hisataka Ii SW, Neil A. Tenn, Diana Quinonez, David W. Holdsworth, James R. 
Hammond,  S. Jeffrey Dixon, and Cheryle A. Séguin (In Preparation) Investigating 
the expression of genes that regulate mineralization in a mouse model of diffuse 
idiopathic skeletal hyperostosis. 
30. Hinton DJ, McGee-Lawrence ME, Lee MR, Kwong HK, Westendorf JJ, & Choi DS 
(2014) Aberrant bone density in aging mice lacking the adenosine transporter ENT1. 
PloS one 9(2):e88818. 
31. Choi DS, Cascini MG, Mailliard W, Young H, Paredes P, McMahon T, Diamond I, 
Bonci A, & Messing RO (2004) The type 1 equilibrative nucleoside transporter 
regulates ethanol intoxication and preference. Nat Neurosci 7(8):855-861. 
32. Dang AK, Jain RW, Craig HC, & Kerfoot SM (2015) B cell recognition of myelin 
oligodendrocyte glycoprotein autoantigen depends on immunization with protein 
rather than short peptide, while B cell invasion of the CNS in autoimmunity does not. 
Journal of Neuroimmunology 278C:73-84. 
76	  
	  
33. Rawadi G, Vayssiere B, Dunn F, Baron R, & Roman-Roman S (2003) BMP-2 
controls alkaline phosphatase expression and osteoblast mineralization by a Wnt 
autocrine loop. J Bone Miner Res 18(10):1842-1853. 
34. Iwamoto T, Nakamura T, Doyle A, Ishikawa M, de Vega S, Fukumoto S, & Yamada 
Y (2010) Pannexin 3 regulates intracellular ATP/cAMP levels and promotes 
chondrocyte differentiation. J Biol Chem 285(24):18948-18958. 
35. Meininger CJ, Schelling ME, & Granger HJ (1988) Adenosine and hypoxia stimulate 
proliferation and migration of endothelial cells. Am J Physiol 255(3 Pt 2):H554-562. 
36. Shimegi S (1998) Mitogenic action of adenosine on osteoblast-like cells, MC3T3-E1. 
Calcif Tissue Int 62(5):418-425. 
37. Rozengurt E (1986) Early signals in the mitogenic response. Science 234(4773):161-
166. 
38. Schulte G & Fredholm BB (2003) Signalling from adenosine receptors to mitogen-
activated protein kinases. Cell Signal 15(9):813-827. 
39. Konnecke I, Serra A, El Khassawna T, Schlundt C, Schell H, Hauser A, Ellinghaus 
A, Volk HD, Radbruch A, Duda GN, & Schmidt-Bleek K (2014) T and B cells 
participate in bone repair by infiltrating the fracture callus in a two-wave fashion. 
Bone 64:155-165. 
40. Gao Y, Wu X, Terauchi M, Li JY, Grassi F, Galley S, Yang X, Weitzmann MN, & 
Pacifici R (2008) T cells potentiate PTH-induced cortical bone loss through CD40L 
signaling. Cell Metab 8(2):132-145. 
 
77	  
	  
 
 
CHAPTER 4 
DISCUSSION 
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4.1 Summary and Conclusions 
 The studies presented in this thesis aimed to elucidate the mechanism(s) associated 
with the ectopic mineralization of spinal tissues in ENT1-/- mice (1). We hypothesized that 
the ectopic mineralization observed in ENT1-/- tissues was caused by altered levels of 
adenosine and could be modeled in vitro following exposure of intervertebral disc cells to 
elevated extracellular adenosine. This hypothesis was explored with the following specific 
objectives: 
Objective 1: To investigate the role of adenosine signaling and alkaline phosphatase activity 
in ectopic mineralization of the IVD. 
Objective 2: To examine alterations in the annulus fibrosus cell phenotype between ENT1-/- 
and WT mice using global transcriptome analysis.  
  
 In Chapter 2, we characterized the expression and activity of alkaline phosphatase 
(ALP), a known promoter of mineralization, in the IVD of ENT1-/- mice. 
Conclusion 2.1:  Both in vivo and in vitro, AF cells from ENT1-/- mice demonstrate altered 
ALP activity (increased prevalence in the inner AF in vivo, increased overall activity in 
vitro). The maintenance of altered ALP activity in AF cells in vitro suggests that this 
represents a cell-autonomous change in ENT1-/- cells. Furthermore, the fact that ALP activity 
was not previously identified outside of the AF-vertebral body interface in IVD tissues (2) 
suggests an important role for ALP in the ectopic mineralization observed in ENT1-/- mice. 
Conclusion 2.2: Pharmacologic inhibition of ENT1, along with elevated extracellular 
adenosine, increased ALP activity in WT AF cell cultures, recapitulating in part the 
phenotype of ENT1-/- AF cells. 
Conclusion 2.3: Basal levels of adenosine receptor activation (indicated by intracellular 
cAMP levels) were not altered in ENT1-/- AF cells; however, levels of intracellular adenosine 
were significantly increased in ENT1-/- cells compared to WT controls.   
 In Chapter 3, we investigated differences in gene expression associated with the 
progressive mineralization of AF tissues in ENT1-/- mice. The global AF transcriptional 
profile was determined in 2- and 6-month-old WT and ENT1-/- mice to quantify changes in 
gene expression both preceding (2 months) and associated with (6 months) mineralization of 
the AF in ENT1-/- mice.  
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Conclusion 3.1: Microarray analysis validated, at least in part, our previous findings 
examining changes in the expression of genes associated with biomineralization in ENT1-/- 
AF tissues. Furthermore, we identified intriguing changes in AF gene expression that precede 
the accumulation of ectopic mineral, including alteration in WNT signaling, that may 
regulate and/or initiate the onset of mineralization.  
Conclusion 3.2: Bioinformatics analysis identified a common enriched biological signature 
in ENT1-/- AF tissues, suggesting that deregulation of cell cycle and the activation of B cell 
immune responses are associated with AF mineralization in ENT1-/- tissues.  
Conclusion 3.3: Functional characterization demonstrated a localized change in B cell 
accumulation in IVD tissues of ENT1-/- mice without accompanying changes in systemic B or 
T cell frequencies.  
 
4.2 Significance of Research 
Identification of mechanisms responsible for ectopic mineralization in a mouse model of 
diffuse idiopathic skeletal hyperostosis (DISH). 
 Disorders of ectopic mineralization affecting the paraspinal ligaments, including 
ossification of the posterior longitudinal ligament (OPLL) and DISH, are common disorders 
in the elderly, where the etiology remains unknown (3-6). Since diseases of ectopic 
mineralization, such as DISH, are largely asymptomatic in early stages and access to patient 
samples are limited, access to appropriate animal models is essential to characterize disease 
progression and assess the mechanisms involved. 
 Our group characterized a novel mouse model of DISH in mice lacking the 
expression of equilibrative nucleoside transporter 1 (ENT1-/-) (1). Equilibrative nucleoside 
transporter 1 (ENT1) is responsible for the bi-directional transport of nucleosides, such as 
adenosine, across the plasma membrane (7). ENT1-/- mice demonstrated lesions of ectopic 
mineralization, which resemble the radiographic appearance of patients diagnosed with DISH 
(1). Similarly, in patient populations with a null mutation in ENT1, researchers report the 
presentation of ectopic mineral formation in multiple joints (8). 
 In this study, we identified critical proteins, which may be involved in the ectopic 
mineralization in ENT1-/- mice. Alkaline phosphatase (ALP) is a necessary promoter of 
mineralization responsible for metabolizing pyrophosphate (PPi) into inorganic phosphate 
(Pi), ultimately supplying the substrate for calcium phosphate minerals (9). In Chapter 2 we 
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demonstrated a correlation between increased adenosine and increased ALP activity. 
Additionally, we show that increased ALP activity in ENT1-/- IVD tissues both in vivo and in 
vitro suggest an important role for ALP in the ectopic mineralization observed in ENT1-/- 
mice. 
It is well established that BMP-2 and WNT signaling control the expression and 
activity of ALP (10, 11). Several studies have investigated the ability of adenosine receptor 
signaling to induce ALP activity and expression in mesenchymal stem cells (MSC) and have 
implicated WNT signaling as a downstream effector (12-14). Interestingly, our 
characterization of the global gene expression profiles of AF tissues from ENT1-/- mice 
(Chapter 3) identified dickkopf 1 (Dkk1), an inhibitor of WNT signaling, as downregulated 
in AF tissues derived from 2-month-old ENT1-/- mice compared to WT, but not at 6 months. 
It is thus tempting to speculate that increased WNT signaling may regulate the induction of 
ALP activity in ENT1-/- AF cells, serving to initiate the ectopic mineralization. Further 
suggesting a key role for DKK1, deregulation of WNT signaling via reduced circulating 
levels of DKK1 has been associated with the onset of DISH (15). Conversely, we did not 
observe gene expression changes in the BMP-2 signaling cascade in our microarray analysis. 
These results provide a possible pathway responsible for elevated ALP activity observed in 
ENT1-/- mice and help to delineate the mechanism underlying ectopic mineralization.  
Unexpectedly, the global transcriptome analysis reported in Chapter 3 identified B 
cell-related immune response pathways as deregulated in AF tissues of ENT1-/- mice. The 
role of immune cells during bone healing has been gaining increasing interest (16). 
Interestingly, one study showed that during bone regeneration, B cells exert a prominent role 
during fracture healing (17). Furthermore, the increased expression of B cell associated 
chemokines (Cxcl12 and Cxcr4) in AF tissues and the IHC location of B cells within the AF 
tissues suggest that alterations in the immune system may indeed contribute to tissue 
mineralization or are in response to mineralization. 
Taken together, the findings from this thesis paired both in vivo and in vitro models to 
identify at least one potential mechanism responsible for ectopic mineralization. 
Furthermore, by global gene expression analysis, we have identified specific subsets of genes 
altered at the onset and in response to mineralization, providing numerous targets for 
subsequent studies. Finally, we have developed a novel in vitro culture model that will enable 
us to test and/or validate candidate effectors. Figure 4.1 shows a working model of WT cells 
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(left) following exogenous treatment to partially recapitulate the ENT1-/- phenotype and 
phenotypic observed in ENT1-/- cells (right). These findings may lead to the identification of 
risk factors and therapies to prevent and reverse DISH associated pathologies.  
 
4.3 Limitations of Research & Suggestions for Future Studies 
In Chapter 2, we developed an in vitro cell micromass culture model to investigate 
the mechanism involved in ectopic mineralization of AF tissues in ENT1-/- mice. The in vitro 
culture of primary AF cells is associated with certain limitations. First, the intervertebral disc 
is a heterogeneous tissue consisting of three different tissues (the nucleus pulposus, annulus 
fibrosus, and cartlagenous endplates) and, as a result, it was necessary to demonstrate that the 
primary cells isolated demonstrated the phenotype of AF cells. Due to the lack of cell-type 
specific markers to differentiate IVD cell types, we were not able to quantify the percentage 
of AF cells in culture, but relied instead on assessing cell type-associated markers by PCR.  
While this characterization suggests that cells demonstrated an AF and not NP cell 
phenotype, our findings are limited by the lack of robust cell type specific markers. 
Furthermore, the in vitro culture of primary AF cells was technically difficult due to low 
adherence of primary cells after enzymatic tissue dissociation. Reduced cell yields were 
further exacerbated by our desire to conduct in vitro studies using AF cells at low passage 
number (passage 1 or 2) to avoid cell de-differentiation and/or changes in cell phenotype. 
Furthermore, early experiments demonstrated that primary mouse AF cells were resistant to 
transfection using multiple methods, preventing the use of strategies associated with 
candidate gene overexpression or the use of plasmid-based reporter systems.  Finally, in vitro 
treatment of cell cultures with exogenous adenosine may be limited by its rapid metabolism; 
daily supplementation may not be sufficient to elicit a response similar to the physiological in 
vivo response.  
Chapter 3 presents bioinformatic analysis of data obtained from microarray-based 
evaluation of global gene expression. It is important to note that many of the changes in gene 
expression have not yet been validated by real-time PCR or protein quantification, both of 
which are experiments that are currently ongoing in the lab. 
In this study, we identified potential mechanisms responsible for ectopic 
mineralization in ENT1-/- mice; however, we are only scratching the surface of what may be  
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Figure 4.1. Working model illustrating candidate pathways influencing ectopic 
mineralization of AF cells, showing in vitro WT (A) and in vivo WT and ENT1-/- (B) models. 
A) In vitro WT AF cells (right) were treated with high extracellular adenosine and the 
pharmacological inhibitor of ENT1 (NBMPR) demonstrated increased alkaline phosphatase 
(ALP) activity (possibly mediated through adenosine receptor mediated signaling). Increased 
ALP activity promotes mineralization by metabolizing inorganic pyrophosphate (PPi) to 
inorganic phosphate (Pi), which is required for biomineralization. (B) In vivo ENT1-/- AF 
cells (right) exhibit elevated ALP activity (cell autonomous) along with elevated levels of 
intracellular adenosine observed in vitro. Decreased expression of the WNT inhibitor, 
dickopf 1  (Dkk1), may result in increased WNT signaling, which may contribute to the 
increased ALP activity. The presence of ectopic mineral in AF tissues may stimulate the 
expression of chemokines (i.e. Cxcr4, Cxcl12), promoting B cell localization to areas of 
mineral formation in the AF. Additionally, elevated serum levels of adenosine detected in 
ENT1-/- mice may activate adenosine receptors to increase cell proliferation. 
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involved in this pathology. As such, there are many future studies that can be undertaken 
using this model. In Chapter 2 we associated increased ALP activity with the induction of 
ectopic AF mineralization. Future studies may involve investigating the signaling pathway(s) 
responsible for the regulation of ALP. In the current study, we suggest that ALP is regulated, 
in part, by adenosine signaling; however, it would be interesting to see if WNT signaling is 
also associated with the aberrant activation of ALP in ENT1-/- mice. The potential role of 
WNT signaling is supported by observing the downregulation of Dkk1, an inhibitor of WNT 
signaling, in AF tissue from 2-month-old ENT1-/- mice compared to WT. Future studies could 
investigate if pharmacological WNT inhibition can prevent the increased ALP activity 
observed in ENT1-/- AF cultures or the induction of tissue mineralization in vivo.   
 Using our in vitro cell-based model, we observed that the addition of the ENT1 
inhibitor, NBMPR, alone was not sufficient to completely recapitulate the phenotype 
observed in ENT1-/- mice. As such, it would be interesting to test if long-term administration 
of the pharmacological ENT1 inhibitor results in ectopic mineralization in WT mice. If the 
administration of the ENT1 inhibitor recapitulates the ectopic mineralization, it would 
suggest that systemic factors are also involved in the pathology. In vivo pharmacological 
studies would help determine whether loss of ENT1 function directly results in ectopic 
mineralization or if it acts indirectly throughout normal development affecting 
mineralization.  
In Chapter 3, we assessed global differences in gene expression in AF tissues of 
ENT1-/- mice; however, without complementary protein or functional data, strong conclusions 
as to the role of candidate effectors cannot be drawn. Complementary analysis of differences 
in protein expression between AF tissues of the ENT1-/- mouse and age- and gender-matched 
WT controls could be conducted using mass spectrometry-based proteomics. Following up 
on the pathways generated by microarray analysis is crucial to validate potential effectors of 
disease initiation or progression in the ENT1-/- mouse model of DISH. Additional discovery-
based studies that may yield interesting results would be metabolomics analysis on both 
blood plasma and IVD tissues from WT and ENT1-/- mice. Metabolomic profiling can 
provide a snapshot of the physiology of a particular tissue, which may aid in elucidating the 
mechanism involved in ectopic mineralization in ENT1-/- mice. 
The experiments outlined above have the potential to provide valuable insight to 
delineate the mechanisms controlling the development of ectopic mineralization in ENT1-/- 
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mice, which could be correlated to changes in human DISH patients to develop possible 
therapies to prevent the formation or progression of ectopic mineralization. 
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APPENDIX A 
Gene Expression Analysis from Chapter 3 
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Table 3.1: Fold change in expression of probes altered in ENT1-/- AF at 2 months of age 
compared to WT AF tissue, but not 6 months. 
 
Gene Symbol Transcript ID RefSeq Fold Change 
Gm2083 17425990 NM_001134644 3.219 
Gm2083 17425888 NM_001134644 3.150 
Gm2083 17426062 NM_001134644 2.694 
Gm20727 17276817 ENSMUST00000164535 2.549 
AW822073 17240957 ENSMUST00000174056 2.508 
Gm2083 17425900 NM_001134644 2.464 
Mmp3 17514515 AK148467 2.290 
Mir3471-1 17423207 NR_037304 2.197 
mt-Tt 17550580 ENSMUST00000082422 2.154 
LOC100038987 17366314 XR_141508 2.139 
mt-Tt 17532635 ENSMUST00000082422 2.122 
mt-Tp 17532653 ENSMUST00000082423 2.108 
mt-Tp 17550582 ENSMUST00000082423 2.034 
Map3k6 17419553 AK014061 -2.000 
Dkk1 17363895 AK141693 -2.007 
Ggta1 17384484 AK004753 -2.024 
Adarb1 17242281 BC051107 -2.027 
Chac1 17374807 BC025169 -2.169 
Fam83d 17378958 AK040615 -2.175 
Wee1 17481743 AK011212 -2.283 
Stc2 17261425 AK002527 -2.335 
Klf15 17460826 AK007479 -2.963 
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Table 3.2: Fold change in expression of probes altered in ENT1-/- AF at both 2 and 6 months 
of age compared to each respective WT AF tissue. 
 
Gene Symbol Transcript ID RefSeq Fold Change 
Asb2 17459306 U54511 21.537 
Ear7 17549170 NM_017385 20.900 
Prg2 17372662 AK010901 19.391 
Igk 17459383 GQ984293 16.962 
Epx 17267520 AK132416 15.300 
Igkv9-120 17459321 L41880 11.163 
Ear7 17299638 NM_017385 8.474 
Igk 17459392 D88409 8.024 
A530064D06Rik 17345775 AK170607 7.509 
Cpa3 17404337 BC108409 7.330 
Ces2g 17504572 BC027185 7.291 
Rgs18 17227797 AK036407 6.777 
Apol11b 17318815 AY662646 6.755 
Bin2 17321768 NM_001270537 6.735 
Igkv1-133 17459294 Z17401 6.721 
Ndc80 17347042 AK011497 6.705 
Ltf 17531701 AK036491 6.583 
Prg3 17372670 AK158110 6.561 
Clec5a 17466228 AK036697 6.483 
Chi3l3 17408897 AK137503 6.478 
Kel 17466360 AK028430 6.471 
Hist1h2ab 17285867 BC117110 6.436 
Fpr2 17333731 AK054286 6.412 
Alox5 17470031 AK089344 6.398 
Birc5 17258867 AK018022 6.371 
Cdk1 17241692 AK030231 6.348 
Serpinb10 17216469 AK036537 6.346 
Gapt 17296128 BC116629 6.319 
Gm5593 17490038 XM_001005050 6.179 
Ltf 17522555 AK036491 6.084 
Top2a 17268909 AK033321 6.080 
Cdkn3 17299268 AK010426 6.042 
Hist1h1b 17291005 AK020117 6.020 
Itgam 17483577 AK039444 6.019 
Hist1h2bk 17285742 BC147143 6.004 
Ccr3 17523646 AK041106 5.991 
E2f8 17491378 AY957576 5.990 
Clec12a 17463509 BC094904 5.989 
Rrm2 17274540 AK088907 5.981 
Gp9 17460569 AB007464 5.929 
Kif11 17359020 AK050778 5.899 
Ms4a3 17362998 AK036464 5.840 
Asf1b 17503023 AK005646 5.805 
Alas2 17538575 AK002642 5.731 
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Mki67 17497334 AK052772 5.645 
Cks2 17547744 AK002451 5.640 
Cks2 17548303 AK002451 5.640 
Nkg7 17477101 AK010872 5.625 
Myo1f 17336114 AK021181 5.613 
Igh-VX24 17284379 L41878 5.562 
E2f2 17420024 AK087452 5.528 
Igh-VX24 17284354 AK035224 5.515 
Plk1 17482739 AK134045 5.505 
Aurkb 17251485 AK075951 5.500 
Trim10 17337458 AK011082 5.466 
Mpeg1 17357810 AK030216 5.450 
Ect2 17404402 AK040174 5.411 
Nckap1l 17315570 AK019793 5.353 
Kif15 17523494 AK050821 5.310 
Kif23 17527934 BC028559 5.291 
Pilrb2 17454187 AK036467 5.241 
Nxpe2 17526663 AK019469 5.230 
AI662270 17254194 AK028715 5.215 
I830077J02Rik 17408856 AK152510 5.202 
Slco4c1 17225837 AY654588 5.196 
Ermap 17429316 AK028170 5.190 
Itga4 17372307 AK039959 5.142 
Igk 17459389 FN422002 5.118 
Rhag 17337706 AK143851 5.109 
Nuf2 17229433 AK010351 5.098 
Gca 17371201 AK033740 5.069 
Slfn14 17266885 NM_001166028 5.056 
Igk 17459400 HE681447 5.055 
Casc5 17374692 NM_029617 5.040 
Bub1 17391376 AK021258 5.029 
Tspan33 17456710 AK004954 5.019 
Mfsd2b 17279864 AK133061 5.013 
Pik3cg 17280609 AK040543 4.998 
Cenpk 17289584 BC028655 4.969 
Kif18b 17270369 AK013867 4.968 
Arhgap11a 17389481 AK129034 4.940 
Ccnb2 17528586 AK013312 4.912 
Tubb1 17380360 BC147322 4.904 
Cd84 17219418 AK040694 4.900 
Hmbs 17526225 AK028234 4.876 
Serpinb1a 17291694 AK003930 4.870 
Tspan32 17485282 AK013248 4.823 
Arhgap19 17364707 AK016763 4.809 
Slc4a1 17270162 AK010967 4.784 
Plac8 17450121 AF263458 4.783 
Cdc6 17256225 AK012192 4.752 
Hmmr 17261840 AK020144 4.748 
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Ahsp 17549906 AK011084 4.743 
Hemgn 17425028 AK006588 4.721 
Ncaph 17391212 AK028919 4.693 
Cldn13 17453492 AK010869 4.676 
Far2 17464455 AK043388 4.671 
Plbd1 17472114 AK003169 4.640 
H2afx 17516558 AK008124 4.623 
Dtl 17231066 AK012919 4.619 
Mcm5 17502583 AK033196 4.609 
Epb4.2 17390371 BC053739 4.587 
AB124611 17515238 AB124611 4.583 
Gypa 17502789 AK145998 4.583 
Gatm 17390810 AK007325 4.577 
Rhd 17419799 AK079335 4.577 
Clec4e 17470627 AK036493 4.572 
Mis18bp1 17281428 AK164473 4.537 
Neurl3 17222149 AK040949 4.536 
Nusap1 17374833 AK042697 4.533 
Fam111a 17357815 AK018830 4.507 
Ncapg 17437278 AK017756 4.498 
Btnl10 17250149 AK029784 4.475 
Emr4 17338617 AK036459 4.474 
Gfi1b 17383413 AK157262 4.469 
Dck 17438823 AK004592 4.437 
5430401H09Rik 17280606 AK017255 4.416 
F830002L21Rik 17233027 AK089577 4.387 
Car2 17396162 AK002333 4.385 
Cks2 17287330 AK002451 4.364 
Stil 17417117 AK019471 4.349 
Pkhd1l1 17311350 AK143662 4.314 
Igk 17459421 GQ984293 4.257 
Hist2h2ab 17400539 NM_178213 4.245 
Trim59 17405789 AK079899 4.243 
Gm20236 17547835 XR_141751 4.229 
Gm20236 17547844 XR_141751 4.229 
Spta1 17219698 AK086017 4.225 
Esco2 17307774 AK083728 4.217 
Ptpn7 17217566 AK041415 4.206 
Cyfip2 17262065 AK018280 4.196 
Clec1b 17463520 AK007925 4.162 
Siglece 17490160 AF329269 4.158 
Stat4 17212724 AK037598 4.154 
Gm5593 17295757 XM_001005050 4.118 
Ccna2 17404821 AK044924 4.103 
Btk 17544491 BC053392 4.101 
Prkcb 17482766 AK051862 4.100 
Ska3 17307203 AK158142 4.079 
Ly86 17286587 AK027929 4.052 
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Mbnl3 17541618 AK030856 4.031 
Blvrb 17475580 AK153153 4.024 
Ank1 17500005 AK134267 4.000 
Gm12839 17428473 NR_033575 3.985 
Dhrs11 17267066 BC022224 3.937 
Rnasel 17218328 AK053125 3.927 
Ctss 17400375 AK028366 3.898 
Kif4 17536566 AK084837 3.889 
1190002F15Rik 17463724 AK012387 3.884 
Prr11 17267454 BC023918 3.873 
Pip5k1b 17363605 AK077334 3.868 
LOC664787 17366352 ENSMUST00000111423 3.867 
9430076G02Rik 17350673 AK020489 3.851 
Vcam1 17409649 AK016465 3.835 
Prom1 17447835 AK029921 3.811 
Cmpk2 17274620 AK004595 3.807 
Gp49a 17233210 AK089366 3.787 
Ube2l6 17372604 AK010942 3.785 
Car1 17404180 AK003066 3.780 
Klf1 17503254 AK158037 3.776 
Hp 17512809 AK150430 3.756 
Sp100 17214948 AK042095 3.729 
Zfpm1 17506356 AF006492 3.716 
Ctse 17217035 AK143581 3.681 
Igk 17459415 AM745100 3.663 
Emr1 17339013 AK133202 3.647 
Msrb1 17334419 AK002339 3.635 
Slc25a37 17308132 AK006155 3.635 
Fech 17354995 AK004718 3.609 
Cmah 17285944 AK040274 3.594 
Fhdc1 17406363 BC042779 3.587 
Ctsc 17480018 AK002454 3.579 
Reep6 17235320 AK002562 3.571 
Slfn3 17254188 AF099974 3.569 
F2rl2 17289281 AK089444 3.507 
Gm8995 17494674 AK134184 3.497 
Pf4 17438969 AK159278 3.469 
Alad 17426206 AK002300 3.413 
Ube2c 17379523 AK003722 3.377 
Snca 17467250 AK014472 3.360 
Cd68 17264835 AK002264 3.355 
Hbq1b 17248270 AK157060 3.350 
Nusap1 17374848 AK140455 3.341 
Nusap1 17550138 AK140455 3.341 
Ucp2 17480740 BC006072 3.332 
Mctp1 17288780 AK013379 3.328 
LOC101055672 17366201 XM_003945676 3.327 
Igk 17459347 BC045155 3.313 
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Ceacam1 17487952 BC016891 3.309 
Gp5 17329636 AK031272 3.302 
Gclm 17402283 AK028236 3.282 
Glrx5 17278345 AK009158 3.268 
Tlr8 17546101 AY035890 3.257 
Tuba4a 17224540 AK002427 3.227 
Rsad2 17280327 AK010906 3.225 
Lgals9 17266520 AK146044 3.213 
Ckap2l 17391544 AK012040 3.213 
LOC100040974 17366271 XM_003689476 3.048 
Hbb-bs 17494228 AK002258 2.996 
Dach1 17309041 AK047409 2.951 
Lyn 17411527 AK028112 2.944 
Slc16a1 17401335 AK033516 2.882 
Mlkl 17513076 BC023755 2.874 
Cd74 17350982 AK002232 2.873 
Mapk13 17335383 AK146993 2.857 
Ms4a7 17362953 AK018686 2.805 
Igkv19-93 17467392 ENSMUST00000103331 2.803 
Cxcl12 17462149 AK045092 2.770 
Ccne2 17411761 AK010929 2.756 
Igk 17459423 AM745100 2.558 
Clec1b 17463530 AK154961 2.544 
Rgs2 17227764 AK029310 2.455 
Sp100 17214979 ENSMUST00000145440 2.387 
Il1a 17391554 AK156449 2.386 
Timp1 17533713 BC008107 2.243 
Ifitm3 17497718 AK003407 2.194 
Slc19a3 17224942 AK079566 -2.039 
Timp4 17469879 AK038820 -2.079 
Galnt15 17298473 AK019470 -2.146 
4930417O13Rik 17463164 AK015159 -2.550 
Angptl7 17432976 AK031675 -2.550 
Rasgef1a 17462202 AK018120 -2.697 
Arhgap42 17523921 AK018520 -2.705 
Glp1r 17335726 AJ001692 -2.778 
Slc29a1 17345202 AK004756 -2.887 
LOC100504898 17548748 AK080917 -3.099 
2610204G07Rik 17289632 AK011877 -3.162 
Zbtb16 17526707 AK040211 -3.502 
1500015O10Rik 17212364 AK018770 -3.529 
Gpld1 17286055 AK004957 -3.555 
Gm15963 17236620 ENSMUST00000131387 -3.858 
4933400C23Rik 17520386 AK077069 -3.948 
Scel 17302490 AK020346 -4.850 
Tprg 17324479 AK017323 -6.121 
Serpina6 17283573 AK145842 -8.050 
Sectm1b 17273447 AK007321 -8.379 
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Table 3.3: Fold change in expression of probes altered in ENT1-/- AF at 6 months of age 
compared to WT AF tissue, but not 2 months. 
 
Gene Symbol Transcript ID RefSeq Fold Change 
Igkv4-59 17467453 M12767 23.059 
Ighg 17284334 AK134155 21.587 
Ighm 17284339 AK041235 20.592 
Igj 17449447 AK078865 12.902 
Igh-VJ558 17284574 X65767 12.860 
Ear3 17549898 NM_017388 10.731 
Ifitm6 17497724 AK039626 10.067 
Fcnb 17383353 AK010913 9.760 
Igkv4-72 17467430 AY835663 9.649 
Atp8b4 17391056 AK040903 8.811 
Igh-VJ558 17284605 BC110688 8.674 
Igkv4-91 17467398 X53350 8.567 
Ear1 17305520 AY316149 8.368 
Igkv4-71 17467435 ENSMUST00000101325 8.301 
Ctsg 17306975 BC125511 8.254 
Apol11a 17312669 NM_001177533 8.182 
Aoah 17285586 AK084452 7.551 
Camp 17531482 AK158005 7.289 
Ang5 17299101 ENSMUST00000066719 7.252 
Prtn3 17235002 FM210470 7.179 
Ighg 17284423 BC010327 7.023 
Ly6g 17312219 XM_001475753 6.893 
Igh-VJ558 17284314 BC018461 6.883 
Ighj2 17284360 ENSMUST00000103429 6.808 
Hbb-bt 17494221 AK002394 6.768 
Igh-VJ558 17284435 BC096617 6.753 
Cybb 17540154 AK033570 6.570 
Iglv1 17329013 BC046910 6.526 
A430104N18Rik 17254835 AK020764 6.516 
Igkv4-55 17467466 X72797 6.504 
Cxcr2 17214142 AK158234 6.432 
Cd177 17487759 BC005615 6.415 
Igk-V28 17467540 V00810 6.401 
Igkv5-43 17467483 X14625 6.267 
Igkv4-69 17467438 ENSMUST00000103349 6.164 
Cebpe 17306472 AK143561 6.107 
Trem3 17338371 AK079407 6.055 
Parvg 17313721 AK028329 6.020 
F630028O10Rik 17536383 AK036748 6.011 
Mpo 17254877 AK160229 6.009 
Ighm 17284399 GQ984292 5.921 
Abca13 17247241 AY160971 5.913 
Clec7a 17471541 AF262985 5.908 
Pglyrp1 17474371 AK008335 5.864 
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Tyrobp 17476364 AK154480 5.807 
Elane 17235011 AK143710 5.802 
Stap1 17438584 AK041474 5.786 
Csf3r 17418485 AK089305 5.776 
Klra2 17471828 AK017140 5.680 
Igkv4-68 17467441 X76023 5.661 
Gm12891 17548955 ENSMUST00000119358 5.640 
Cd53 17408960 AK156510 5.623 
Depdc1a 17403919 AK050456 5.592 
Mmp8 17514553 AK089234 5.470 
Glipr1 17244949 AK010768 5.469 
Rac2 17319037 AK007561 5.466 
Il1f9 17367652 AK081783 5.454 
Igh-VJ558 17284507 FM179740 5.421 
Alox15 17265229 AK142371 5.421 
Mcpt8 17306968 AK136485 5.413 
Gm11505 17267501 ENSMUST00000130442 5.383 
Ear12 17549888 NM_001012766 5.367 
Itgb2l 17332473 AK036640 5.365 
Sell 17218835 AK137509 5.350 
Ccl6 17266960 AK002697 5.347 
Cd33 17490149 AK046303 5.343 
Fpr1 17341276 AK137714 5.343 
Selplg 17451437 AK089188 5.339 
Lilrb4 17233226 AK089334 5.332 
Ptprc 17227536 AK054056 5.330 
Igsf6 17495839 AK040569 5.318 
Myb 17239664 AK036518 5.313 
Pilra 17454166 AK041413 5.292 
Itgb2 17234647 AK088435 5.204 
Igh-V7183 17284387 AB447365 5.199 
Ly6c2 17318100 BC092082 5.177 
Mrgpra2b 17491323 AK156116 5.113 
Ighm 17284633 L16690 5.088 
Iglv1 17329020 M34598 5.047 
Dock2 17261650 AK037611 5.034 
Rabggtb 17411319 BC057661 5.020 
Ikzf1 17247336 AK036833 4.952 
Plxnc1 17244439 AK011113 4.909 
Tlr13 17537081 AY510706 4.901 
Cxcr4 17226593 AK088663 4.819 
Iglv1 17329009 BC046910 4.810 
Vav1 17338982 AK088586 4.769 
Was 17539997 U29673 4.761 
Alox5ap 17444961 AK004002 4.746 
Plcb2 17389740 BC038048 4.719 
Cenpe 17402797 AK133445 4.686 
LOC100038947 17404217 AK155731 4.684 
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Slfn4 17254176 AK137559 4.659 
Klrb1f 17463482 AK041601 4.658 
Orm1 17414729 AK138985 4.646 
Tm6sf1 17479736 AY512939 4.611 
Cenpa 17435825 BC012280 4.611 
Trim30b 17494370 AK040770 4.589 
Uba7 17521541 BC022160 4.523 
Olr1 17471550 AK154687 4.518 
Knstrn 17374632 AK006328 4.518 
Kif14 17217789 AK087451 4.485 
Pld4 17279404 AK079878 4.481 
Stfa2l1 17325324 AK050597 4.468 
Clec4a2 17462764 AK020363 4.467 
Oip5 17389920 AK017825 4.464 
Prc1 17479575 AK029140 4.463 
Igll1 17328567 AK137514 4.447 
Ncf1 17453288 AK149619 4.436 
Pram1 17336157 AK169990 4.428 
Il1b 17391565 AK156396 4.399 
Hdc 17391094 AK076384 4.394 
Tnfrsf14 17433683 AF515707 4.390 
Adam8 17497525 AK089086 4.382 
Slfn2 17254166 AF099973 4.377 
Bex6 17324745 BC132130 4.375 
Grap2 17313147 AK030809 4.339 
Fermt3 17362223 AK090332 4.327 
Racgap1 17321597 AK052423 4.318 
Cdk6 17434297 AK078973 4.309 
Ckap2 17508025 AK034534 4.304 
Cdc20 17429177 AK011131 4.295 
Gpr97 17504207 AK014445 4.293 
Igh-VJ558 17284466 X14624 4.291 
Hist1h1a 17285879 BC116820 4.291 
Gpr141 17290894 AK154526 4.289 
Ncf4 17312700 AK150510 4.280 
S100a9 17407363 AK143826 4.268 
Cd52 17431174 AK088161 4.258 
Tpx2 17377793 AK011311 4.251 
Hcls1 17325438 AK040049 4.248 
Inpp5d 17215309 AK143560 4.244 
Mmp25 17341508 AK089273 4.241 
Dlgap5 17305789 AK036384 4.231 
Clec4b2 17462778 AK156711 4.199 
Gda 17363470 AK041056 4.198 
Padi4 17432014 AK084904 4.193 
Gm10521 17219431 XR_140471 4.155 
Ms4a6c 17357671 AK008652 4.128 
Napsa 17477508 AK002520 4.126 
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Lyl1 17503208 AK076114 4.126 
Spag5 17253570 AK052228 4.120 
Milr1 17257599 AK136488 4.116 
Pilrb1 17454179 AB122024 4.107 
Hist1h2ak 17291001 BC119335 4.105 
Sash3 17534555 AK156202 4.094 
Hmox1 17502573 AK150934 4.090 
Il2rg 17543572 AK143669 4.084 
Fyb 17309981 AK037454 4.077 
C330027C09Rik 17326081 BC021874 4.076 
Plek 17260761 AK033872 4.036 
Arhgap25 17468612 AK048450 4.016 
Ccr1 17532569 AK031109 4.012 
Ticrr 17479425 AK157802 4.012 
Gpr84 17322355 AF272948 4.009 
Nfam1 17319738 AK150635 3.995 
Nfe2 17322337 AK156702 3.991 
Atp1a3 17487805 AK053751 3.975 
Olfm4 17302279 AK133536 3.975 
Dnah8 17335628 BC032888 3.971 
Bub1b 17374569 AK088502 3.968 
Laptm5 17419287 AK031802 3.967 
Stmn1 17419773 AK002606 3.958 
Pole 17440465 AK136313 3.956 
Susd1 17425816 AK041075 3.953 
Aurka 17395016 AK077513 3.950 
Gm4759 17494668 NR_003967 3.946 
Ncapd2 17471023 AK011352 3.943 
Tfec 17464950 AK137141 3.936 
Cyp4f18 17510462 AK007863 3.933 
Rasgrp2 17356897 BC027446 3.921 
Ankrd22 17364090 AK037242 3.917 
Sla 17317637 AK036167 3.910 
Kif20a 17349433 AK051201 3.901 
Rps6ka1 17431101 AK132856 3.901 
Hist1h2ag 17291057 BC065803 3.883 
Gm5423 17233329 ENSMUST00000168554 3.879 
Kif18a 17374058 AK036722 3.866 
1810033B17Rik 17498730 AK007679 3.856 
5430427O19Rik 17536191 BC115576 3.838 
Rasgrp4 17476076 AK049562 3.837 
Ncapg2 17279608 AY455829 3.828 
Bank1 17410581 AK041071 3.827 
Lilrb3 17485589 AK142375 3.823 
Kif22 17496568 AK044826 3.820 
Cd37 17490702 AK154250 3.818 
Cit 17441275 BC031156 3.818 
Slc43a1 17372621 AK011417 3.817 
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Il7r 17315891 AK040364 3.813 
Tk1 17272594 AK085188 3.776 
Arhgap15 17370551 AK018058 3.770 
Cyth4 17312759 AK010908 3.764 
Gm6314 17548593 XM_916764 3.762 
B430306N03Rik 17338403 AK036709 3.760 
Slpi 17394153 AK010170 3.744 
Chek2 17440575 AK044913 3.738 
Apobec3 17313050 BC007182 3.738 
Trgv2 17290850 AK042318 3.730 
Hck 17377870 AK149736 3.724 
Hist1h4j 17285687 AK010085 3.722 
Tmem71 17317622 AK043745 3.721 
Hmgb2 17501292 AK003773 3.720 
Ptpn6 17470796 AK132509 3.718 
Dennd1c 17346477 AK014482 3.714 
Il18rap 17212252 AK053176 3.712 
Iqgap2 17295136 AK080384 3.712 
Myo1g 17260369 AK030825 3.702 
Kcnn4 17474941 AK010943 3.693 
Mmp9 17379606 AK004651 3.679 
Cst7 17377464 AK004420 3.675 
Fcer1g 17229658 AK155600 3.670 
Rrm1 17481102 AK049601 3.667 
Hk3 17292775 AK140444 3.662 
Irf8 17506279 AK018533 3.650 
Chaf1b 17327331 AK011243 3.650 
Mad2l1 17459236 AK008638 3.646 
Dock10 17224813 AK034064 3.627 
Slc40a1 17222777 AK008700 3.626 
Cd180 17289527 AK089255 3.626 
Snhg4 17349549 AK012754 3.619 
Pla2g7 17337796 AK005158 3.619 
Cenpn 17505913 AK012097 3.617 
Treml2 17338388 DQ087184 3.606 
Neil3 17509361 AB072931 3.606 
Trav9d-3 17300247 AB183189 3.606 
Hmha1 17235136 AK018130 3.603 
Lcp1 17301968 AK009211 3.601 
Ncf2 17218261 AK036379 3.600 
LOC101055663 17366278 XM_003945674 3.595 
Epsti1 17302141 AK017174 3.594 
Mtfr2 17231963 AK011410 3.582 
Spib 17490274 BC141118 3.574 
Mgam 17457609 AK031332 3.567 
Hist1h4m 17291019 ENSMUST00000102979 3.567 
Clec4a3 17462738 AK014135 3.562 
Gm15821 17343813 ENSMUST00000121995 3.562 
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Dbf4 17445507 AK014480 3.560 
Lilra6 17485609 AK030846 3.559 
Arrb2 17252013 AK089542 3.558 
Smc4 17398233 AK010848 3.550 
Fam117a 17255372 AK077747 3.549 
Cd48 17219397 AK007741 3.549 
Slc16a10 17240330 AK036743 3.527 
Lig1 17473856 AK053906 3.523 
Gm20506 17336494 ENSMUST00000172952 3.523 
Foxm1 17463401 AK041638 3.518 
I830127L07Rik 17318105 XM_909906 3.515 
Fcgr4 17219199 AK076532 3.511 
Slamf6 17219435 AK042280 3.505 
Cdca8 17429896 AK020070 3.499 
D930015E06Rik 17406285 BC023391 3.499 
D17H6S56E-5 17344140 AK037701 3.495 
Mcm2 17468798 AK037751 3.490 
Naip2 17295569 AF102871 3.478 
Add2 17460366 AK014496 3.478 
AI839979 17447013 AK036733 3.474 
Hvcn1 17442046 BC021548 3.465 
Clec4d 17462796 AK089500 3.461 
Tspan8 17237412 AK077301 3.459 
Atp8a1 17448475 AK039919 3.458 
Abcb4 17434585 AK050345 3.452 
Csf2rb2 17318950 AK154650 3.443 
1100001G20Rik 17254300 AK003352 3.441 
Mcm7 17454226 AK076059 3.439 
Fam65b 17285964 BC059179 3.436 
Ebi3 17338642 AK155023 3.434 
Tac2 17238141 AF186116 3.425 
Anln 17524969 AK013624 3.412 
Ccdc125 17289497 BC085249 3.406 
Themis2 17430906 AK137465 3.404 
Arhgdib 17472210 AK002516 3.398 
Ptafr 17419437 AK032547 3.397 
Ipcef1 17239005 AK081159 3.394 
Fignl1 17260633 AK051324 3.387 
AI504432 17401530 AK046860 3.384 
Ampd3 17481776 AK133465 3.384 
Hpse 17450142 AK040471 3.384 
Muc13 17325093 AK132274 3.372 
Stab2 17243763 AK034522 3.371 
Cdc45 17328978 AK134420 3.369 
Cd79a 17475127 AK143605 3.366 
Tnfsf13b 17498897 AK050384 3.364 
Fgr 17419483 AK036438 3.351 
Itgb3 17257235 AK156518 3.349 
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LOC100862024 17373177 XR_141964 3.347 
Lpcat2 17503841 AB244716 3.346 
Gria3 17534385 AK046158 3.343 
Syk 17287381 AK036736 3.340 
Vrk1 17278470 BC051072 3.340 
Lcp2 17248380 AK036727 3.333 
Unc93b1 17356002 AK030488 3.327 
Cdkn2c 17428217 AK003933 3.323 
Frrs1 17402072 AK075573 3.318 
Cdca5 17356622 AK199612 3.315 
Gm14198 17393184 ENSMUST00000153208 3.315 
Bard1 17223999 AK041449 3.315 
Clec4a1 17462729 AY397675 3.310 
Sirpb1a 17404209 BC039636 3.307 
Smc2 17414114 BC021847 3.300 
Ptplad2 17427051 AK016968 3.286 
Fmnl1 17257100 AK020206 3.281 
Cpox 17326428 AK089471 3.270 
Rassf4 17470060 AK036528 3.267 
Parpbp 17243850 AK030970 3.267 
Adpgk 17517934 BC094657 3.267 
Ceacam10 17475081 AK018529 3.266 
Slc38a5 17533093 AK054485 3.259 
Slc16a6 17271244 AK032026 3.257 
Gen1 17279962 AK045081 3.251 
Fes 17492575 BC049358 3.236 
Mlf1ip 17501025 BC094675 3.230 
Trim58 17250080 BC147805 3.228 
Ccr2 17523650 AK039755 3.222 
Gas2l3 17244057 AK136054 3.209 
Atp6v0d2 17423577 AK075745 3.208 
Aim2 17219643 BC009664 3.208 
Bst1 17437198 AK041059 3.205 
Gm8113 17299089 AK142214 3.203 
Cyba 17513672 BC060635 3.201 
Cep128 17282980 AK017333 3.200 
Rab32 17239227 AK012701 3.199 
Cd19 17496193 AK089835 3.198 
Cenpf 17230918 AK029517 3.194 
Aspm 17217914 AK048277 3.189 
Cd79b 17270837 AK143573 3.170 
Lrmp 17464210 AK040180 3.155 
Tfrc 17324835 BC067403 3.153 
Acap1 17265030 BC027569 3.149 
Stom 17384457 AK077435 3.146 
Coro1a 17496376 AK040885 3.145 
Lbr 17230550 AK028426 3.141 
Apobec1 17470580 AK146427 3.139 
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Hist1h2bh 17291177 AK158416 3.138 
Ccnf 17341781 BC021658 3.136 
Sema4a 17406760 AK035918 3.133 
Dapp1 17410617 AK076886 3.133 
Fn3k 17259623 AK010151 3.122 
Sp140 17214924 BC069971 3.121 
Lmo2 17373781 AK013416 3.119 
H2-Eb1 17336502 AK155968 3.115 
Hbq1a 17248282 AK039049 3.112 
Cfp 17540521 AK150212 3.111 
Pyhin1 17219662 AK076726 3.105 
Kntc1 17442332 NM_001042421 3.104 
P2rx1 17252523 AK007650 3.101 
Hist2h2bb 17400562 BC019122 3.098 
Iglv1 17329016 AF138741 3.096 
Fcgr2b 17229607 AK080885 3.093 
Brca2 17445162 AK087379 3.090 
Ttk 17519910 AK041487 3.088 
Sgol1 17345977 AK014357 3.087 
Rab8b 17528405 AK031251 3.086 
Diap3 17308965 AK137073 3.086 
Mxd1 17468511 AK036504 3.085 
Lta4h 17236531 AK005161 3.080 
Brca1 17269921 AK086173 3.080 
Tbxas1 17457472 AK048544 3.076 
Pim1 17335540 AK154127 3.070 
Slc7a8 17306477 AK044620 3.068 
Xdh 17347163 AK008517 3.063 
Atad5 17253858 AK048355 3.061 
Gpr56 17504190 AK087268 3.052 
Cenph 17295745 AK006208 3.052 
6330407A03Rik 17411545 NR_028126 3.051 
Parvb 17313705 AK143614 3.046 
H2-Q5 17337110 AK013097 3.045 
Fbxo5 17238974 AK011820 3.041 
Depdc1b 17289728 AK036550 3.041 
Epor 17524847 AK010968 3.040 
Mcm3 17221633 AK088142 3.035 
Fam107b 17366437 AK013932 3.031 
Dennd2d 17401480 BC008266 3.027 
Cers6 17371374 AK135798 3.025 
H2-DMb2 17336414 AK154923 3.025 
Nup210 17468961 AK036378 3.023 
Il10ra 17526492 AK137663 3.023 
Evi2a 17266590 AK005353 3.021 
Dyrk3 17226752 AK035114 3.020 
Cdca7 17371941 AK011289 3.017 
Wdhd1 17305757 AK036390 3.009 
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Slc11a1 17214197 AK090303 3.008 
Gm9733 17404195 DQ055452 3.007 
Cytip 17385405 AK030882 3.007 
Ptk2b 17307860 AK088696 3.004 
Sptb 17282025 AK052321 3.001 
Mapkapk3 17530863 AK051962 2.997 
Mns1 17519155 AK013048 2.994 
Shcbp1 17507288 AK051205 2.992 
Il1rl1 17212211 AK033417 2.991 
Hist1h2af 17285819 BC125011 2.988 
Mcm4 17328432 AK011743 2.987 
Nt5c3 17467128 AK160139 2.986 
Emb 17290083 AK010733 2.986 
Fam49b 17317486 AK028062 2.983 
Bglap3 17406730 BC069910 2.980 
Brip1 17267209 AK033205 2.977 
Igkj3 17459417 ENSMUST00000103407 2.975 
Prss57 17242687 AK013841 2.974 
Psd4 17367698 AK043669 2.974 
Akna 17426277 AK029701 2.970 
Csf1r 17351053 AK004947 2.968 
Fancd2 17461739 AK019136 2.968 
Kpna2 17271033 AK075952 2.968 
Ighv1-73 17284638 ENSMUST00000081809 2.959 
Fanci 17479371 BC025462 2.958 
Abcd2 17320652 AK051445 2.957 
2810417H13Rik 17518636 AK011090 2.957 
Dok3 17292915 BC048784 2.949 
Arl6ip1 17495466 AK090001 2.944 
Hells 17359212 BC090671 2.941 
Urod 17428735 AK002844 2.940 
Prkar2b 17280590 AK011647 2.939 
Ulbp1 17239040 AK085119 2.938 
Nxpe4 17516978 AK048132 2.934 
Gdpd2 17536600 BC023365 2.927 
Abca7 17235087 BC036566 2.922 
Acpp 17530406 AK020693 2.915 
4930438A08Rik 17249994 XM_001477470 2.913 
Lyz2 17245223 AK150998 2.906 
Il17ra 17462351 AK036587 2.906 
Fzr1 17243312 AK051993 2.901 
Glipr2 17413500 AK089960 2.900 
Aldh3b1 17361041 AK004004 2.898 
Kmo 17219789 AK133074 2.882 
Tnfaip2 17279131 AK087680 2.881 
Abcb10 17514033 AK081143 2.879 
Cd300ld 17271724 AK028662 2.878 
Rhog 17494081 AK143623 2.867 
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Rab27a 17519282 AK010373 2.862 
Tmc8 17258813 AK136329 2.861 
Abcg4 17526175 BC030301 2.860 
H2-T24 17344558 AK153655 2.859 
Rfc4 17329380 AK146954 2.857 
Gpr65 17277794 AK134113 2.857 
Nsl1 17220776 AK029421 2.857 
Ltb4r1 17300666 AK010895 2.856 
Ikzf3 17268820 AK004152 2.855 
Wdfy4 17304906 AK155186 2.855 
Pigq 17342509 AK016852 2.853 
Incenp 17362559 AK034764 2.849 
Ighm 17284500 GQ984290 2.847 
Lrg1 17346150 AK004940 2.846 
Abracl 17239501 AK013984 2.845 
Ogfrl1 17221756 BC041673 2.845 
Cdca3 17462958 AK008606 2.844 
Gm16538 17356523 ENSMUST00000162407 2.839 
Cenpl 17218682 AK028960 2.836 
Slc14a1 17355565 AK012066 2.833 
Mctp2 17492078 AK037524 2.828 
Gsr 17500478 AK019177 2.827 
Spic 17243943 AK041260 2.827 
Kit 17438272 AK046795 2.824 
Plk4 17397268 AK006459 2.822 
Cd226 17352330 AK036455 2.821 
Spc25 17386161 AK003408 2.817 
Rab3il1 17357425 AK004767 2.812 
Dna2 17233811 AK087594 2.811 
Chi3l7 17408885 AB081756 2.807 
Exoc6 17359055 AK076455 2.803 
Lipa 17364114 AK083099 2.800 
Itgal 17483264 AK141575 2.797 
Cdc25b 17376446 BC048164 2.797 
Hgf 17434933 AK042121 2.796 
B4galnt1 17237937 AK040324 2.795 
Paqr9 17520416 AK006159 2.794 
Gm5150 17404230 DQ055451 2.794 
Msra 17307695 AK002356 2.793 
Cd300lf 17271776 AK154273 2.791 
Pbk 17301428 AK003838 2.785 
Oas3 17452070 AK158392 2.784 
S1pr3 17287325 AK028043 2.781 
Cd3g 17526456 AK133993 2.781 
Pde2a 17480880 AK158354 2.780 
Melk 17413528 AK010498 2.778 
Cdca7l 17279701 AK149673 2.777 
Cnn2 17235077 AK051845 2.777 
104	  
	  
Ly9 17229767 AK040306 2.776 
Cdc25c 17353520 AK046840 2.775 
Pip4k2a 17382038 AK012196 2.773 
Tbc1d8 17222527 AK138630 2.773 
Gins1 17377525 BC027537 2.773 
Bcl11a 17247852 AK004395 2.772 
4632434I11Rik 17493358 BC066148 2.770 
Map4k1 17476036 AK011024 2.767 
AI467606 17483235 AK041954 2.765 
Zwilch 17528137 AK012004 2.765 
Cdt1 17506418 AK012041 2.765 
Tifab 17292990 AK220206 2.763 
Slc2a3 17470597 AK028041 2.760 
Atp2a3 17252497 AK089487 2.755 
Pstpip2 17352036 AK033996 2.755 
Hist1h2bg 17285834 BC060304 2.748 
Polq 17325454 AK020790 2.748 
Mkrn1 17466119 AK004225 2.743 
Gpcpd1 17391997 AK009137 2.742 
Hebp1 17472063 AK165308 2.742 
Samd11 17434061 AK149268 2.741 
Gm13157 17432770 AK163132 2.740 
9830166K06Rik 17362447 AK036719 2.726 
Oasl2 17441037 AK010034 2.726 
C1qb 17431607 AK140712 2.725 
Hmgn2 17510494 NM_016957 2.725 
Me2 17355391 AK039906 2.724 
Arg2 17276776 AK137142 2.724 
Anp32b 17548324 AK165807 2.717 
Siglecg 17477073 AK042488 2.716 
Aqp1 17458813 AK081886 2.711 
Pole2 17281506 AK011194 2.711 
Pik3ap1 17364642 AK087295 2.709 
Tacc3 17436457 AK076282 2.709 
Gm11274 17285693 ENSMUST00000146857 2.707 
Casp4 17514435 AK078836 2.704 
Casp1 17514424 AK132826 2.700 
Gm15448 17485649 XM_003084682 2.700 
Ranbp10 17512511 AY337314 2.698 
Tcf19 17344336 AK004231 2.696 
H2-T23 17344568 BC004093 2.695 
Kng2 17329361 AY462056 2.694 
Gm20161 17343076 AK137594 2.690 
Rad51ap1 17471201 BC040809 2.688 
Cdca2 17307969 AK031083 2.686 
Tmem173 17353663 BC046640 2.686 
Itga2b 17270222 AK048700 2.684 
Cybb 17533223 AK160031 2.681 
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Fli1 17525310 AK036655 2.680 
Stxbp2 17498699 AK088364 2.677 
Dennd4a 17518378 NM_001162917 2.676 
Aldh1a1 17358103 BC054386 2.675 
Eif2ak1 17444398 AK014775 2.673 
Hist2h2ac 17408011 BC117094 2.667 
Hist4h4 17548561 AK045187 2.665 
Hpcal1 17274310 AK002849 2.664 
Apbb1ip 17367536 AK021331 2.657 
Mms22l 17412237 AY512923 2.655 
Gm16494 17345666 ENSMUST00000165525 2.653 
Psat1 17363204 AK032487 2.652 
Hist1h3d 17285842 AK020421 2.651 
Igk-V4 17467407 L12155 2.648 
Gypc 17353337 AK002769 2.647 
Mybl2 17379206 AK028497 2.646 
Sord 17375396 AK004692 2.645 
H2-Q9 17337120 ENSMUST00000173016 2.643 
E2f1 17393160 AK017841 2.639 
Hsd11b1 17231229 AK149518 2.635 
Wfdc17 17254289 BC038870 2.634 
Stk17b 17223069 AK014023 2.633 
Cenpi 17537648 BC024848 2.629 
Ubash3a 17335798 AK040572 2.628 
H2-Q9 17549216 NM_001201460 2.627 
Mmrn1 17459097 AK014984 2.626 
Tipin 17518331 AK003802 2.625 
Rgs19 17395933 AK003967 2.624 
Plcl2 17338521 AK134985 2.624 
Pou2af1 17517209 AK088587 2.623 
Il1r2 17212174 AK132264 2.622 
Atad2 17317233 AK134319 2.620 
6030468B19Rik 17258834 NM_029964 2.620 
Nrg1 17508609 AK048708 2.618 
1700020L24Rik 17254244 AK006174 2.615 
Nbeal2 17531591 BC157956 2.614 
Prdx2 17503287 AK005225 2.614 
St8sia4 17225815 AK003690 2.613 
Tcn2 17259907 AK133707 2.613 
Ncoa4 17298510 AK014479 2.611 
Sft2d1 17262046 ENSMUST00000093169 2.609 
Nrm 17337269 BC021750 2.608 
Gpsm3 17336595 AK144833 2.607 
Tfpi 17387407 AK028356 2.605 
Cotl1 17513491 AK007994 2.599 
Dpp4 17385719 AK040409 2.598 
Fcrla 17229596 AK041572 2.598 
Hpgds 17467269 AK020246 2.596 
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Gm6594 17548012 ENSMUST00000097278 2.596 
Sorl1 17525894 AK029071 2.595 
Cd244 17219382 AK033178 2.593 
Mpl 17429191 AK041166 2.590 
Gm16372 17280294 ENSMUST00000073088 2.587 
Gp6 17485713 AK079424 2.587 
Arhgap9 17237984 AK047280 2.584 
Stx11 17239354 AK017897 2.576 
Ccl9 17266952 AK151131 2.576 
Mir5123 17424088 NR_039584 2.575 
4930422G04Rik 17402485 NM_197997 2.575 
Tagap 17333023 BC030886 2.574 
Casp3 17501041 BC021500 2.574 
Treml1 17338425 AY078502 2.573 
Tubb5 17344444 AK010960 2.572 
St3gal5 17459591 AK012961 2.572 
Tlr7 17546109 AK036549 2.570 
Tspo2 17345802 AK011003 2.569 
Gm13710 17387426 ENSMUST00000126679 2.563 
Emilin2 17346975 AK154230 2.562 
Gsto1 17360216 AK027922 2.557 
Ammecr1 17545078 AK018092 2.552 
Lmnb1 17350740 AK079511 2.551 
Slc25a5 17534112 AK002283 2.548 
Lair1 17485673 AK017222 2.546 
Col1a1 17255260 BC042642 2.543 
Cd7 17273440 AK136444 2.542 
Slc6a20a 17532509 AK043297 2.539 
Epb4.1 17430729 AK019923 2.539 
Tmem156 17448256 XM_144292 2.538 
Asns 17464718 AK076207 2.538 
Tmem8 17334846 AK044384 2.538 
H2-DMa 17336407 AK146950 2.532 
Arhgap4 17542450 AK040687 2.531 
Celf2 17381475 AK037436 2.531 
Klra17 17471635 AK080021 2.531 
Slamf1 17219407 AK016818 2.531 
Pml 17527678 AK028044 2.527 
A530032D15Rik 17225080 ENSMUST00000161675 2.526 
Gpnmb 17458439 AK044764 2.526 
Trem1 17338364 AK089439 2.525 
Nanp 17340397 AK005566 2.523 
H2-Q7 17337133 BC090638 2.521 
Sephs2 17496651 AK077573 2.521 
Wdr76 17375308 AK031592 2.519 
B4galt6 17352985 AK137385 2.518 
Tmsb4x 17546093 AK010659 2.516 
Clca1 17410845 AK032511 2.514 
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Dmtn 17308413 AK046217 2.512 
Pag1 17404058 AK040230 2.512 
Gm13012 17431740 XR_168838 2.512 
Serpina3b 17278261 AK037160 2.509 
BE692007 17362966 AK079938 2.507 
Ccl5 17266946 AK003101 2.504 
Gm1966 17494677 NM_001277179 2.502 
Trak2 17223446 AK014647 2.502 
BC035044 17471473 AK088258 2.501 
Ms4a6b 17357688 AK007613 2.501 
Aqp9 17528644 AK006167 2.495 
Pik3cd 17433169 AK011923 2.493 
E2f7 17237186 AK051521 2.489 
Dnajc9 17303757 AK043725 2.487 
Plaur 17474974 AK002580 2.487 
Apol8 17318822 AK036408 2.486 
Rpia 17467556 AK137235 2.481 
Mpp1 17542751 AK036415 2.477 
Blnk 17364565 AK089704 2.477 
Ifi204 17230045 BC010546 2.477 
Pola2 17361855 AK020656 2.476 
Tarm1 17485510 DQ973493 2.475 
Gmip 17501721 AK019874 2.474 
Cd4 17470960 AK040115 2.472 
Lfng 17444106 AK004642 2.472 
A130040M12Rik 17550474 AK037717 2.471 
Btla 17325938 AY293285 2.470 
Ly6e 17312209 AK014207 2.470 
Gch1 17305748 AK150657 2.465 
Ezh2 17466507 AK088575 2.462 
Rasa3 17507637 AK053353 2.462 
Myh9 17318830 AK083071 2.455 
Fn3krp 17259613 AK034934 2.450 
Samhd1 17393658 AK054490 2.450 
Cd72 17424608 AK134132 2.449 
1300017J02Rik 17530269 AK005035 2.447 
Slc25a21 17281312 AK036988 2.447 
Rnf123 17531080 AK137599 2.436 
Ccl3 17266967 AK137525 2.432 
Dhfr 17289085 AK031241 2.432 
Hist2h2aa1 17400545 AK002725 2.431 
Hist2h2aa1 17408017 AK002725 2.431 
Bora 17302362 AK020138 2.430 
LOC101056305 17343710 XM_003945997 2.426 
Cmas 17464146 AK087150 2.424 
Sipa1 17361683 AK028151 2.420 
Hmga1 17259507 AK010617 2.416 
Ube2o 17272415 AK035970 2.413 
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A730089K16Rik 17548458 AK036552 2.411 
Ubac1 17382802 AK004060 2.410 
Ankrd13a 17440998 AK039432 2.409 
Terc 17408052 NR_001579 2.407 
Sirpb1a 17404200 BC039636 2.407 
Cdk2 17246299 BC026145 2.406 
Ighm 17284396 AK144480 2.405 
Xk 17533207 BC027097 2.404 
4632428N05Rik 17233646 AK162635 2.403 
Alox12 17265193 AK036898 2.402 
Baz1a 17281148 AK135668 2.398 
LOC73899 17360344 AK014661 2.398 
Cpt1a 17355915 AK050213 2.396 
F730016J06Rik 17368633 AK089376 2.395 
Uhrf1 17338747 AK075819 2.393 
Gm13139 17421476 NM_001083918 2.392 
Mir687 17308598 NR_030459 2.390 
Gm21188 17296558 XM_003688909 2.390 
Ypel4 17372592 AK043577 2.389 
Espl1 17315352 AK076351 2.389 
G6pdx 17542695 AK088135 2.388 
Pqlc1 17352146 AK009256 2.386 
Rnase6 17299585 AK038708 2.386 
Metap2 17244378 AK053691 2.386 
Oas1b 17441759 AK080152 2.385 
Usp18 17462437 AK004296 2.376 
Rad54l 17428553 AK030753 2.375 
Ncapd3 17515577 AK014555 2.374 
Nek2 17220844 AK077627 2.373 
Slamf7 17229782 AK016183 2.373 
Atg4a 17538206 AK041379 2.372 
Gpx1 17521681 AK002245 2.371 
Abtb1 17468765 AK049100 2.369 
Pgd 17433040 AK002894 2.367 
Pkmyt1 17334102 AK031787 2.367 
Ptdss2 17484752 AK021249 2.366 
Stk10 17248309 AK148118 2.366 
Troap 17314712 AK021408 2.364 
Gnpda1 17353948 AK077625 2.361 
Rassf2 17391920 AK028384 2.360 
Tlr6 17448251 AK137502 2.357 
Plscr1 17520315 AK003628 2.354 
Mis18a 17331987 AK011719 2.353 
Ggt5 17234403 AK029138 2.350 
Prkcd 17304406 AK144231 2.350 
A930006K02Rik 17327066 AK020819 2.349 
Rfc5 17451867 AK011489 2.343 
Fam46c 17408414 BC018793 2.339 
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Ppox 17229681 AK134341 2.338 
D730005E14Rik 17319364 AK035732 2.336 
Orc1 17416690 AK042130 2.334 
Tmem40 17469919 BC019416 2.329 
Pstpip1 17517554 AK037936 2.329 
Rnaseh2b 17301131 BC047997 2.329 
H2-Q6 17337122 NM_207648 2.328 
Ifih1 17385797 AK018602 2.328 
E2f4 17504715 BC027030 2.326 
Snord53 17339499 NR_028551 2.325 
Gm15987 17471480 AK040061 2.325 
Gm14005 17391406 AK144927 2.324 
GM8989 17494664 ENSMUST00000179307 2.321 
Nt5dc2 17298364 AK010966 2.320 
Fcho1 17510428 AK137333 2.319 
Slc7a5 17513641 AK142288 2.318 
Kcnj10 17219536 AK031990 2.318 
Tm4sf19 17324787 BC147727 2.316 
Asap1 17317500 AK132979 2.316 
Suv39h1 17539986 AK021174 2.316 
Bmp2k 17439481 AK046752 2.314 
Iqgap3 17398929 BC068159 2.313 
Gna15 17243382 AK010411 2.313 
5330427O13Rik 17547829 XR_141214 2.312 
Kif20b 17358838 AK045067 2.312 
Gins2 17513525 AK028375 2.311 
Kif2c 17428803 AK015046 2.310 
Trim30d 17494408 AK136456 2.310 
Cenpm 17319596 AK010885 2.309 
Tnfrsf26 17498301 AK142511 2.308 
Ighm 17284349 BC096772 2.305 
Reep4 17301757 AY562232 2.303 
Tcrb-J 17457804 AB183190 2.300 
Cdc25a 17522235 AK036499 2.299 
Fen1 17362609 AK042942 2.299 
Tfr2 17443613 AK004848 2.297 
Tspan14 17305211 AK030593 2.293 
C1qc 17431612 BC069926 2.293 
Fam132a 17422832 AK002876 2.292 
Dscc1 17317115 AK052329 2.290 
A130040M12Rik 17267418 AK037717 2.289 
Tal1 17417138 AK144164 2.288 
Col1a2 17455801 AK031577 2.287 
Spdl1 17261710 BC025900 2.287 
Gm18853 17494649 NR_040456 2.285 
Capn1 17361890 AK088547 2.284 
Naip6 17295607 AK136436 2.284 
Glrx 17288716 AK013722 2.282 
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Kif21b 17217728 AK048770 2.282 
Nfkbid 17476372 AK155969 2.281 
Grk6 17287682 AK051405 2.280 
Slc25a51 17424945 AK020275 2.280 
Gclc 17519579 AK143228 2.279 
Apeh 17531130 BC005716 2.278 
Gm12999 17419420 ENSMUST00000124471 2.278 
Osbpl8 17237219 AK050244 2.276 
Rbm38 17380199 BC006687 2.274 
Cep55 17359098 AK012311 2.274 
Slbp 17447128 BC025113 2.271 
Tnfrsf1b 17432674 AK004752 2.270 
Cenpq 17344990 AK011998 2.270 
Gm18853 17494662 NR_040456 2.269 
Atp6v1b2 17501652 AK146499 2.269 
Psme3 17256673 AK140597 2.267 
Ccdc18 17440164 AK016519 2.265 
Pmf1 17406745 AK011174 2.265 
Il4ra 17482943 AK034466 2.259 
Slfn1 17254171 AK138710 2.259 
Adrbk1 17361223 BC033272 2.256 
Tmcc2 17226874 AK172720 2.255 
Gm20269 17506327 XR_106131 2.254 
Ccnd3 17338269 AK083384 2.253 
E230029C05Rik 17480074 AK046045 2.250 
Casp7 17360561 AK079250 2.250 
Slfn9 17266851 AK050355 2.249 
Unc119 17253630 AK131955 2.248 
Rbl1 17393684 AK033402 2.248 
Vars 17336838 AK019157 2.247 
Sema4b 17479497 AK028896 2.246 
Ifrd2 17521454 AK002702 2.246 
Pklr 17399266 AK149508 2.245 
Kif24 17424219 AK016916 2.244 
Selp 17218845 AK136243 2.243 
Tom1l1 17267745 AK009826 2.242 
Pcna 17391971 AK012614 2.241 
Haus4 17306384 AK186048 2.241 
Gpm6a 17501191 AK003422 2.241 
Igfbp4 17256264 AK003243 2.239 
Shkbp1 17488221 AK047434 2.237 
Chaf1a 17338701 AK034839 2.235 
Fbln5 17283380 AK084895 2.234 
Zfand4 17462092 BC019579 2.232 
Cd3e 17526464 BC028636 2.232 
Hist1h2bb 17285863 BC116853 2.232 
Xpo7 17308454 AK028303 2.231 
Gbp7 17403224 AK036666 2.229 
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Ighm 17284373 M26466 2.227 
Gsap 17435055 BC043137 2.227 
Ighj2 17284358 ENSMUST00000103429 2.226 
Prdx5 17362101 AK002383 2.225 
Coro2a 17425058 AK030097 2.225 
Cyb5r4 17520043 AK009272 2.224 
Rassf5 17226757 AK005059 2.223 
Taldo1 17484881 AK003092 2.220 
Mmp13 17514482 AK150728 2.219 
Slc37a2 17525578 AK028984 2.219 
Mrc1 17367102 AK156137 2.218 
Mogat2 17493643 AK049560 2.217 
Trpc6 17514623 AK133864 2.215 
Anp32b 17413821 BC003489 2.213 
Ly6g5b 17344216 BC131964 2.213 
Cecr2 17462373 AK137536 2.211 
Rad18 17469636 AK012795 2.211 
Cndp2 17355825 AK003779 2.210 
Man2b1 17503397 BC052517 2.209 
P2ry14 17405463 AK039791 2.208 
Slc28a2 17375454 AK080957 2.207 
Gm7148 17378678 ENSMUST00000061746 2.207 
Fam78a 17383825 BC137951 2.206 
Atpif1 17430878 AK008346 2.205 
Prss34 17334638 AK081986 2.204 
Oscar 17485520 AF391159 2.204 
Dsn1 17393620 AK006246 2.204 
Abcg3 17450414 BC029095 2.204 
Gm20634 17400549 ENSMUST00000090779 2.202 
Arap3 17353881 BC069932 2.202 
Gad1-ps 17236892 ENSMUST00000167243 2.202 
Limd2 17270730 AK171794 2.200 
Gtse1 17313895 AK012870 2.200 
2310005G13Rik 17331092 AK036849 2.198 
Lpcat1 17288467 AB244717 2.195 
Cklf 17504422 BC027684 2.194 
Frmd4a 17366451 BC082808 2.194 
Kctd12 17309154 AK032276 2.193 
Gm4070 17494651 AY167973 2.192 
Samd14 17255335 AK044765 2.192 
Gm15915 17244371 AK131848 2.192 
Tmpo 17244191 AK011988 2.191 
Haus6 17426956 AK173206 2.189 
Rfwd3 17513061 AK146451 2.189 
Pik3r5 17251303 BC115850 2.188 
Mastl 17382169 AK150580 2.187 
Gm10872 17318422 NR_045747 2.186 
Lin9 17220148 BC099695 2.186 
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Actn1 17282226 BC038919 2.185 
Adam19 17248754 AK147217 2.185 
Dnmt1 17524535 BC022927 2.185 
Kcnab2 17433493 AK143166 2.184 
Stx2 17453087 AK146462 2.182 
Coro7 17327765 BC028650 2.181 
Mtss1 17317327 AK030533 2.181 
Gata1 17539966 AK146915 2.179 
Adam10 17519088 AK036599 2.178 
Tinagl1 17430576 AK003901 2.177 
Tmem194 17238097 AK132974 2.174 
Il1rl2 17212199 AK054530 2.174 
Art4 17472185 AK004744 2.174 
Dpep1 17506532 AK002380 2.173 
Nabp1 17222825 AK042351 2.171 
Exo1 17219848 AK028728 2.170 
Bak1 17342676 AK089220 2.170 
Klhl6 17329063 AY350736 2.169 
Flna 17542588 AK089195 2.169 
Fcer1a 17229974 BC125455 2.165 
8430419L09Rik 17463761 BC137674 2.160 
2810442I21Rik 17260747 AK013290 2.159 
Lst1 17344303 AF000428 2.158 
D1Ertd622e 17225888 BC034088 2.156 
Sh2d1b1 17219171 AK089191 2.156 
Memo1 17347210 AK053089 2.156 
Ubash3b 17525868 AK013361 2.155 
Fanca 17513908 AK019196 2.154 
Stat1 17212750 AK018544 2.154 
Usp46 17448847 AK029604 2.153 
1810058I24Rik 17457297 AK004512 2.149 
Khsrp 17346427 AK018152 2.149 
Mcph1 17499540 AY070216 2.147 
AU020206 17492239 XR_105121 2.145 
Rogdi 17327876 AK002523 2.142 
Ube2s 17485937 AK003078 2.141 
Afmid 17258851 AF399717 2.139 
Rab44 17335480 BC139372 2.138 
Zeb2 17384951 AK031541 2.137 
Myh9 17318875 AK052845 2.135 
Zbtb14 17548038 AK080769 2.135 
Dgat1 17318502 AK008995 2.131 
Trim12a 17494353 AK009769 2.130 
Gm19279 17548763 XR_140947 2.130 
Mcm10 17381306 BC023236 2.130 
Cd97 17510948 AK004577 2.126 
Irf9 17300591 AK043697 2.124 
Gimap4 17458362 BC005577 2.124 
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Gm13371 17383366 ENSMUST00000137756 2.124 
Tbc1d10c 17361153 BC094901 2.123 
Psmb10 17512554 AK144096 2.121 
Micall2 17454428 AK151086 2.121 
Gm5637 17548850 ENSMUST00000153890 2.119 
Tmem14c 17286732 BC069899 2.118 
Ly75 17385574 AK049301 2.117 
Bmx 17545955 AK036707 2.116 
Zfp367 17293665 AK033288 2.115 
Nrgn 17525649 AK002933 2.115 
Ms4a6d 17362973 AK004295 2.114 
BC030867 17256910 BC019642 2.114 
Plekho2 17528274 BC028908 2.112 
Tubb5 17548000 AK010960 2.112 
Cd69 17471502 AK017979 2.111 
Gm7665 17352882 ENSMUST00000076710 2.110 
Specc1 17250638 AK032662 2.106 
Ly6d 17318020 BC025135 2.104 
Zdhhc14 17332766 AK036699 2.104 
Ehd1 17548123 BC018268 2.102 
Plin2 17426981 AK002911 2.102 
Ttyh3 17454574 BC059083 2.102 
Fcgr3 17229620 AK077227 2.102 
Hmgn2 17431136 AK146285 2.099 
Blm 17492619 AK137022 2.098 
Rhou 17506697 AK009513 2.098 
Ms4a8a 17362874 AK008099 2.098 
Fmnl2 17370807 AF513716 2.097 
Cep76 17355213 AK035879 2.097 
Pfkfb4 17522110 AK048999 2.096 
Rffl 17266797 AK006757 2.095 
Mir5104 17231600 NR_039563 2.094 
LOC100041057 17366244 ENSMUST00000111360 2.094 
Pnp 17299551 AK049817 2.093 
Ifi30 17510136 AK077725 2.092 
Rfc2 17443114 AK011353 2.091 
Prkab1 17451769 AK088250 2.088 
Ms4a14 17362941 XM_908720 2.086 
Azin1 17316700 BC046814 2.085 
Zyx 17457942 AK031415 2.085 
Abi3 17268227 AK008928 2.085 
Ebf3 17497366 AK138602 2.084 
BC064078 17463478 AK134020 2.084 
Pnkp 17477597 AK049992 2.083 
C5ar1 17486864 AK150407 2.080 
2700099C18Rik 17340411 AK012623 2.079 
Irak3 17245399 AK014783 2.079 
Irf5 17456692 AK150598 2.079 
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Nuak2 17217182 AK004737 2.078 
Gpr128 17331059 AK033593 2.077 
Trim30a 17494394 AK089726 2.074 
Itpripl1 17391233 BC130218 2.074 
Galns 17513779 AK033946 2.074 
Ikbke 17226771 AK088580 2.073 
Rhoh 17437830 AK017885 2.072 
1500012F01Rik 17379871 ENSMUST00000136378 2.070 
Ly6i 17318076 AF232024 2.070 
Lincred1 17373778 JQ173108 2.070 
Rb1 17308570 AK011246 2.069 
Hist1h2an 17291012 NM_178184 2.067 
Entpd1 17359344 AK028625 2.067 
Arhgef39 17424633 AK087493 2.065 
Samsn1 17331543 AK041340 2.064 
F10 17499224 AK149449 2.063 
Bglap 17406737 NM_001037939 2.063 
Sh3bp1 17312800 AK145156 2.061 
Tfdp1 17499310 AK013180 2.059 
Usp32 17267115 NM_001029934 2.057 
Faim3 17216976 AK007714 2.055 
Rad51 17374722 AK011242 2.055 
Trpv2 17250710 AK008689 2.054 
Il2rg 17536665 ENSMUST00000033664 2.054 
Arhgap30 17219324 AK030911 2.053 
Asb1 17215788 BC049699 2.053 
Topbp1 17520932 AK031389 2.053 
Gm4070 17494656 AY167973 2.050 
Oas2 17452054 AK049218 2.050 
Slc2a6 17383216 BC025498 2.049 
Serpinb2 17216458 AK081487 2.047 
E2f3 17291559 AK085296 2.046 
Rab3d 17524827 AK048395 2.046 
B3gnt5 17323828 AK032911 2.045 
2610318N02Rik 17328610 AK012048 2.045 
Htr2a 17301926 AK053140 2.043 
Slc25a39 17270193 AK002381 2.042 
Ak2 17418904 AK010936 2.040 
Sass6 17402052 AK145076 2.040 
Adrb2 17354857 AK080241 2.040 
Tnfrsf19 17307433 AK011232 2.040 
Tyms 17446627 AK011435 2.036 
Trpm2 17242335 AK034099 2.035 
Rel 17261107 AK031627 2.034 
Nubp1 17322829 BC031430 2.033 
Tap1 17336432 BC031584 2.033 
Slc7a11 17405082 AK037490 2.032 
Pnp2 17299559 AK008143 2.031 
115	  
	  
Neto2 17511377 BC068168 2.029 
Ankrd44 17223169 AK038343 2.028 
Uck2 17229391 AK051894 2.028 
Igh-VJ558 17284474 AK142609 2.023 
Dclre1b 17408684 AK046571 2.023 
Traf3ip3 17231203 AK031400 2.022 
Necap2 17432124 AK009714 2.020 
Gimap6 17466606 AK030902 2.020 
Slc46a3 17455386 AK004609 2.019 
Arpc4 17461638 AK017993 2.019 
Ifnlr1 17419880 AK141338 2.019 
Mapk14 17335364 AK089059 2.018 
Fxn 17363598 BC038010 2.015 
Clec2i 17463454 AK041724 2.012 
Fam105a 17316197 BC052328 2.010 
Galnt10 17249898 AK033515 2.010 
Serpina3f 17278268 AK138954 2.009 
Map4k2 17356811 AK011708 2.008 
Sgol2 17212970 AK049230 2.007 
Golm1 17293237 AK009072 2.007 
Tec 17448712 AK133418 2.007 
Palb2 17495932 BC055302 2.006 
Usp25 17326658 AK036456 2.006 
Ppp1r15a 17490878 AK079339 2.005 
Cd101 17408470 NM_001099332 2.005 
Ms4a1 17362922 AK017903 2.004 
Slc9a9 17520396 AK156494 2.004 
Fcna 17382737 AK133539 2.003 
Cd22 17489320 AK041230 2.003 
Kcna3 17401526 BC132349 2.001 
Ccne1 17489886 AK089950 2.000 
Popdc3 17233095 AK039691 -2.001 
Mir466g 17550130 NR_030569 -2.002 
Hapln1 17289009 AK003582 -2.003 
Pgm5 17363626 AK035507 -2.003 
Extl1 17431282 AK085075 -2.005 
Mir341 17278749 NR_029770 -2.005 
Nfatc2 17394806 AK081853 -2.006 
A830039N20Rik 17304010 XR_106836 -2.007 
Gm11547 17256429 ENSMUST00000137154 -2.007 
Tmem117 17314476 AK034024 -2.008 
Camk2a 17351001 AK083245 -2.012 
Ppp4r4 17278209 AK173221 -2.014 
Dmd 17536078 AK013510 -2.014 
Mir701 17440618 NR_030482 -2.018 
Chadl 17319494 AK139481 -2.018 
Cadm2 17331447 AK033973 -2.019 
Mss51 17303821 AK162338 -2.020 
116	  
	  
Gm12406 17412907 ENSMUST00000155382 -2.022 
Gm10808 17547949 AK084721 -2.024 
Ptgds 17382592 AK002382 -2.025 
Mir669m-2 17366924 NR_035475 -2.026 
Auts2 17453242 AK052418 -2.026 
Cilp2 17509879 NM_026818 -2.028 
Cdon 17515921 AK029199 -2.029 
Cacna2d1 17434890 AK014825 -2.029 
Ap2m1 17329149 AK080095 -2.029 
Col15a1 17413866 AK134030 -2.033 
Mir544 17278850 NR_030610 -2.034 
Syt8 17485200 AK075832 -2.035 
Itga10 17400650 NM_001081053 -2.036 
Rftn2 17223245 AK031158 -2.036 
Mir761 17416811 NR_030432 -2.037 
Pkd1 17334304 AK147429 -2.037 
Gli2 17226170 AK051858 -2.037 
Wif1 17237701 AK077698 -2.038 
Sdk2 17271632 AK031283 -2.040 
Gm4980 17493685 NM_001195529 -2.041 
Gdap10 17274889 BC052902 -2.041 
Pam 17225929 AK049423 -2.043 
Ift81 17452430 AK013424 -2.044 
Slc6a12 17462472 BC019211 -2.046 
Wnk4 17256632 AK008047 -2.047 
Gm4392 17410130 XM_001480045 -2.047 
Mall 17391339 AK078971 -2.049 
Mir329 17278818 NR_029762 -2.052 
Rora 17518911 XR_105287 -2.053 
Pcolce2 17520425 AK010249 -2.053 
Nova1 17280913 AK047565 -2.053 
Atp1b4 17534337 AK053500 -2.055 
Uggt2 17309482 NM_001081252 -2.057 
Pde4dip 17408211 AK028810 -2.061 
Pax1 17377328 AK134066 -2.062 
Maob 17540378 AK031833 -2.063 
Cd109 17519738 AK036799 -2.064 
Gjc3 17454209 AK034037 -2.070 
Tmtc1 17472955 AK046396 -2.070 
Car5b 17545936 AK046691 -2.071 
Kcnq5 17221686 AK033079 -2.076 
Vcan 17294738 AK014525 -2.077 
Pdk4 17464654 AK004543 -2.078 
Slc1a4 17260869 AK044280 -2.080 
Zfp9 17470187 AK007823 -2.080 
Mug2 17462566 M65238 -2.082 
Mir1933 17260931 NR_035454 -2.083 
Xirp1 17532264 AF051945 -2.084 
117	  
	  
Higd1a 17532403 AK004166 -2.086 
Tmem233 17451785 NM_001101546 -2.087 
Phka1 17543691 AK030426 -2.089 
Celsr2 17409284 AB028499 -2.091 
Tuft1 17407578 AK132488 -2.091 
Arhgap32 17515786 AK036860 -2.092 
Cobll1 17385879 AK037010 -2.095 
Stxbp1 17384021 AK004780 -2.097 
Myom1 17339395 AK041025 -2.097 
Nipal2 17316402 BC016107 -2.101 
Gm20382 17548482 XR_140752 -2.108 
Csgalnact2 17470105 BC060169 -2.109 
Gm15270 17239773 AK014660 -2.110 
Olfr382 17265781 NM_146443 -2.112 
Mir541 17278884 NR_030263 -2.115 
Efnb2 17507321 AK132512 -2.119 
Nov 17311519 AK039481 -2.123 
Mtmr11 17400486 AK132375 -2.126 
Scn1b 17489464 BC009652 -2.127 
Vit 17339824 AK013193 -2.130 
Rcan1 17332228 AK010696 -2.130 
Car8 17423121 AK004896 -2.135 
Loxl2 17301670 AK034957 -2.135 
Fibin 17389157 AK012026 -2.136 
Sod3 17437385 AK075570 -2.137 
BC030870 17509682 AK131860 -2.139 
Hoxc8 17315514 AK051173 -2.139 
Mir872 17415467 NR_030604 -2.144 
Fras1 17439388 AK043422 -2.144 
Fsd2 17492810 NM_172904 -2.146 
Scube1 17319887 AK041590 -2.147 
Clmn 17283725 AK077023 -2.148 
Zcchc5 17544073 BC064821 -2.148 
Zdhhc2 17500662 AK017566 -2.150 
Tacc2 17483842 AK050985 -2.150 
Gas1 17293313 BC058628 -2.153 
DQ267102 17278777 NR_046306 -2.155 
Baiap2l1 17454977 AK004918 -2.155 
Zbtb20 17325723 AK080813 -2.156 
Gm10554 17548040 AK136357 -2.157 
Gm6307 17380757 NR_045331 -2.157 
Muc19 17314373 BC108997 -2.157 
Klf12 17309099 AK021307 -2.161 
Sox9 17257946 AK030187 -2.163 
Ndrg2 17306147 AK076514 -2.164 
Gm19274 17548671 XR_140878 -2.165 
Frmd7 17541597 BC147257 -2.166 
Gprasp2 17537839 AK030638 -2.166 
118	  
	  
Micu3 17500644 AK086433 -2.167 
Slc38a3 17530967 BC021324 -2.170 
Cep170b 17279381 BC050077 -2.170 
Usp53 17409997 AK040332 -2.174 
Pde11a 17386725 AK042383 -2.177 
Sgca 17268107 AK009015 -2.178 
Pdgfrl 17500735 AK004179 -2.180 
Sertad4 17231163 AK047877 -2.181 
Pappa2 17228667 AK084006 -2.181 
Bmpr1b 17410729 AK086130 -2.189 
Glt8d2 17243493 AK086276 -2.193 
Gpr52 17228790 NM_001146330 -2.196 
Itih5l-ps 17538614 XM_003085300 -2.197 
Cryab 17517132 AK146556 -2.200 
Ppnr 17360532 X65588 -2.204 
4930403O15Rik 17239656 AK015069 -2.206 
Gm10664 17509676 NR_040692 -2.217 
Mn1 17440633 AK142207 -2.218 
Has2as 17311633 NR_002874 -2.222 
Abi3bp 17326318 AK043879 -2.223 
Lmod3 17469360 AK030676 -2.226 
Fitm1 17300544 AB054000 -2.227 
Htra1 17483912 AK090320 -2.228 
Eef1a2 17395766 BC018235 -2.230 
Cilp 17518512 AK036473 -2.231 
Nexn 17411201 AK135919 -2.232 
Mir668 17278856 NR_030424 -2.236 
Cables1 17352704 AK046777 -2.239 
Slc38a4 17320947 AK005887 -2.242 
Fbln1 17313811 AK035388 -2.246 
Sema3e 17434813 AK049580 -2.247 
Adm 17481770 AK144181 -2.247 
Rbp4 17364341 AK004839 -2.248 
Cyp3a13 17454193 AK136494 -2.253 
Cxcr7 17215605 AK031100 -2.256 
Col9a1 17211458 AK004383 -2.256 
2900092D14Rik 17212316 AK013838 -2.257 
Itga5 17322369 AK142241 -2.259 
2900055J20Rik 17350078 NR_045177 -2.261 
Rian 17278715 AK032566 -2.262 
Sbsn 17476528 BC029705 -2.266 
Hhipl2 17220464 AK019671 -2.273 
Dmkn 17476535 AY444557 -2.275 
9230110C19Rik 17523898 BC115525 -2.275 
R3hdml 17379260 NM_001099331 -2.275 
Gprc5a 17463747 BC036173 -2.280 
Pcsk2 17376993 AK039783 -2.282 
Pamr1 17373680 AK035434 -2.285 
119	  
	  
Hoxc6 17315519 AK050798 -2.290 
Kcnma1 17304012 AK135652 -2.291 
Stk38l 17464316 AK045971 -2.293 
Htr1f 17331431 AK045364 -2.293 
Mir382 17278852 NR_029883 -2.294 
Cdr1 17542034 NM_001166658 -2.295 
Mgat4a 17222332 AK052278 -2.296 
E330013P04Rik 17360863 AK163106 -2.299 
Osr1 17274021 AK004397 -2.300 
Ablim3 17354831 AK086538 -2.300 
Npy 17458514 AK002982 -2.302 
Mir365-1 17323040 NR_029855 -2.308 
Gm10400 17464061 AK084536 -2.316 
Mir337 17278692 NR_029765 -2.317 
Gm6642 17363923 BC096400 -2.326 
Scin 17280817 AK133484 -2.329 
Gm10561 17212900 XR_168381 -2.329 
Colgalt2 17218233 AK052838 -2.336 
Il16 17492905 AK038014 -2.345 
Kif21a 17320614 AK008213 -2.346 
Ppp1r3c 17364208 AK078506 -2.363 
Gabre 17542194 AK079258 -2.370 
Tmem45a 17331078 AK049837 -2.372 
Vnn1 17232162 AK002773 -2.380 
Chst1 17373521 AK011344 -2.381 
Mirlet7c-1 17326702 NR_029728 -2.383 
Gpr126 17239435 AB183545 -2.391 
Tppp3 17512434 AK003376 -2.392 
Slc1a1 17358466 AK018188 -2.392 
Cry2 17388389 AK041696 -2.394 
Nr4a2 17385374 AK087495 -2.399 
Mustn1 17298262 AK003945 -2.405 
1110002E22Rik 17403039 AK003290 -2.409 
Yipf7 17448535 AK009405 -2.414 
Igfbp6 17315305 AK157982 -2.415 
Plod2 17520364 AK033363 -2.419 
Map3k19 17226489 NM_011737 -2.432 
Rian 17278775 AB076245 -2.436 
Ppnr 17548110 X65588 -2.437 
Mir140 17505309 NR_029553 -2.445 
Prkg1 17363903 AK040353 -2.448 
Ston1 17340356 AK014958 -2.449 
Hs3st1 17447726 AK087753 -2.453 
Mir667 17278832 NR_030426 -2.460 
Sema3c 17434973 AK034239 -2.462 
Gfpt2 17249036 AK053670 -2.477 
Meox2 17275062 AK028352 -2.477 
Smpx 17539110 AK003105 -2.490 
120	  
	  
Nr4a3 17413945 AF191211 -2.494 
Lgr6 17227198 AK052873 -2.502 
Necab1 17423444 AK039240 -2.503 
Mir376b 17278838 NR_029915 -2.503 
Trpm3 17358165 AK044454 -2.504 
Apod 17329759 AK135046 -2.512 
Mirg 17278860 AK013406 -2.512 
P4ha2 17249611 AK053504 -2.515 
Mia 17488151 BC009815 -2.515 
Arhgap20 17517222 AK035563 -2.517 
Mir107 17364163 NR_029783 -2.526 
Rian 17278769 AK032566 -2.527 
Mir99a 17326700 NR_029535 -2.527 
Matn3 17273973 AK048456 -2.536 
Tpm2 17424656 AK003186 -2.543 
Boc 17330577 AK028770 -2.544 
Ppp2r3a 17530159 AK035077 -2.546 
Bnip3 17497421 AK014223 -2.547 
Klf4 17425401 AK141244 -2.548 
Ednra 17510685 AK017486 -2.562 
Lrrc2 17522536 AK010252 -2.562 
Hspb8 17451816 BC003971 -2.564 
Serpina1d 17283617 AK002537 -2.565 
Ppil6 17232881 BC147756 -2.568 
Cryab 17548750 AK146556 -2.577 
Ak4 17415932 AK134600 -2.588 
Tnnc2 17394267 AK133548 -2.621 
Nrk 17538018 AK041377 -2.632 
Ntn4 17236604 AF268066 -2.633 
Gm19845 17547813 XR_141230 -2.636 
Mkx 17352517 AK034675 -2.638 
Rian 17550446 EU434919 -2.644 
Mirg 17550418 EU616813 -2.654 
Ano5 17478435 AB125740 -2.656 
Sdr39u1 17423030 AK047709 -2.657 
Uaca 17518109 AK012454 -2.663 
Sobp 17240586 AK160837 -2.668 
Omd 17287170 AK050297 -2.668 
Sgcg 17307446 AK132610 -2.669 
Has2 17317167 AK045020 -2.671 
Flnc 17456627 AK004264 -2.674 
Hectd2 17358905 AK035511 -2.681 
Pank1 17364150 AK017345 -2.718 
Panx3 17525673 AK014690 -2.723 
Mir32 17425521 NR_029789 -2.733 
Htra4 17508325 AK046614 -2.738 
Dapl1 17371011 AK009567 -2.746 
Tbx15 17400901 AK132578 -2.748 
121	  
	  
Tmem182 17212301 BC147440 -2.748 
Lrig3 17237811 AK018522 -2.751 
Bves 17233104 AK046765 -2.759 
Scn4a 17270848 NM_133199 -2.775 
Prkd1 17280934 NM_008858 -2.778 
Hif1a 17549380 AK034087 -2.781 
Serpina1c 17283634 BC009818 -2.785 
Capn6 17545106 AK145116 -2.794 
1700086D15Rik 17264153 AK007013 -2.794 
Bcat1 17472678 AK012821 -2.811 
Bmp6 17286682 AK014797 -2.812 
Ppp1r3a 17464943 AK084518 -2.828 
Slurp1 17318002 AK003904 -2.830 
Sfrp5 17364820 AF117759 -2.850 
Efemp1 17247948 AK077302 -2.856 
Mypn 17241553 AK036458 -2.859 
AF357426 17278765 NR_046303 -2.868 
Asb5 17501170 AK003770 -2.869 
Prkg2 17449964 AK038739 -2.883 
Map3k7cl 17326887 AY033899 -2.887 
Asb12 17543315 AK009644 -2.887 
Txlnb 17231789 AK052324 -2.911 
C230004F18Rik 17535130 AK163488 -2.921 
9330159F19Rik 17232417 AK034141 -2.932 
8430431K14Rik 17363925 BC020133 -2.942 
Creb5 17458682 AK051306 -2.948 
Mir493 17278690 NR_030573 -2.958 
Mirg 17278882 AK077315 -2.967 
Pkia 17396003 AK031123 -2.971 
n-R5s8 17535296 ENSMUST00000104121 -2.986 
Myom2 17499485 AK142174 -2.990 
Mylk2 17377816 AK079396 -3.001 
Rian 17278759 AK034848 -3.012 
4933407I18Rik 17548721 XR_108093 -3.015 
Tmod4 17400231 AK144408 -3.016 
Ecm2 17287148 BC038144 -3.030 
Hspb7 17421074 AK030025 -3.039 
Mir300 17278842 NR_029651 -3.048 
Cmya5 17294959 AK010194 -3.062 
3632451O06Rik 17305910 AK014563 -3.081 
Il17b 17351137 AK003506 -3.088 
Cox6a2 17496857 AK002506 -3.120 
Klhl41 17371451 AK132622 -3.123 
Gpr64 17539271 AK041291 -3.130 
Csrp3 17491368 AK003120 -3.138 
Gm17225 17410124 ENSMUST00000172051 -3.165 
Fry 17445160 AK085859 -3.166 
Ldb3 17305070 AK004020 -3.174 
122	  
	  
Abra 17316775 AK081696 -3.190 
Hhip 17510772 AK031539 -3.215 
Mirg 17278858 EU434920 -3.253 
Gm15562 17299313 ENSMUST00000161397 -3.301 
Mir3095 17425701 NR_037278 -3.302 
Mir453 17278876 NR_030559 -3.326 
Lmod2 17456428 AK147141 -3.439 
Srl 17327737 AK036394 -3.453 
Tmem38a 17502462 AB261158 -3.464 
Rian 17278761 AK034848 -3.513 
Rtn2 17474547 AK144271 -3.529 
Hspa1b 17344126 AK159139 -3.531 
Mb 17318741 AK137456 -3.562 
Hspa1a 17344132 AK132331 -3.643 
Pdlim3 17500922 AK016447 -3.689 
Tnni2 17485215 BC028515 -3.762 
Mylk4 17291674 NM_001166030 -3.823 
Gm13659 17372133 ENSMUST00000145460 -3.867 
Myl1 17223916 AK003182 -3.955 
Des 17214476 AK131922 -4.022 
Klhl31 17519573 AK053085 -4.077 
Apobec2 17345797 AK009047 -4.138 
Asb15 17456414 AK019556 -4.193 
Ampd1 17401126 AK132524 -4.215 
Hfe2 17400592 BC022603 -4.435 
Ryr1 17488608 AK042482 -4.448 
Mybpc1 17243910 AK078761 -5.052 
Xirp2 17371296 AK040786 -5.166 
Myh2 17251001 BC008538 -5.253 
Tnnt3 17485246 AK003147 -5.574 
Trdn 17232453 AK036470 -5.689 
Neb 17385099 AK086142 -5.799 
Ttn 17386778 AK003152 -5.962 
Casq1 17229851 AK049865 -7.310 
Myh4 17251091 AK138608 -8.680 
Myot 17350267 AK017447 -8.903 
 
 
123	  
	  
 
APPENDIX B 
PERMISSION TO REUSE COPYRIGHTED 
MATERIAL FROM SPRINGER FOR CHAPTER 1 
124	  
	  
 
SPRINGER LICENSE TERMS AND CONDITIONS 
Jun 23, 2015 
 
This is a License Agreement between Neil A Tenn ("You") and Springer ("Springer") provided by Copyright 
Clearance Center ("CCC"). The license consists of your order details, the terms and conditions provided by 
Springer, and the payment terms and conditions. 
All payments must be made in full to CCC. For payment instructions, please see information listed at 
the bottom of this form. 
License Number 3654860719520   
License date Jun 23, 2015   
Licensed content publisher Springer   
Licensed content publication Pflügers Archiv European Journal of Physiology   
Licensed content title The equilibrative nucleoside transporter family, SLC29   
Licensed content author Stephen A. Baldwin   
Licensed content date Jan 1, 2004   
Volume number 447 
Issue number 5 
Type of Use Thesis/Dissertation   
Portion Figures 
Author of this Springer article No 
Order reference number None 
Original figure numbers Fig. 2 
Title of your thesis / dissertation Investigating the mechanism underlying ectopic mineralization in a mouse 
model of diffuse idiopathic skeletal hyperostosis (DISH) 
Expected completion date Jul 2015 
Estimated size (pages) 100 
 
125	  
	  
Curriculum Vitae 
Neil Alexander Tenn 
 
 
Education: 
MSc in Physiology and Pharmacology          September 2013 -  
Supervisors:    Dr. Cheryle Séguin 
Co-Supervisor:  Dr. Jeffrey Dixon 
Thesis Topic: Investigating the mechanisms underlying ectopic mineralization in a mouse 
model of diffuse idiopathic skeletal hyperostosis (DISH) 
 
Bachelor of Medical Sciences, Honors               September 2009- June 2013 
Western University, Department of Physiology and Pharmacology 
Honors Specialization in Physiology and Pharmacology 
Minor in Medical Sciences  
Supervisor: Dr. Gerald Kidder 
Thesis Topic: Meiosis arrest female 1 (Marf1) expression levels in oocyte-like cells (OLC) 
and wild type (WT) oocytes 
 
 
Teaching Experience: 
 
Supervisory Experience (Séguin Lab) 
Western University, London, ON 
Summer Undergraduate 
2015 
 
Teaching Assistant 
Human Physiology Laboratory (3rd year course) 
Western University, London, ON 
2014-2015 
 
Supervisory Experience (Séguin Lab) 
Western University, London, ON 
Summer Undergraduate 
2014 
 
Teaching Assistant 
Human Physiology Laboratory (3rd year course) 
Western University, London, ON 
2013-2014 
 
 
Honours and Awards: 
21st Canadian Connective Tissue Conference 
Best Poster Presentation Award ($300) 
Université Laval, Quebec City, Quebec 
2015 
 
126	  
	  
Joint Motion Program (JuMP) ($13,500/year) 
CIHR Graduate Fellow in Musculoskeletal Health Research 
Western University, London, ON 
2013-2015 
 
CIHR - Undergraduate: Mobility, musculoskeletal health and arthritis ($4,950) 
Western University, London, ON 
2013 
 
Western Graduate Research Scholarship ($4,500/year) 
Western University, London, ON 
 
Western Scholarship of Distinction ($1,500) 
Western University, London, ON 
2009 
 
Dean’s List 
Western University, London, ON 
2010-2013 
 
 
Papers:  
1. Ii H., Warraich S., Tenn N. A., Quinonez D., Holdsworth D., Hammond J., Dixon S. J., 
Séguin C. A., (In Preparation) Investigating the expression of genes that regulate 
mineralization in a mouse model of diffuse idiopathic skeletal hyperostosis. 
 
Presentations: 
1. Tenn N. A., Quinonez D., Hammond J. R., Dixon S. J., Séguin C. A. (May 2015) 
Investigating the link between adenosine transport and ectopic mineralization of spinal 
tissues. Canadian Connective Tissue Conference. Quebec City, Quebec Poster Presentation 
 
2. Tenn N. A., Quinonez D., Hammond J. R., Dixon S. J., Séguin C. A. (April 2015) 
Investigating the link between adenosine transport and ectopic mineralization of spinal 
tissues. London Health Research Day, London, Ontario. Poster Presentation 
 
3. Tenn N. A., Ii H., Warraich S., Quinonez D., Chidiac P., Hammond J. R., Dixon S. J., Séguin 
C. A. (November 2014) Adenosine signaling in cells of the intervertebral disc – Possible role 
in ectopic mineralization in mice lacking equilibrative nucleoside transporter 1. Schulich 
Dental Research Day, London, Ontario. Poster Presentation 
 
4. Ii H., Warraich S., Tenn N. A., Quinonez D., Holdsworth D. W., Hammond J. R., Séguin C. 
A., Dixon S. J. (September 2014) Mechanism underlying ectopic mineralization in a mouse 
model of diffuse idiopathic skeletal hyperostosis. ASBMR, Houston, Texas. 
 
5. Tenn N. A., Ii H., Warraich S., Quinonez D., Chidiac P., Hammond J. R., Dixon S. J., Séguin 
C. A. (June 2014) Adenosine signaling in cells of the intervertebral disc – Possible role in 
ectopic mineralization in mice lacking equilibrative nucleoside transporter 1. Canadian 
Connective Tissue Conference, London, Ontario. Poster Presentation 
 
6. Ii H., Warraich S., Tenn N. A., Quinonez D., Hammond J. R., Dixon S. J., Séguin C. A. 
(January 2014). Ectopic mineralization of spinal tissues in mice lacking equlibrative 
nucleoside transporter 1: Age-dependent alterations in the expression of genes regulating 
127	  
	  
biomineralization. Bone and Joint Injury & Repair Conference, London, Ontario. Poster 
Presentation 
 
7. Tenn N. A., Dyce P. W., Barr K. J., Kidder G. M. (April 2013) Retinoic Acid enhances the 
expression of Meiosis Arrest Female – 1 (Marf1) and the meiotic competence of Skin-
Derived Oocyte Like Cells. Southern Ontario Reproductive Biology Conference, Toronto, 
Ontario. Poster Presentation 
 
8. Tenn N. A., Dyce P. W., Barr K. J., Kidder G. M. (April 2013) Meiosis Arrest Female – 1 
(Marf1) expression in Oocyte Like Cells (OLCs) and Natural Oocytes. Western University 
Physiology and Pharmacology Poster Day, London, Ontario. Poster Presentation 
 
